[{"arc":[[52.421459197998,-1.43792998790741],[25.8990993499756,45.3538589477539]],"countries":["United Kingdom","Saudi Arabia"],"title":"Frequency and clinical relevance of human bocavirus infection in acute exacerbations of chronic obstructive pulmonary disease"},{"arc":[[38.0169372558594,-87.5912551879883],[40.9437103271484,40.2619209289551]],"countries":["Turkey","United States"],"title":"Whole-genome Sequencing for Tracing the Transmission Link between Two ARD Outbreaks Caused by a Novel HAdV Serotype 7 Variant, China OPEN"},{"arc":[[39.4827499389648,-76.1320495605469],[39.3291282653809,-76.6179275512695]],"countries":["United States"],"title":"Genomic Signatures of Strain Selection and Enhancement in Bacillus atrophaeus var. globigii, a Historical Biowarfare Simulant"},{"arc":[[39.4827499389648,-76.1320495605469],[35.8810081481934,-106.305221557617]],"countries":["United States"],"title":"Genomic Signatures of Strain Selection and Enhancement in Bacillus atrophaeus var. globigii, a Historical Biowarfare Simulant"},{"arc":[[39.4827499389648,-76.1320495605469],[54.9739990234375,-1.66799998283386]],"countries":["United States","United Kingdom"],"title":"Genomic Signatures of Strain Selection and Enhancement in Bacillus atrophaeus var. globigii, a Historical Biowarfare Simulant"},{"arc":[[39.4827499389648,-76.1320495605469],[44.6417846679688,-89.7367401123047]],"countries":["United States"],"title":"Genomic Signatures of Strain Selection and Enhancement in Bacillus atrophaeus var. globigii, a Historical Biowarfare Simulant"},{"arc":[[39.3291282653809,-76.6179275512695],[35.8810081481934,-106.305221557617]],"countries":["United States"],"title":"Genomic Signatures of Strain Selection and Enhancement in Bacillus atrophaeus var. globigii, a Historical Biowarfare Simulant"},{"arc":[[39.3291282653809,-76.6179275512695],[54.9739990234375,-1.66799998283386]],"countries":["United States","United Kingdom"],"title":"Genomic Signatures of Strain Selection and Enhancement in Bacillus atrophaeus var. globigii, a Historical Biowarfare Simulant"},{"arc":[[39.3291282653809,-76.6179275512695],[44.6417846679688,-89.7367401123047]],"countries":["United States"],"title":"Genomic Signatures of Strain Selection and Enhancement in Bacillus atrophaeus var. globigii, a Historical Biowarfare Simulant"},{"arc":[[35.8810081481934,-106.305221557617],[54.9739990234375,-1.66799998283386]],"countries":["United States","United Kingdom"],"title":"Genomic Signatures of Strain Selection and Enhancement in Bacillus atrophaeus var. globigii, a Historical Biowarfare Simulant"},{"arc":[[35.8810081481934,-106.305221557617],[44.6417846679688,-89.7367401123047]],"countries":["United States"],"title":"Genomic Signatures of Strain Selection and Enhancement in Bacillus atrophaeus var. globigii, a Historical Biowarfare Simulant"},{"arc":[[54.9739990234375,-1.66799998283386],[44.6417846679688,-89.7367401123047]],"countries":["United Kingdom","United States"],"title":"Genomic Signatures of Strain Selection and Enhancement in Bacillus atrophaeus var. globigii, a Historical Biowarfare Simulant"},{"arc":[[40.5150184631348,20.8693809509277],[34.7472496032715,113.624931335449]],"countries":["Albania","China"],"title":"Nonstructural Protein 5A Is Incorporated into Hepatitis C Virus Low-Density Particle through Interaction with Core Protein and Microtubules during Intracellular Transport"},{"arc":[[40.5150184631348,20.8693809509277],[35.7130813598633,139.445846557617]],"countries":["Albania","Japan"],"title":"Nonstructural Protein 5A Is Incorporated into Hepatitis C Virus Low-Density Particle through Interaction with Core Protein and Microtubules during Intracellular Transport"},{"arc":[[34.7472496032715,113.624931335449],[35.7130813598633,139.445846557617]],"countries":["China","Japan"],"title":"Nonstructural Protein 5A Is Incorporated into Hepatitis C Virus Low-Density Particle through Interaction with Core Protein and Microtubules during Intracellular Transport"},{"arc":[[40.5150184631348,20.8693809509277],[63.513111114502,10.0196399688721]],"countries":["Albania","Norway"],"title":"Supporting Information Crowning Proteins: Modulating the Protein Surface Properties using Crown Ethers**"},{"arc":[[40.9437103271484,40.2619209289551],[43.8378410339355,126.549438476562]],"countries":["Turkey","China"],"title":"Identification of NCAM that interacts with the PHE-CoV spike protein"},{"arc":[[40.9437103271484,40.2619209289551],[23.1290798187256,113.264358520508]],"countries":["Turkey","China"],"title":"Epidemiology and clinical characteristics of human coronaviruses OC43, 229E, NL63, and HKU1: a study of hospitalized children with acute respiratory tract infection in Guangzhou, China"},{"arc":[[40.9437103271484,40.2619209289551],[31.2988891601562,121.499168395996]],"countries":["Turkey","China"],"title":"The potential of the human immune system to develop broadly neutralizing HIV-1 antibodies: implications for vaccine development"},{"arc":[[40.9437103271484,40.2619209289551],[22.2802925109863,114.142951965332]],"countries":["Turkey","Hong Kong SAR"],"title":"The potential of the human immune system to develop broadly neutralizing HIV-1 antibodies: implications for vaccine development"},{"arc":[[31.2988891601562,121.499168395996],[22.2802925109863,114.142951965332]],"countries":["China","Hong Kong SAR"],"title":"The potential of the human immune system to develop broadly neutralizing HIV-1 antibodies: implications for vaccine development"},{"arc":[[52.1751708984375,0.140450000762939],[52.598876953125,-1.46688103675842]],"countries":["United Kingdom"],"title":"Survival of Influenza A(H1N1) on Materials Found in Households: Implications for Infection Control"},{"arc":[[52.1751708984375,0.140450000762939],[52.2025413513184,0.119549997150898]],"countries":["United Kingdom"],"title":"Survival of Influenza A(H1N1) on Materials Found in Households: Implications for Infection Control"},{"arc":[[52.1751708984375,0.140450000762939],[52.9340705871582,-1.20404005050659]],"countries":["United Kingdom"],"title":"Survival of Influenza A(H1N1) on Materials Found in Households: Implications for Infection Control"},{"arc":[[52.598876953125,-1.46688103675842],[52.2025413513184,0.119549997150898]],"countries":["United Kingdom"],"title":"Survival of Influenza A(H1N1) on Materials Found in Households: Implications for Infection Control"},{"arc":[[52.598876953125,-1.46688103675842],[52.9340705871582,-1.20404005050659]],"countries":["United Kingdom"],"title":"Survival of Influenza A(H1N1) on Materials Found in Households: Implications for Infection Control"},{"arc":[[52.2025413513184,0.119549997150898],[52.9340705871582,-1.20404005050659]],"countries":["United Kingdom"],"title":"Survival of Influenza A(H1N1) on Materials Found in Households: Implications for Infection Control"},{"arc":[[36.6518402099609,117.120086669922],[36.4687042236328,118.517120361328]],"countries":["China"],"title":"Clinical Study Viral Aetiology in Adults with Acute Upper Respiratory Tract Infection in Jinan, Northern China"},{"arc":[[36.6518402099609,117.120086669922],[30.5363693237305,114.365432739258]],"countries":["China"],"title":"Clinical Study Viral Aetiology in Adults with Acute Upper Respiratory Tract Infection in Jinan, Northern China"},{"arc":[[36.4687042236328,118.517120361328],[30.5363693237305,114.365432739258]],"countries":["China"],"title":"Clinical Study Viral Aetiology in Adults with Acute Upper Respiratory Tract Infection in Jinan, Northern China"},{"arc":[[11.0134401321411,76.9366226196289],[30.5701999664307,104.064758300781]],"countries":["India","China"],"title":"Loop-Mediated Isothermal Amplification (LAMP): Emergence As an Alternative Technology for Herbal Medicine Identification"},{"arc":[[11.0134401321411,76.9366226196289],[30.973201751709,112.276123046875]],"countries":["China","India"],"title":"Loop-Mediated Isothermal Amplification (LAMP): Emergence As an Alternative Technology for Herbal Medicine Identification"},{"arc":[[11.0134401321411,76.9366226196289],[22.6545104980469,110.180976867676]],"countries":["India","China"],"title":"Loop-Mediated Isothermal Amplification (LAMP): Emergence As an Alternative Technology for Herbal Medicine Identification"},{"arc":[[30.5701999664307,104.064758300781],[30.973201751709,112.276123046875]],"countries":["China"],"title":"Loop-Mediated Isothermal Amplification (LAMP): Emergence As an Alternative Technology for Herbal Medicine Identification"},{"arc":[[30.5701999664307,104.064758300781],[22.6545104980469,110.180976867676]],"countries":["China"],"title":"Loop-Mediated Isothermal Amplification (LAMP): Emergence As an Alternative Technology for Herbal Medicine Identification"},{"arc":[[30.973201751709,112.276123046875],[22.6545104980469,110.180976867676]],"countries":["China"],"title":"Loop-Mediated Isothermal Amplification (LAMP): Emergence As an Alternative Technology for Herbal Medicine Identification"},{"arc":[[43.305290222168,5.38076019287109],[48.5444183349609,12.1591682434082]],"countries":["France","Germany"],"title":"The methyltransferase domain of the Sudan ebolavirus L protein specifically targets internal adenosines of RNA substrates, in addition to the cap structure"},{"arc":[[43.305290222168,5.38076019287109],[51.9582099914551,66.4045791625977]],"countries":["France","Kazakhstan"],"title":"The methyltransferase domain of the Sudan ebolavirus L protein specifically targets internal adenosines of RNA substrates, in addition to the cap structure"},{"arc":[[43.305290222168,5.38076019287109],[43.6319427490234,3.86388897895813]],"countries":["France"],"title":"The methyltransferase domain of the Sudan ebolavirus L protein specifically targets internal adenosines of RNA substrates, in addition to the cap structure"},{"arc":[[43.305290222168,5.38076019287109],[48.7505416870117,30.2246208190918]],"countries":["France","Ukraine"],"title":"The methyltransferase domain of the Sudan ebolavirus L protein specifically targets internal adenosines of RNA substrates, in addition to the cap structure"},{"arc":[[48.5444183349609,12.1591682434082],[51.9582099914551,66.4045791625977]],"countries":["Germany","Kazakhstan"],"title":"The methyltransferase domain of the Sudan ebolavirus L protein specifically targets internal adenosines of RNA substrates, in addition to the cap structure"},{"arc":[[48.5444183349609,12.1591682434082],[43.6319427490234,3.86388897895813]],"countries":["Germany","France"],"title":"The methyltransferase domain of the Sudan ebolavirus L protein specifically targets internal adenosines of RNA substrates, in addition to the cap structure"},{"arc":[[48.5444183349609,12.1591682434082],[48.7505416870117,30.2246208190918]],"countries":["Ukraine","Germany"],"title":"The methyltransferase domain of the Sudan ebolavirus L protein specifically targets internal adenosines of RNA substrates, in addition to the cap structure"},{"arc":[[51.9582099914551,66.4045791625977],[43.6319427490234,3.86388897895813]],"countries":["Kazakhstan","France"],"title":"The methyltransferase domain of the Sudan ebolavirus L protein specifically targets internal adenosines of RNA substrates, in addition to the cap structure"},{"arc":[[51.9582099914551,66.4045791625977],[48.7505416870117,30.2246208190918]],"countries":["Ukraine","Kazakhstan"],"title":"The methyltransferase domain of the Sudan ebolavirus L protein specifically targets internal adenosines of RNA substrates, in addition to the cap structure"},{"arc":[[43.6319427490234,3.86388897895813],[48.7505416870117,30.2246208190918]],"countries":["Ukraine","France"],"title":"The methyltransferase domain of the Sudan ebolavirus L protein specifically targets internal adenosines of RNA substrates, in addition to the cap structure"},{"arc":[[49.0121917724609,0.703100025653839],[40.9437103271484,40.2619209289551]],"countries":["Turkey","France"],"title":"EPIDEMIOLOGIC INVESTIGATION Epidemiological investigation of the 119th confirmed Middle East Respiratory Syndrome coronavirus case with an indefinite mode of transmission during the Pyeongtaek outbreak in Korea"},{"arc":[[49.0121917724609,0.703100025653839],[14.477560043335,120.89826965332]],"countries":["France","Philippines"],"title":"EPIDEMIOLOGIC INVESTIGATION Epidemiological investigation of the 119th confirmed Middle East Respiratory Syndrome coronavirus case with an indefinite mode of transmission during the Pyeongtaek outbreak in Korea"},{"arc":[[40.9437103271484,40.2619209289551],[14.477560043335,120.89826965332]],"countries":["Turkey","Philippines"],"title":"EPIDEMIOLOGIC INVESTIGATION Epidemiological investigation of the 119th confirmed Middle East Respiratory Syndrome coronavirus case with an indefinite mode of transmission during the Pyeongtaek outbreak in Korea"},{"arc":[[40.9437103271484,40.2619209289551],[40.9437103271484,40.2619209289551]],"countries":["Turkey"],"title":"EPIDEMIOLOGIC INVESTIGATION Epidemiological investigation of the 119th confirmed Middle East Respiratory Syndrome coronavirus case with an indefinite mode of transmission during the Pyeongtaek outbreak in Korea"},{"arc":[[14.477560043335,120.89826965332],[40.9437103271484,40.2619209289551]],"countries":["Turkey","Philippines"],"title":"EPIDEMIOLOGIC INVESTIGATION Epidemiological investigation of the 119th confirmed Middle East Respiratory Syndrome coronavirus case with an indefinite mode of transmission during the Pyeongtaek outbreak in Korea"},{"arc":[[40.8510894775391,-73.8444290161133],[40.9437103271484,40.2619209289551]],"countries":["Turkey","United States"],"title":"Citation: Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry"},{"arc":[[40.8510894775391,-73.8444290161133],[43.383487701416,142.571090698242]],"countries":["United States","Japan"],"title":"Citation: Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry"},{"arc":[[40.8510894775391,-73.8444290161133],[39.0048141479492,-77.0975341796875]],"countries":["United States"],"title":"Citation: Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry"},{"arc":[[40.8510894775391,-73.8444290161133],[42.8098297119141,-88.3805541992188]],"countries":["United States"],"title":"Citation: Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry"},{"arc":[[40.8510894775391,-73.8444290161133],[37.8056831359863,-122.268104553223]],"countries":["United States"],"title":"Citation: Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry"},{"arc":[[40.8510894775391,-73.8444290161133],[30.2787208557129,-97.7324523925781]],"countries":["United States"],"title":"Citation: Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry"},{"arc":[[40.8510894775391,-73.8444290161133],[43.0670013427734,-89.4000015258789]],"countries":["United States"],"title":"Citation: Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry"},{"arc":[[40.9437103271484,40.2619209289551],[40.9437103271484,40.2619209289551]],"countries":["Turkey"],"title":"Citation: Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry"},{"arc":[[40.9437103271484,40.2619209289551],[43.383487701416,142.571090698242]],"countries":["Turkey","Japan"],"title":"Citation: Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry"},{"arc":[[40.9437103271484,40.2619209289551],[39.0048141479492,-77.0975341796875]],"countries":["Turkey","United States"],"title":"Citation: Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry"},{"arc":[[40.9437103271484,40.2619209289551],[42.8098297119141,-88.3805541992188]],"countries":["Turkey","United States"],"title":"Citation: Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry"},{"arc":[[40.9437103271484,40.2619209289551],[37.8056831359863,-122.268104553223]],"countries":["Turkey","United States"],"title":"Citation: Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry"},{"arc":[[40.9437103271484,40.2619209289551],[30.2787208557129,-97.7324523925781]],"countries":["Turkey","United States"],"title":"Citation: Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry"},{"arc":[[40.9437103271484,40.2619209289551],[43.0670013427734,-89.4000015258789]],"countries":["Turkey","United States"],"title":"Citation: Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry"},{"arc":[[43.383487701416,142.571090698242],[39.0048141479492,-77.0975341796875]],"countries":["Japan","United States"],"title":"Citation: Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry"},{"arc":[[43.383487701416,142.571090698242],[42.8098297119141,-88.3805541992188]],"countries":["Japan","United States"],"title":"Citation: Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry"},{"arc":[[43.383487701416,142.571090698242],[37.8056831359863,-122.268104553223]],"countries":["Japan","United States"],"title":"Citation: Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry"},{"arc":[[43.383487701416,142.571090698242],[30.2787208557129,-97.7324523925781]],"countries":["Japan","United States"],"title":"Citation: Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry"},{"arc":[[43.383487701416,142.571090698242],[43.0670013427734,-89.4000015258789]],"countries":["Japan","United States"],"title":"Citation: Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry"},{"arc":[[39.0048141479492,-77.0975341796875],[42.8098297119141,-88.3805541992188]],"countries":["United States"],"title":"Citation: Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry"},{"arc":[[39.0048141479492,-77.0975341796875],[37.8056831359863,-122.268104553223]],"countries":["United States"],"title":"Citation: Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry"},{"arc":[[39.0048141479492,-77.0975341796875],[30.2787208557129,-97.7324523925781]],"countries":["United States"],"title":"Citation: Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry"},{"arc":[[39.0048141479492,-77.0975341796875],[43.0670013427734,-89.4000015258789]],"countries":["United States"],"title":"Citation: Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry"},{"arc":[[42.8098297119141,-88.3805541992188],[37.8056831359863,-122.268104553223]],"countries":["United States"],"title":"Citation: Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry"},{"arc":[[42.8098297119141,-88.3805541992188],[30.2787208557129,-97.7324523925781]],"countries":["United States"],"title":"Citation: Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry"},{"arc":[[42.8098297119141,-88.3805541992188],[43.0670013427734,-89.4000015258789]],"countries":["United States"],"title":"Citation: Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry"},{"arc":[[37.8056831359863,-122.268104553223],[30.2787208557129,-97.7324523925781]],"countries":["United States"],"title":"Citation: Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry"},{"arc":[[37.8056831359863,-122.268104553223],[43.0670013427734,-89.4000015258789]],"countries":["United States"],"title":"Citation: Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry"},{"arc":[[30.2787208557129,-97.7324523925781],[43.0670013427734,-89.4000015258789]],"countries":["United States"],"title":"Citation: Human, Nonhuman Primate, and Bat Cells Are Broadly Susceptible to Tibrovirus Particle Cell Entry"},{"arc":[[40.9437103271484,40.2619209289551],[37.9761390686035,23.736400604248]],"countries":["Turkey","Greece"],"title":"Surveillance of Community Outbreaks of Respiratory Tract Infections Based on House-Call Visits in the Metropolitan Area of Athens, Greece"},{"arc":[[40.9437103271484,40.2619209289551],[30.1303195953369,-81.7378082275391]],"countries":["Turkey","United States"],"title":"Surveillance of Community Outbreaks of Respiratory Tract Infections Based on House-Call Visits in the Metropolitan Area of Athens, Greece"},{"arc":[[37.9761390686035,23.736400604248],[30.1303195953369,-81.7378082275391]],"countries":["Greece","United States"],"title":"Surveillance of Community Outbreaks of Respiratory Tract Infections Based on House-Call Visits in the Metropolitan Area of Athens, Greece"},{"arc":[[40.7840995788574,-84.1892776489258],[42.3354797363281,-71.1043930053711]],"countries":["United States"],"title":"Journal of Translational Medicine Transfusion-transmitted infections"},{"arc":[[40.7840995788574,-84.1892776489258],[30.5934391021729,31.2882404327393]],"countries":["United States","Egypt"],"title":"Journal of Translational Medicine Transfusion-transmitted infections"},{"arc":[[42.3354797363281,-71.1043930053711],[30.5934391021729,31.2882404327393]],"countries":["United States","Egypt"],"title":"Journal of Translational Medicine Transfusion-transmitted infections"},{"arc":[[51.7589988708496,-1.26400005817413],[22.5428600311279,114.059562683105]],"countries":["United Kingdom","China"],"title":"Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome"},{"arc":[[51.7589988708496,-1.26400005817413],[17.51869,78.39728]],"countries":["United Kingdom","India"],"title":"Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome"},{"arc":[[51.7589988708496,-1.26400005817413],[29.649730682373,-82.3411331176758]],"countries":["United Kingdom","United States"],"title":"Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome"},{"arc":[[51.7589988708496,-1.26400005817413],[44.9734497070312,-93.2378997802734]],"countries":["United Kingdom","United States"],"title":"Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome"},{"arc":[[51.7589988708496,-1.26400005817413],[40.9437103271484,40.2619209289551]],"countries":["Turkey","United Kingdom"],"title":"Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome"},{"arc":[[22.5428600311279,114.059562683105],[17.51869,78.39728]],"countries":["China","India"],"title":"Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome"},{"arc":[[22.5428600311279,114.059562683105],[22.5428600311279,114.059562683105]],"countries":["China"],"title":"Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome"},{"arc":[[22.5428600311279,114.059562683105],[29.649730682373,-82.3411331176758]],"countries":["China","United States"],"title":"Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome"},{"arc":[[22.5428600311279,114.059562683105],[44.9734497070312,-93.2378997802734]],"countries":["China","United States"],"title":"Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome"},{"arc":[[22.5428600311279,114.059562683105],[40.9437103271484,40.2619209289551]],"countries":["Turkey","China"],"title":"Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome"},{"arc":[[17.51869,78.39728],[22.5428600311279,114.059562683105]],"countries":["China","India"],"title":"Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome"},{"arc":[[17.51869,78.39728],[29.649730682373,-82.3411331176758]],"countries":["India","United States"],"title":"Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome"},{"arc":[[17.51869,78.39728],[44.9734497070312,-93.2378997802734]],"countries":["India","United States"],"title":"Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome"},{"arc":[[17.51869,78.39728],[40.9437103271484,40.2619209289551]],"countries":["Turkey","India"],"title":"Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome"},{"arc":[[29.649730682373,-82.3411331176758],[44.9734497070312,-93.2378997802734]],"countries":["United States"],"title":"Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome"},{"arc":[[29.649730682373,-82.3411331176758],[40.9437103271484,40.2619209289551]],"countries":["Turkey","United States"],"title":"Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome"},{"arc":[[44.9734497070312,-93.2378997802734],[40.9437103271484,40.2619209289551]],"countries":["Turkey","United States"],"title":"Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome"},{"arc":[[31.823558807373,117.231567382812],[40.9437103271484,40.2619209289551]],"countries":["Turkey","China"],"title":"Genome-wide data inferring the evolution and population 1 demography of the novel pneumonia coronavirus (SARS-CoV-2)"},{"arc":[[31.823558807373,117.231567382812],[52.3687591552734,4.89012002944946]],"countries":["Netherlands","China"],"title":"Genome-wide data inferring the evolution and population 1 demography of the novel pneumonia coronavirus (SARS-CoV-2)"},{"arc":[[40.9437103271484,40.2619209289551],[52.3687591552734,4.89012002944946]],"countries":["Turkey","Netherlands"],"title":"Genome-wide data inferring the evolution and population 1 demography of the novel pneumonia coronavirus (SARS-CoV-2)"},{"arc":[[41.7091674804688,-87.9819946289062],[33.9756317138672,-117.331169128418]],"countries":["United States"],"title":"Crystal structure of Nsp15 endoribonuclease NendoU from SARS-CoV-2 Running Title: Structure of Nsp15 from SARS-CoV-2"},{"arc":[[41.7091674804688,-87.9819946289062],[41.7922172546387,-87.6018371582031]],"countries":["United States"],"title":"Crystal structure of Nsp15 endoribonuclease NendoU from SARS-CoV-2 Running Title: Structure of Nsp15 from SARS-CoV-2"},{"arc":[[33.9756317138672,-117.331169128418],[41.7922172546387,-87.6018371582031]],"countries":["United States"],"title":"Crystal structure of Nsp15 endoribonuclease NendoU from SARS-CoV-2 Running Title: Structure of Nsp15 from SARS-CoV-2"},{"arc":[[33.4219207763672,-111.934936523438],[33.7531509399414,-84.384880065918]],"countries":["United States"],"title":"Title: Transmission potential of COVID-19 in South Korea"},{"arc":[[33.4219207763672,-111.934936523438],[42.9547386169434,-78.8192367553711]],"countries":["United States"],"title":"Title: Transmission potential of COVID-19 in South Korea"},{"arc":[[33.7531509399414,-84.384880065918],[42.9547386169434,-78.8192367553711]],"countries":["United States"],"title":"Title: Transmission potential of COVID-19 in South Korea"},{"arc":[[40.9437103271484,40.2619209289551],[42.373161315918,-71.1181182861328]],"countries":["Turkey","United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[40.9437103271484,40.2619209289551],[42.3600006103516,-71.0920028686523]],"countries":["Turkey","United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[40.9437103271484,40.2619209289551],[39.0048141479492,-77.0975341796875]],"countries":["Turkey","United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[40.9437103271484,40.2619209289551],[11.5965204238892,124.39527130127]],"countries":["Turkey","Philippines"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[40.9437103271484,40.2619209289551],[48.6535606384277,-0.836489975452423]],"countries":["Turkey","France"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[40.9437103271484,40.2619209289551],[38.9969291687012,-77.0291366577148]],"countries":["Turkey","United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[40.9437103271484,40.2619209289551],[32.2988700866699,-90.1804504394531]],"countries":["Turkey","United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[40.9437103271484,40.2619209289551],[42.8098297119141,-88.3805541992188]],"countries":["Turkey","United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[40.9437103271484,40.2619209289551],[39.4959106445312,-98.9899826049805]],"countries":["Turkey","United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[40.9437103271484,40.2619209289551],[9.51126956939697,-83.7094879150391]],"countries":["Turkey","Costa Rica"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[42.373161315918,-71.1181182861328],[42.3600006103516,-71.0920028686523]],"countries":["United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[42.373161315918,-71.1181182861328],[39.0048141479492,-77.0975341796875]],"countries":["United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[42.373161315918,-71.1181182861328],[11.5965204238892,124.39527130127]],"countries":["United States","Philippines"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[42.373161315918,-71.1181182861328],[48.6535606384277,-0.836489975452423]],"countries":["United States","France"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[42.373161315918,-71.1181182861328],[38.9969291687012,-77.0291366577148]],"countries":["United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[42.373161315918,-71.1181182861328],[32.2988700866699,-90.1804504394531]],"countries":["United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[42.373161315918,-71.1181182861328],[42.8098297119141,-88.3805541992188]],"countries":["United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[42.373161315918,-71.1181182861328],[39.4959106445312,-98.9899826049805]],"countries":["United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[42.373161315918,-71.1181182861328],[9.51126956939697,-83.7094879150391]],"countries":["Costa Rica","United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[42.3600006103516,-71.0920028686523],[39.0048141479492,-77.0975341796875]],"countries":["United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[42.3600006103516,-71.0920028686523],[11.5965204238892,124.39527130127]],"countries":["United States","Philippines"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[42.3600006103516,-71.0920028686523],[48.6535606384277,-0.836489975452423]],"countries":["United States","France"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[42.3600006103516,-71.0920028686523],[38.9969291687012,-77.0291366577148]],"countries":["United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[42.3600006103516,-71.0920028686523],[32.2988700866699,-90.1804504394531]],"countries":["United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[42.3600006103516,-71.0920028686523],[42.8098297119141,-88.3805541992188]],"countries":["United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[42.3600006103516,-71.0920028686523],[39.4959106445312,-98.9899826049805]],"countries":["United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[42.3600006103516,-71.0920028686523],[9.51126956939697,-83.7094879150391]],"countries":["Costa Rica","United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[39.0048141479492,-77.0975341796875],[11.5965204238892,124.39527130127]],"countries":["United States","Philippines"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[39.0048141479492,-77.0975341796875],[48.6535606384277,-0.836489975452423]],"countries":["United States","France"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[39.0048141479492,-77.0975341796875],[38.9969291687012,-77.0291366577148]],"countries":["United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[39.0048141479492,-77.0975341796875],[32.2988700866699,-90.1804504394531]],"countries":["United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[39.0048141479492,-77.0975341796875],[42.8098297119141,-88.3805541992188]],"countries":["United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[39.0048141479492,-77.0975341796875],[39.4959106445312,-98.9899826049805]],"countries":["United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[39.0048141479492,-77.0975341796875],[9.51126956939697,-83.7094879150391]],"countries":["Costa Rica","United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[11.5965204238892,124.39527130127],[48.6535606384277,-0.836489975452423]],"countries":["Philippines","France"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[11.5965204238892,124.39527130127],[38.9969291687012,-77.0291366577148]],"countries":["Philippines","United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[11.5965204238892,124.39527130127],[32.2988700866699,-90.1804504394531]],"countries":["United States","Philippines"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[11.5965204238892,124.39527130127],[42.8098297119141,-88.3805541992188]],"countries":["Philippines","United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[11.5965204238892,124.39527130127],[39.4959106445312,-98.9899826049805]],"countries":["United States","Philippines"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[11.5965204238892,124.39527130127],[9.51126956939697,-83.7094879150391]],"countries":["Costa Rica","Philippines"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[48.6535606384277,-0.836489975452423],[38.9969291687012,-77.0291366577148]],"countries":["France","United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[48.6535606384277,-0.836489975452423],[32.2988700866699,-90.1804504394531]],"countries":["United States","France"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[48.6535606384277,-0.836489975452423],[42.8098297119141,-88.3805541992188]],"countries":["France","United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[48.6535606384277,-0.836489975452423],[39.4959106445312,-98.9899826049805]],"countries":["United States","France"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[48.6535606384277,-0.836489975452423],[9.51126956939697,-83.7094879150391]],"countries":["Costa Rica","France"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[38.9969291687012,-77.0291366577148],[32.2988700866699,-90.1804504394531]],"countries":["United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[38.9969291687012,-77.0291366577148],[42.8098297119141,-88.3805541992188]],"countries":["United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[38.9969291687012,-77.0291366577148],[39.4959106445312,-98.9899826049805]],"countries":["United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[38.9969291687012,-77.0291366577148],[9.51126956939697,-83.7094879150391]],"countries":["Costa Rica","United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[32.2988700866699,-90.1804504394531],[42.8098297119141,-88.3805541992188]],"countries":["United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[32.2988700866699,-90.1804504394531],[39.4959106445312,-98.9899826049805]],"countries":["United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[32.2988700866699,-90.1804504394531],[9.51126956939697,-83.7094879150391]],"countries":["Costa Rica","United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[42.8098297119141,-88.3805541992188],[39.4959106445312,-98.9899826049805]],"countries":["United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[42.8098297119141,-88.3805541992188],[9.51126956939697,-83.7094879150391]],"countries":["Costa Rica","United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[39.4959106445312,-98.9899826049805],[9.51126956939697,-83.7094879150391]],"countries":["Costa Rica","United States"],"title":"The Journal of Infectious Diseases Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate"},{"arc":[[40.9437103271484,40.2619209289551],[40.8081588745117,-73.9636535644531]],"countries":["Turkey","United States"],"title":"Identifying Hosts of Families of Viruses: A Machine Learning Approach"},{"arc":[[36.835375,126.965889],[37.4599990844727,126.949996948242]],"countries":["South Korea"],"title":"Characteristics and trends of traumatic injuries in children visiting emergency departments in South Korea: A retrospective serial cross-sectional study using both nationwide-sample and single-institutional data"},{"arc":[[43.377571105957,5.36300992965698],[33.5566825866699,23.774206161499]],"countries":["France","NOCOUNTRY"],"title":"RNA and DNA Bacteriophages as Molecular Diagnosis Controls in Clinical Virology: A Comprehensive Study of More than 45,000 Routine PCR Tests"},{"arc":[[43.377571105957,5.36300992965698],[40.9437103271484,40.2619209289551]],"countries":["Turkey","France"],"title":"RNA and DNA Bacteriophages as Molecular Diagnosis Controls in Clinical Virology: A Comprehensive Study of More than 45,000 Routine PCR Tests"},{"arc":[[43.377571105957,5.36300992965698],[51.1218070983887,10.4006948471069]],"countries":["France","Germany"],"title":"RNA and DNA Bacteriophages as Molecular Diagnosis Controls in Clinical Virology: A Comprehensive Study of More than 45,000 Routine PCR Tests"},{"arc":[[33.5566825866699,23.774206161499],[40.9437103271484,40.2619209289551]],"countries":["Turkey","NOCOUNTRY"],"title":"RNA and DNA Bacteriophages as Molecular Diagnosis Controls in Clinical Virology: A Comprehensive Study of More than 45,000 Routine PCR Tests"},{"arc":[[33.5566825866699,23.774206161499],[51.1218070983887,10.4006948471069]],"countries":["Germany","NOCOUNTRY"],"title":"RNA and DNA Bacteriophages as Molecular Diagnosis Controls in Clinical Virology: A Comprehensive Study of More than 45,000 Routine PCR Tests"},{"arc":[[40.9437103271484,40.2619209289551],[51.1218070983887,10.4006948471069]],"countries":["Turkey","Germany"],"title":"RNA and DNA Bacteriophages as Molecular Diagnosis Controls in Clinical Virology: A Comprehensive Study of More than 45,000 Routine PCR Tests"},{"arc":[[52.7308082580566,-122.448257446289],[-37.797981262207,144.959045410156]],"countries":["Canada","Australia"],"title":"Improving immunological insights into the ferret model of human viral infectious disease"},{"arc":[[52.7308082580566,-122.448257446289],[52.7308082580566,-122.448257446289]],"countries":["Canada"],"title":"Phenotypic and functional characterization of the major lymphocyte populations in the fruit-eating bat Pteropus alecto OPEN"},{"arc":[[52.7308082580566,-122.448257446289],[1.29718005657196,103.77774810791]],"countries":["Canada","Singapore"],"title":"Phenotypic and functional characterization of the major lymphocyte populations in the fruit-eating bat Pteropus alecto OPEN"},{"arc":[[-33.5961112976074,-58.1748695373535],[48.5203514099121,9.0491304397583]],"countries":["Uruguay","Germany"],"title":"molecules Inhibition of Porcine Aminopeptidase M (pAMP) by the Pentapeptide Microginins"},{"arc":[[-33.5961112976074,-58.1748695373535],[-23.5594444274902,-46.7238883972168]],"countries":["Uruguay","NOCOUNTRY"],"title":"molecules Inhibition of Porcine Aminopeptidase M (pAMP) by the Pentapeptide Microginins"},{"arc":[[48.5203514099121,9.0491304397583],[-23.5594444274902,-46.7238883972168]],"countries":["NOCOUNTRY","Germany"],"title":"molecules Inhibition of Porcine Aminopeptidase M (pAMP) by the Pentapeptide Microginins"},{"arc":[[44.773998260498,-117.829887390137],[42.4463500976562,-76.4826889038086]],"countries":["United States"],"title":"Expression of 9-O-and 7,9-O-acetyl modified sialic acid in cells and their effects 5 on influenza viruses 6 7"},{"arc":[[47.8398208618164,8.53275966644287],[41.7278709411621,44.764778137207]],"countries":["Georgia","Germany"],"title":"IFITM Genes, Variants, and Their Roles in the Control and Pathogenesis of Viral Infections"},{"arc":[[47.8398208618164,8.53275966644287],[40.0063018798828,-83.0163803100586]],"countries":["Germany","United States"],"title":"IFITM Genes, Variants, and Their Roles in the Control and Pathogenesis of Viral Infections"},{"arc":[[41.7278709411621,44.764778137207],[40.0063018798828,-83.0163803100586]],"countries":["Georgia","United States"],"title":"IFITM Genes, Variants, and Their Roles in the Control and Pathogenesis of Viral Infections"},{"arc":[[29.7107791900635,-95.3966522216797],[33.7483100891113,-84.39111328125]],"countries":["United States"],"title":"Cell attachment protein VP8* of a human rotavirus specifically interacts with A-type histo-blood group antigen HHS Public Access"},{"arc":[[29.7107791900635,-95.3966522216797],[42.3374290466309,-71.1058197021484]],"countries":["United States"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[29.7107791900635,-95.3966522216797],[39.75265,30.48148]],"countries":["United States","Turkey"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[29.7107791900635,-95.3966522216797],[51.4269409179688,-0.174720004200935]],"countries":["United States","United Kingdom"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[29.7107791900635,-95.3966522216797],[32.8808288574219,-84.6852798461914]],"countries":["United States"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[29.7107791900635,-95.3966522216797],[47.3191909790039,5.06463003158569]],"countries":["United States","France"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[29.7107791900635,-95.3966522216797],[51.1638,4.40115]],"countries":["United States","Belgium"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[29.7107791900635,-95.3966522216797],[-26.193000793457,28.18630027771]],"countries":["United States","South Africa"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[42.3374290466309,-71.1058197021484],[39.75265,30.48148]],"countries":["United States","Turkey"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[42.3374290466309,-71.1058197021484],[51.4269409179688,-0.174720004200935]],"countries":["United States","United Kingdom"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[42.3374290466309,-71.1058197021484],[32.8808288574219,-84.6852798461914]],"countries":["United States"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[42.3374290466309,-71.1058197021484],[47.3191909790039,5.06463003158569]],"countries":["United States","France"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[42.3374290466309,-71.1058197021484],[51.1638,4.40115]],"countries":["United States","Belgium"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[42.3374290466309,-71.1058197021484],[-26.193000793457,28.18630027771]],"countries":["United States","South Africa"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[39.75265,30.48148],[51.4269409179688,-0.174720004200935]],"countries":["Turkey","United Kingdom"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[39.75265,30.48148],[32.8808288574219,-84.6852798461914]],"countries":["United States","Turkey"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[39.75265,30.48148],[47.3191909790039,5.06463003158569]],"countries":["Turkey","France"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[39.75265,30.48148],[51.1638,4.40115]],"countries":["Turkey","Belgium"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[39.75265,30.48148],[-26.193000793457,28.18630027771]],"countries":["Turkey","South Africa"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[51.4269409179688,-0.174720004200935],[32.8808288574219,-84.6852798461914]],"countries":["United States","United Kingdom"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[51.4269409179688,-0.174720004200935],[47.3191909790039,5.06463003158569]],"countries":["United Kingdom","France"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[51.4269409179688,-0.174720004200935],[51.1638,4.40115]],"countries":["United Kingdom","Belgium"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[51.4269409179688,-0.174720004200935],[-26.193000793457,28.18630027771]],"countries":["United Kingdom","South Africa"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[32.8808288574219,-84.6852798461914],[47.3191909790039,5.06463003158569]],"countries":["United States","France"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[32.8808288574219,-84.6852798461914],[51.1638,4.40115]],"countries":["United States","Belgium"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[32.8808288574219,-84.6852798461914],[-26.193000793457,28.18630027771]],"countries":["United States","South Africa"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[47.3191909790039,5.06463003158569],[51.1638,4.40115]],"countries":["France","Belgium"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[47.3191909790039,5.06463003158569],[-26.193000793457,28.18630027771]],"countries":["France","South Africa"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[51.1638,4.40115],[-26.193000793457,28.18630027771]],"countries":["Belgium","South Africa"],"title":"The Fourth International Neonatal and Maternal Immunization Symposium (INMIS 2017): Toward Integrating Maternal and Infant Immunization Programs"},{"arc":[[39.9219017028809,116.443550109863],[40.1861572265625,116.418983459473]],"countries":["China"],"title":"Thrombocytopenia Is Associated with Acute Respiratory Distress Syndrome Mortality: An International Study"},{"arc":[[39.9219017028809,116.443550109863],[27.3303279876709,128.57194519043]],"countries":["China","Japan"],"title":"Thrombocytopenia Is Associated with Acute Respiratory Distress Syndrome Mortality: An International Study"},{"arc":[[39.9219017028809,116.443550109863],[42.3354797363281,-71.1043930053711]],"countries":["China","United States"],"title":"Thrombocytopenia Is Associated with Acute Respiratory Distress Syndrome Mortality: An International Study"},{"arc":[[39.9219017028809,116.443550109863],[39.9925537109375,116.310485839844]],"countries":["China"],"title":"Thrombocytopenia Is Associated with Acute Respiratory Distress Syndrome Mortality: An International Study"},{"arc":[[39.9219017028809,116.443550109863],[14.3596153259277,-14.4684610366821]],"countries":["China","Senegal"],"title":"Thrombocytopenia Is Associated with Acute Respiratory Distress Syndrome Mortality: An International Study"},{"arc":[[40.1861572265625,116.418983459473],[27.3303279876709,128.57194519043]],"countries":["China","Japan"],"title":"Thrombocytopenia Is Associated with Acute Respiratory Distress Syndrome Mortality: An International Study"},{"arc":[[40.1861572265625,116.418983459473],[42.3354797363281,-71.1043930053711]],"countries":["China","United States"],"title":"Thrombocytopenia Is Associated with Acute Respiratory Distress Syndrome Mortality: An International Study"},{"arc":[[40.1861572265625,116.418983459473],[39.9925537109375,116.310485839844]],"countries":["China"],"title":"Thrombocytopenia Is Associated with Acute Respiratory Distress Syndrome Mortality: An International Study"},{"arc":[[40.1861572265625,116.418983459473],[14.3596153259277,-14.4684610366821]],"countries":["China","Senegal"],"title":"Thrombocytopenia Is Associated with Acute Respiratory Distress Syndrome Mortality: An International Study"},{"arc":[[27.3303279876709,128.57194519043],[42.3354797363281,-71.1043930053711]],"countries":["Japan","United States"],"title":"Thrombocytopenia Is Associated with Acute Respiratory Distress Syndrome Mortality: An International Study"},{"arc":[[27.3303279876709,128.57194519043],[39.9925537109375,116.310485839844]],"countries":["China","Japan"],"title":"Thrombocytopenia Is Associated with Acute Respiratory Distress Syndrome Mortality: An International Study"},{"arc":[[27.3303279876709,128.57194519043],[14.3596153259277,-14.4684610366821]],"countries":["Japan","Senegal"],"title":"Thrombocytopenia Is Associated with Acute Respiratory Distress Syndrome Mortality: An International Study"},{"arc":[[42.3354797363281,-71.1043930053711],[39.9925537109375,116.310485839844]],"countries":["China","United States"],"title":"Thrombocytopenia Is Associated with Acute Respiratory Distress Syndrome Mortality: An International Study"},{"arc":[[42.3354797363281,-71.1043930053711],[14.3596153259277,-14.4684610366821]],"countries":["Senegal","United States"],"title":"Thrombocytopenia Is Associated with Acute Respiratory Distress Syndrome Mortality: An International Study"},{"arc":[[39.9925537109375,116.310485839844],[14.3596153259277,-14.4684610366821]],"countries":["China","Senegal"],"title":"Thrombocytopenia Is Associated with Acute Respiratory Distress Syndrome Mortality: An International Study"},{"arc":[[40.1861572265625,116.418983459473],[32.8808288574219,-84.6852798461914]],"countries":["China","United States"],"title":"Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study"},{"arc":[[40.1861572265625,116.418983459473],[38.0572509765625,-97.9326782226562]],"countries":["China","United States"],"title":"Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study"},{"arc":[[40.1861572265625,116.418983459473],[31.2988891601562,121.499168395996]],"countries":["China"],"title":"Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study"},{"arc":[[40.1861572265625,116.418983459473],[22.333080291748,114.191223144531]],"countries":["China","Hong Kong SAR"],"title":"Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study"},{"arc":[[40.1861572265625,116.418983459473],[38.9907493591309,48.5817184448242]],"countries":["China","Azerbaijan"],"title":"Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study"},{"arc":[[40.1861572265625,116.418983459473],[42.3402290344238,-71.0890197753906]],"countries":["China","United States"],"title":"Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study"},{"arc":[[40.1861572265625,116.418983459473],[22.2802925109863,114.142951965332]],"countries":["China","Hong Kong SAR"],"title":"Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study"},{"arc":[[32.8808288574219,-84.6852798461914],[38.0572509765625,-97.9326782226562]],"countries":["United States"],"title":"Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study"},{"arc":[[32.8808288574219,-84.6852798461914],[31.2988891601562,121.499168395996]],"countries":["China","United States"],"title":"Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study"},{"arc":[[32.8808288574219,-84.6852798461914],[22.333080291748,114.191223144531]],"countries":["United States","Hong Kong SAR"],"title":"Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study"},{"arc":[[32.8808288574219,-84.6852798461914],[38.9907493591309,48.5817184448242]],"countries":["United States","Azerbaijan"],"title":"Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study"},{"arc":[[32.8808288574219,-84.6852798461914],[42.3402290344238,-71.0890197753906]],"countries":["United States"],"title":"Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study"},{"arc":[[32.8808288574219,-84.6852798461914],[22.2802925109863,114.142951965332]],"countries":["United States","Hong Kong SAR"],"title":"Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study"},{"arc":[[38.0572509765625,-97.9326782226562],[31.2988891601562,121.499168395996]],"countries":["China","United States"],"title":"Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study"},{"arc":[[38.0572509765625,-97.9326782226562],[22.333080291748,114.191223144531]],"countries":["United States","Hong Kong SAR"],"title":"Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study"},{"arc":[[38.0572509765625,-97.9326782226562],[38.9907493591309,48.5817184448242]],"countries":["United States","Azerbaijan"],"title":"Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study"},{"arc":[[38.0572509765625,-97.9326782226562],[42.3402290344238,-71.0890197753906]],"countries":["United States"],"title":"Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study"},{"arc":[[38.0572509765625,-97.9326782226562],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR","United States"],"title":"Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study"},{"arc":[[31.2988891601562,121.499168395996],[22.333080291748,114.191223144531]],"countries":["China","Hong Kong SAR"],"title":"Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study"},{"arc":[[31.2988891601562,121.499168395996],[38.9907493591309,48.5817184448242]],"countries":["China","Azerbaijan"],"title":"Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study"},{"arc":[[31.2988891601562,121.499168395996],[42.3402290344238,-71.0890197753906]],"countries":["China","United States"],"title":"Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study"},{"arc":[[31.2988891601562,121.499168395996],[22.2802925109863,114.142951965332]],"countries":["China","Hong Kong SAR"],"title":"Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study"},{"arc":[[22.333080291748,114.191223144531],[38.9907493591309,48.5817184448242]],"countries":["Hong Kong SAR","Azerbaijan"],"title":"Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study"},{"arc":[[22.333080291748,114.191223144531],[42.3402290344238,-71.0890197753906]],"countries":["Hong Kong SAR","United States"],"title":"Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study"},{"arc":[[22.333080291748,114.191223144531],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR"],"title":"Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study"},{"arc":[[38.9907493591309,48.5817184448242],[42.3402290344238,-71.0890197753906]],"countries":["Azerbaijan","United States"],"title":"Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study"},{"arc":[[38.9907493591309,48.5817184448242],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR","Azerbaijan"],"title":"Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study"},{"arc":[[42.3402290344238,-71.0890197753906],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR","United States"],"title":"Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study"},{"arc":[[40.1861572265625,116.418983459473],[30.3002605438232,108.037666320801]],"countries":["China"],"title":"Incidence and Outcomes of Acute Respiratory Distress Syndrome A Nationwide Registry-Based Study in Taiwan, 1997 to 2011"},{"arc":[[35.6814384460449,-88.8572692871094],[38.8350486755371,-77.3112411499023]],"countries":["United States"],"title":"Institute of Geographical Sciences and Natural Resources Research"},{"arc":[[35.6814384460449,-88.8572692871094],[32.7721481323242,-117.071929931641]],"countries":["United States"],"title":"Institute of Geographical Sciences and Natural Resources Research"},{"arc":[[38.8350486755371,-77.3112411499023],[32.7721481323242,-117.071929931641]],"countries":["United States"],"title":"Institute of Geographical Sciences and Natural Resources Research"},{"arc":[[40.1861572265625,116.418983459473],[41.7278709411621,44.764778137207]],"countries":["Georgia","China"],"title":"Thin-Section Computed Tomography Manifestations During Convalescence and Long- Term Follow-Up of Patients with Severe Acute Respiratory Syndrome (SARS) This work is licensed under Creative Common Attribution- NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)"},{"arc":[[52.5014038085938,13.4023313522339],[46.8767318725586,7.36887979507446]],"countries":["Germany","Switzerland"],"title":"The papain-like protease determines a virulence trait that varies among members of the SARS-coronavirus species"},{"arc":[[52.5014038085938,13.4023313522339],[41.9982795715332,-87.6571731567383]],"countries":["Germany","United States"],"title":"The papain-like protease determines a virulence trait that varies among members of the SARS-coronavirus species"},{"arc":[[52.5014038085938,13.4023313522339],[40.9437103271484,40.2619209289551]],"countries":["Turkey","Germany"],"title":"The papain-like protease determines a virulence trait that varies among members of the SARS-coronavirus species"},{"arc":[[52.5014038085938,13.4023313522339],[50.7338905334473,7.10222196578979]],"countries":["Germany"],"title":"The papain-like protease determines a virulence trait that varies among members of the SARS-coronavirus species"},{"arc":[[46.8767318725586,7.36887979507446],[41.9982795715332,-87.6571731567383]],"countries":["Switzerland","United States"],"title":"The papain-like protease determines a virulence trait that varies among members of the SARS-coronavirus species"},{"arc":[[46.8767318725586,7.36887979507446],[40.9437103271484,40.2619209289551]],"countries":["Turkey","Switzerland"],"title":"The papain-like protease determines a virulence trait that varies among members of the SARS-coronavirus species"},{"arc":[[46.8767318725586,7.36887979507446],[50.7338905334473,7.10222196578979]],"countries":["Switzerland","Germany"],"title":"The papain-like protease determines a virulence trait that varies among members of the SARS-coronavirus species"},{"arc":[[41.9982795715332,-87.6571731567383],[41.9982795715332,-87.6571731567383]],"countries":["United States"],"title":"The papain-like protease determines a virulence trait that varies among members of the SARS-coronavirus species"},{"arc":[[41.9982795715332,-87.6571731567383],[40.9437103271484,40.2619209289551]],"countries":["Turkey","United States"],"title":"The papain-like protease determines a virulence trait that varies among members of the SARS-coronavirus species"},{"arc":[[41.9982795715332,-87.6571731567383],[50.7338905334473,7.10222196578979]],"countries":["United States","Germany"],"title":"The papain-like protease determines a virulence trait that varies among members of the SARS-coronavirus species"},{"arc":[[40.9437103271484,40.2619209289551],[50.7338905334473,7.10222196578979]],"countries":["Turkey","Germany"],"title":"The papain-like protease determines a virulence trait that varies among members of the SARS-coronavirus species"},{"arc":[[50.7338905334473,7.10222196578979],[50.7338905334473,7.10222196578979]],"countries":["Germany"],"title":"The papain-like protease determines a virulence trait that varies among members of the SARS-coronavirus species"},{"arc":[[52.5014038085938,13.4023313522339],[57.6894683837891,11.9732599258423]],"countries":["Germany","Sweden"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[52.5014038085938,13.4023313522339],[55.84738,-4.25425]],"countries":["Germany","United Kingdom"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[52.5014038085938,13.4023313522339],[47.4264907836914,9.37360954284668]],"countries":["Germany","Switzerland"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[52.5014038085938,13.4023313522339],[50.7338905334473,7.10222196578979]],"countries":["Germany"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[52.5014038085938,13.4023313522339],[57.6986312866211,11.9708204269409]],"countries":["Germany","Sweden"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[52.5014038085938,13.4023313522339],[51.9735984802246,5.66384315490723]],"countries":["Germany","Netherlands"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[57.6894683837891,11.9732599258423],[55.84738,-4.25425]],"countries":["United Kingdom","Sweden"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[57.6894683837891,11.9732599258423],[47.4264907836914,9.37360954284668]],"countries":["Sweden","Switzerland"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[57.6894683837891,11.9732599258423],[50.7338905334473,7.10222196578979]],"countries":["Sweden","Germany"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[57.6894683837891,11.9732599258423],[57.6986312866211,11.9708204269409]],"countries":["Sweden"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[57.6894683837891,11.9732599258423],[51.9735984802246,5.66384315490723]],"countries":["Netherlands","Sweden"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[55.84738,-4.25425],[47.4264907836914,9.37360954284668]],"countries":["United Kingdom","Switzerland"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[55.84738,-4.25425],[50.7338905334473,7.10222196578979]],"countries":["United Kingdom","Germany"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[55.84738,-4.25425],[57.6986312866211,11.9708204269409]],"countries":["United Kingdom","Sweden"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[55.84738,-4.25425],[51.9735984802246,5.66384315490723]],"countries":["United Kingdom","Netherlands"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[47.4264907836914,9.37360954284668],[50.7338905334473,7.10222196578979]],"countries":["Switzerland","Germany"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[47.4264907836914,9.37360954284668],[57.6986312866211,11.9708204269409]],"countries":["Sweden","Switzerland"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[47.4264907836914,9.37360954284668],[51.9735984802246,5.66384315490723]],"countries":["Netherlands","Switzerland"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[50.7338905334473,7.10222196578979],[50.7338905334473,7.10222196578979]],"countries":["Germany"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[50.7338905334473,7.10222196578979],[57.6986312866211,11.9708204269409]],"countries":["Sweden","Germany"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[50.7338905334473,7.10222196578979],[51.9735984802246,5.66384315490723]],"countries":["Netherlands","Germany"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[57.6986312866211,11.9708204269409],[51.9735984802246,5.66384315490723]],"countries":["Netherlands","Sweden"],"title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus"},{"arc":[[40.9437103271484,40.2619209289551],[39.6785011291504,-104.966621398926]],"countries":["Turkey","United States"],"title":"Using Modelling to Disentangle the Relative Contributions of Zoonotic and Anthroponotic Transmission: The Case of Lassa Fever"},{"arc":[[40.9437103271484,40.2619209289551],[51.9100685119629,4.46534013748169]],"countries":["Turkey","Netherlands"],"title":"Using Modelling to Disentangle the Relative Contributions of Zoonotic and Anthroponotic Transmission: The Case of Lassa Fever"},{"arc":[[40.9437103271484,40.2619209289551],[29.9353504180908,-90.123176574707]],"countries":["Turkey","United States"],"title":"Using Modelling to Disentangle the Relative Contributions of Zoonotic and Anthroponotic Transmission: The Case of Lassa Fever"},{"arc":[[40.9437103271484,40.2619209289551],[52.2025413513184,0.119549997150898]],"countries":["Turkey","United Kingdom"],"title":"Using Modelling to Disentangle the Relative Contributions of Zoonotic and Anthroponotic Transmission: The Case of Lassa Fever"},{"arc":[[40.9437103271484,40.2619209289551],[50.8659515380859,-0.0823199972510338]],"countries":["Turkey","United Kingdom"],"title":"Using Modelling to Disentangle the Relative Contributions of Zoonotic and Anthroponotic Transmission: The Case of Lassa Fever"},{"arc":[[39.6785011291504,-104.966621398926],[51.9100685119629,4.46534013748169]],"countries":["United States","Netherlands"],"title":"Using Modelling to Disentangle the Relative Contributions of Zoonotic and Anthroponotic Transmission: The Case of Lassa Fever"},{"arc":[[39.6785011291504,-104.966621398926],[29.9353504180908,-90.123176574707]],"countries":["United States"],"title":"Using Modelling to Disentangle the Relative Contributions of Zoonotic and Anthroponotic Transmission: The Case of Lassa Fever"},{"arc":[[39.6785011291504,-104.966621398926],[52.2025413513184,0.119549997150898]],"countries":["United Kingdom","United States"],"title":"Using Modelling to Disentangle the Relative Contributions of Zoonotic and Anthroponotic Transmission: The Case of Lassa Fever"},{"arc":[[39.6785011291504,-104.966621398926],[50.8659515380859,-0.0823199972510338]],"countries":["United States","United Kingdom"],"title":"Using Modelling to Disentangle the Relative Contributions of Zoonotic and Anthroponotic Transmission: The Case of Lassa Fever"},{"arc":[[51.9100685119629,4.46534013748169],[29.9353504180908,-90.123176574707]],"countries":["Netherlands","United States"],"title":"Using Modelling to Disentangle the Relative Contributions of Zoonotic and Anthroponotic Transmission: The Case of Lassa Fever"},{"arc":[[51.9100685119629,4.46534013748169],[52.2025413513184,0.119549997150898]],"countries":["United Kingdom","Netherlands"],"title":"Using Modelling to Disentangle the Relative Contributions of Zoonotic and Anthroponotic Transmission: The Case of Lassa Fever"},{"arc":[[51.9100685119629,4.46534013748169],[50.8659515380859,-0.0823199972510338]],"countries":["Netherlands","United Kingdom"],"title":"Using Modelling to Disentangle the Relative Contributions of Zoonotic and Anthroponotic Transmission: The Case of Lassa Fever"},{"arc":[[29.9353504180908,-90.123176574707],[52.2025413513184,0.119549997150898]],"countries":["United Kingdom","United States"],"title":"Using Modelling to Disentangle the Relative Contributions of Zoonotic and Anthroponotic Transmission: The Case of Lassa Fever"},{"arc":[[29.9353504180908,-90.123176574707],[50.8659515380859,-0.0823199972510338]],"countries":["United States","United Kingdom"],"title":"Using Modelling to Disentangle the Relative Contributions of Zoonotic and Anthroponotic Transmission: The Case of Lassa Fever"},{"arc":[[52.2025413513184,0.119549997150898],[50.8659515380859,-0.0823199972510338]],"countries":["United Kingdom"],"title":"Using Modelling to Disentangle the Relative Contributions of Zoonotic and Anthroponotic Transmission: The Case of Lassa Fever"},{"arc":[[43.2412185668945,-2.8500440120697],[51.1218070983887,10.4006948471069]],"countries":["Spain","Germany"],"title":"Enterovirus D68-associated respiratory and neurological illness in Spain, 2014-2018"},{"arc":[[43.2412185668945,-2.8500440120697],[-16.499080657959,-68.1337814331055]],"countries":["Spain","Bolivia"],"title":"Enterovirus D68-associated respiratory and neurological illness in Spain, 2014-2018"},{"arc":[[43.2412185668945,-2.8500440120697],[41.6720504760742,2.2520899772644]],"countries":["Spain"],"title":"Enterovirus D68-associated respiratory and neurological illness in Spain, 2014-2018"},{"arc":[[43.2412185668945,-2.8500440120697],[48.5444183349609,12.1591682434082]],"countries":["Spain","Germany"],"title":"Enterovirus D68-associated respiratory and neurological illness in Spain, 2014-2018"},{"arc":[[43.2412185668945,-2.8500440120697],[28.0604705810547,-15.4747295379639]],"countries":["Spain"],"title":"Enterovirus D68-associated respiratory and neurological illness in Spain, 2014-2018"},{"arc":[[51.1218070983887,10.4006948471069],[-16.499080657959,-68.1337814331055]],"countries":["Germany","Bolivia"],"title":"Enterovirus D68-associated respiratory and neurological illness in Spain, 2014-2018"},{"arc":[[51.1218070983887,10.4006948471069],[41.6720504760742,2.2520899772644]],"countries":["Germany","Spain"],"title":"Enterovirus D68-associated respiratory and neurological illness in Spain, 2014-2018"},{"arc":[[51.1218070983887,10.4006948471069],[48.5444183349609,12.1591682434082]],"countries":["Germany"],"title":"Enterovirus D68-associated respiratory and neurological illness in Spain, 2014-2018"},{"arc":[[51.1218070983887,10.4006948471069],[51.1218070983887,10.4006948471069]],"countries":["Germany"],"title":"Enterovirus D68-associated respiratory and neurological illness in Spain, 2014-2018"},{"arc":[[51.1218070983887,10.4006948471069],[28.0604705810547,-15.4747295379639]],"countries":["Germany","Spain"],"title":"Enterovirus D68-associated respiratory and neurological illness in Spain, 2014-2018"},{"arc":[[-16.499080657959,-68.1337814331055],[41.6720504760742,2.2520899772644]],"countries":["Bolivia","Spain"],"title":"Enterovirus D68-associated respiratory and neurological illness in Spain, 2014-2018"},{"arc":[[-16.499080657959,-68.1337814331055],[48.5444183349609,12.1591682434082]],"countries":["Germany","Bolivia"],"title":"Enterovirus D68-associated respiratory and neurological illness in Spain, 2014-2018"},{"arc":[[-16.499080657959,-68.1337814331055],[51.1218070983887,10.4006948471069]],"countries":["Germany","Bolivia"],"title":"Enterovirus D68-associated respiratory and neurological illness in Spain, 2014-2018"},{"arc":[[-16.499080657959,-68.1337814331055],[28.0604705810547,-15.4747295379639]],"countries":["Bolivia","Spain"],"title":"Enterovirus D68-associated respiratory and neurological illness in Spain, 2014-2018"},{"arc":[[41.6720504760742,2.2520899772644],[48.5444183349609,12.1591682434082]],"countries":["Germany","Spain"],"title":"Enterovirus D68-associated respiratory and neurological illness in Spain, 2014-2018"},{"arc":[[41.6720504760742,2.2520899772644],[51.1218070983887,10.4006948471069]],"countries":["Germany","Spain"],"title":"Enterovirus D68-associated respiratory and neurological illness in Spain, 2014-2018"},{"arc":[[41.6720504760742,2.2520899772644],[28.0604705810547,-15.4747295379639]],"countries":["Spain"],"title":"Enterovirus D68-associated respiratory and neurological illness in Spain, 2014-2018"},{"arc":[[48.5444183349609,12.1591682434082],[51.1218070983887,10.4006948471069]],"countries":["Germany"],"title":"Enterovirus D68-associated respiratory and neurological illness in Spain, 2014-2018"},{"arc":[[48.5444183349609,12.1591682434082],[28.0604705810547,-15.4747295379639]],"countries":["Germany","Spain"],"title":"Enterovirus D68-associated respiratory and neurological illness in Spain, 2014-2018"},{"arc":[[-85.0169982910156,-167.5],[40.9437103271484,40.2619209289551]],"countries":["Turkey","NOCOUNTRY"],"title":"SUBJECT AREAS TITLE Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[-85.0169982910156,-167.5],[55.7387313842773,12.5470895767212]],"countries":["NOCOUNTRY","Denmark"],"title":"SUBJECT AREAS TITLE Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[-85.0169982910156,-167.5],[45.8021583557129,126.535797119141]],"countries":["NOCOUNTRY","China"],"title":"SUBJECT AREAS TITLE Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[-85.0169982910156,-167.5],[40.7182693481445,46.4133987426758]],"countries":["Azerbaijan","NOCOUNTRY"],"title":"SUBJECT AREAS TITLE Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[-85.0169982910156,-167.5],[55.6756706237793,12.5675601959229]],"countries":["NOCOUNTRY","Denmark"],"title":"SUBJECT AREAS TITLE Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[40.9437103271484,40.2619209289551],[55.7387313842773,12.5470895767212]],"countries":["Turkey","Denmark"],"title":"SUBJECT AREAS TITLE Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[40.9437103271484,40.2619209289551],[45.8021583557129,126.535797119141]],"countries":["Turkey","China"],"title":"SUBJECT AREAS TITLE Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[40.9437103271484,40.2619209289551],[40.7182693481445,46.4133987426758]],"countries":["Turkey","Azerbaijan"],"title":"SUBJECT AREAS TITLE Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[40.9437103271484,40.2619209289551],[55.6756706237793,12.5675601959229]],"countries":["Turkey","Denmark"],"title":"SUBJECT AREAS TITLE Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[55.7387313842773,12.5470895767212],[45.8021583557129,126.535797119141]],"countries":["Denmark","China"],"title":"SUBJECT AREAS TITLE Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[55.7387313842773,12.5470895767212],[40.7182693481445,46.4133987426758]],"countries":["Azerbaijan","Denmark"],"title":"SUBJECT AREAS TITLE Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[55.7387313842773,12.5470895767212],[55.6756706237793,12.5675601959229]],"countries":["Denmark"],"title":"SUBJECT AREAS TITLE Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[45.8021583557129,126.535797119141],[40.7182693481445,46.4133987426758]],"countries":["Azerbaijan","China"],"title":"SUBJECT AREAS TITLE Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[45.8021583557129,126.535797119141],[55.6756706237793,12.5675601959229]],"countries":["Denmark","China"],"title":"SUBJECT AREAS TITLE Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[40.7182693481445,46.4133987426758],[55.6756706237793,12.5675601959229]],"countries":["Azerbaijan","Denmark"],"title":"SUBJECT AREAS TITLE Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing"},{"arc":[[47.1806716918945,5.77007007598877],[25.7610397338867,-80.3762817382812]],"countries":["France","United States"],"title":"No Evidence of Viral Transmission following Long-Term Implantation of Agarose Encapsulated Porcine Islets in Diabetic Dogs"},{"arc":[[47.1806716918945,5.77007007598877],[37.1157264709473,127.150489807129]],"countries":["France","South Korea"],"title":"No Evidence of Viral Transmission following Long-Term Implantation of Agarose Encapsulated Porcine Islets in Diabetic Dogs"},{"arc":[[47.1806716918945,5.77007007598877],[38.3835906982422,-81.7656936645508]],"countries":["United States","France"],"title":"No Evidence of Viral Transmission following Long-Term Implantation of Agarose Encapsulated Porcine Islets in Diabetic Dogs"},{"arc":[[47.1806716918945,5.77007007598877],[39.6851081848145,-83.9281692504883]],"countries":["France","United States"],"title":"No Evidence of Viral Transmission following Long-Term Implantation of Agarose Encapsulated Porcine Islets in Diabetic Dogs"},{"arc":[[25.7610397338867,-80.3762817382812],[37.1157264709473,127.150489807129]],"countries":["United States","South Korea"],"title":"No Evidence of Viral Transmission following Long-Term Implantation of Agarose Encapsulated Porcine Islets in Diabetic Dogs"},{"arc":[[25.7610397338867,-80.3762817382812],[38.3835906982422,-81.7656936645508]],"countries":["United States"],"title":"No Evidence of Viral Transmission following Long-Term Implantation of Agarose Encapsulated Porcine Islets in Diabetic Dogs"},{"arc":[[25.7610397338867,-80.3762817382812],[39.6851081848145,-83.9281692504883]],"countries":["United States"],"title":"No Evidence of Viral Transmission following Long-Term Implantation of Agarose Encapsulated Porcine Islets in Diabetic Dogs"},{"arc":[[37.1157264709473,127.150489807129],[38.3835906982422,-81.7656936645508]],"countries":["United States","South Korea"],"title":"No Evidence of Viral Transmission following Long-Term Implantation of Agarose Encapsulated Porcine Islets in Diabetic Dogs"},{"arc":[[37.1157264709473,127.150489807129],[39.6851081848145,-83.9281692504883]],"countries":["South Korea","United States"],"title":"No Evidence of Viral Transmission following Long-Term Implantation of Agarose Encapsulated Porcine Islets in Diabetic Dogs"},{"arc":[[38.3835906982422,-81.7656936645508],[39.6851081848145,-83.9281692504883]],"countries":["United States"],"title":"No Evidence of Viral Transmission following Long-Term Implantation of Agarose Encapsulated Porcine Islets in Diabetic Dogs"},{"arc":[[42.3502082824707,-71.0988693237305],[-33.88618,151.18716]],"countries":["United States","Australia"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[42.3502082824707,-71.0988693237305],[54.5704803466797,-1.23447000980377]],"countries":["United States","United Kingdom"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[42.3502082824707,-71.0988693237305],[-23.5594444274902,-46.7238883972168]],"countries":["United States","NOCOUNTRY"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[42.3502082824707,-71.0988693237305],[51.9630088806152,7.61780977249146]],"countries":["United States","Germany"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[42.3502082824707,-71.0988693237305],[28.6008148193359,-81.1996078491211]],"countries":["United States"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[42.3502082824707,-71.0988693237305],[35.1019592285156,-106.591567993164]],"countries":["United States"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[42.3502082824707,-71.0988693237305],[53.3718719482422,-3.0949079990387]],"countries":["United States","United Kingdom"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[-33.88618,151.18716],[54.5704803466797,-1.23447000980377]],"countries":["Australia","United Kingdom"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[-33.88618,151.18716],[-23.5594444274902,-46.7238883972168]],"countries":["NOCOUNTRY","Australia"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[-33.88618,151.18716],[51.9630088806152,7.61780977249146]],"countries":["Australia","Germany"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[-33.88618,151.18716],[28.6008148193359,-81.1996078491211]],"countries":["Australia","United States"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[-33.88618,151.18716],[35.1019592285156,-106.591567993164]],"countries":["Australia","United States"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[-33.88618,151.18716],[53.3718719482422,-3.0949079990387]],"countries":["Australia","United Kingdom"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[54.5704803466797,-1.23447000980377],[-23.5594444274902,-46.7238883972168]],"countries":["NOCOUNTRY","United Kingdom"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[54.5704803466797,-1.23447000980377],[51.9630088806152,7.61780977249146]],"countries":["United Kingdom","Germany"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[54.5704803466797,-1.23447000980377],[28.6008148193359,-81.1996078491211]],"countries":["United Kingdom","United States"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[54.5704803466797,-1.23447000980377],[35.1019592285156,-106.591567993164]],"countries":["United Kingdom","United States"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[54.5704803466797,-1.23447000980377],[53.3718719482422,-3.0949079990387]],"countries":["United Kingdom"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[-23.5594444274902,-46.7238883972168],[51.9630088806152,7.61780977249146]],"countries":["NOCOUNTRY","Germany"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[-23.5594444274902,-46.7238883972168],[28.6008148193359,-81.1996078491211]],"countries":["NOCOUNTRY","United States"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[-23.5594444274902,-46.7238883972168],[35.1019592285156,-106.591567993164]],"countries":["NOCOUNTRY","United States"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[-23.5594444274902,-46.7238883972168],[53.3718719482422,-3.0949079990387]],"countries":["NOCOUNTRY","United Kingdom"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[51.9630088806152,7.61780977249146],[28.6008148193359,-81.1996078491211]],"countries":["Germany","United States"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[51.9630088806152,7.61780977249146],[35.1019592285156,-106.591567993164]],"countries":["Germany","United States"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[51.9630088806152,7.61780977249146],[53.3718719482422,-3.0949079990387]],"countries":["Germany","United Kingdom"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[28.6008148193359,-81.1996078491211],[35.1019592285156,-106.591567993164]],"countries":["United States"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[28.6008148193359,-81.1996078491211],[53.3718719482422,-3.0949079990387]],"countries":["United States","United Kingdom"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[35.1019592285156,-106.591567993164],[53.3718719482422,-3.0949079990387]],"countries":["United States","United Kingdom"],"title":"Developments in Transduction, Connectivity and AI/Machine Learning for Point-of-Care Testing"},{"arc":[[41.66333,-91.54439],[37.7697296142578,-122.466094970703]],"countries":["United States"],"title":"Physicochemical Properties of Cells and Their Effects on Intrinsically Disordered Proteins (IDPs)"},{"arc":[[41.66333,-91.54439],[53.1849708557129,-8.146897315979]],"countries":["United States","Ireland"],"title":"Physicochemical Properties of Cells and Their Effects on Intrinsically Disordered Proteins (IDPs)"},{"arc":[[41.66333,-91.54439],[42.385311126709,-72.5253524780273]],"countries":["United States"],"title":"Physicochemical Properties of Cells and Their Effects on Intrinsically Disordered Proteins (IDPs)"},{"arc":[[41.66333,-91.54439],[35.9053153991699,-79.0477142333984]],"countries":["United States"],"title":"Physicochemical Properties of Cells and Their Effects on Intrinsically Disordered Proteins (IDPs)"},{"arc":[[37.7697296142578,-122.466094970703],[53.1849708557129,-8.146897315979]],"countries":["United States","Ireland"],"title":"Physicochemical Properties of Cells and Their Effects on Intrinsically Disordered Proteins (IDPs)"},{"arc":[[37.7697296142578,-122.466094970703],[42.385311126709,-72.5253524780273]],"countries":["United States"],"title":"Physicochemical Properties of Cells and Their Effects on Intrinsically Disordered Proteins (IDPs)"},{"arc":[[37.7697296142578,-122.466094970703],[35.9053153991699,-79.0477142333984]],"countries":["United States"],"title":"Physicochemical Properties of Cells and Their Effects on Intrinsically Disordered Proteins (IDPs)"},{"arc":[[53.1849708557129,-8.146897315979],[42.385311126709,-72.5253524780273]],"countries":["Ireland","United States"],"title":"Physicochemical Properties of Cells and Their Effects on Intrinsically Disordered Proteins (IDPs)"},{"arc":[[53.1849708557129,-8.146897315979],[35.9053153991699,-79.0477142333984]],"countries":["Ireland","United States"],"title":"Physicochemical Properties of Cells and Their Effects on Intrinsically Disordered Proteins (IDPs)"},{"arc":[[42.385311126709,-72.5253524780273],[35.9053153991699,-79.0477142333984]],"countries":["United States"],"title":"Physicochemical Properties of Cells and Their Effects on Intrinsically Disordered Proteins (IDPs)"},{"arc":[[42.373161315918,-71.1181182861328],[42.373161315918,-71.1181182861328]],"countries":["United States"],"title":"CRISPR-based surveillance for COVID-19 using genomically-comprehensive machine learning design"},{"arc":[[40.9437103271484,40.2619209289551],[23.7489929199219,120.971282958984]],"countries":["Turkey","Taiwan"],"title":"BMC Public Health The immediate effects of the severe acute respiratory syndrome (SARS) epidemic on childbirth in Taiwan"},{"arc":[[40.9437103271484,40.2619209289551],[33.2227516174316,107.54564666748]],"countries":["Turkey","China"],"title":"BMC Public Health The immediate effects of the severe acute respiratory syndrome (SARS) epidemic on childbirth in Taiwan"},{"arc":[[23.7489929199219,120.971282958984],[33.2227516174316,107.54564666748]],"countries":["Taiwan","China"],"title":"BMC Public Health The immediate effects of the severe acute respiratory syndrome (SARS) epidemic on childbirth in Taiwan"},{"arc":[[33.1274299621582,-117.165199279785],[32.3287200927734,-90.1755599975586]],"countries":["United States"],"title":"The Molecular Biology of Frog Virus 3 and other Iridoviruses Infecting Cold-Blooded Vertebrates"},{"arc":[[48.7505416870117,30.2246208190918],[47.4847412109375,1.68438005447388]],"countries":["Ukraine","France"],"title":"R A P I D C O M M U N I C A T I O N Investigation into the Role of Potentially Contaminated Feed as a Source of the First-Detected Outbreaks of Porcine Epidemic Diarrhea in Canada"},{"arc":[[48.7505416870117,30.2246208190918],[43.5278816223145,-80.2231063842773]],"countries":["Ukraine","Canada"],"title":"R A P I D C O M M U N I C A T I O N Investigation into the Role of Potentially Contaminated Feed as a Source of the First-Detected Outbreaks of Porcine Epidemic Diarrhea in Canada"},{"arc":[[47.4847412109375,1.68438005447388],[43.5278816223145,-80.2231063842773]],"countries":["France","Canada"],"title":"R A P I D C O M M U N I C A T I O N Investigation into the Role of Potentially Contaminated Feed as a Source of the First-Detected Outbreaks of Porcine Epidemic Diarrhea in Canada"},{"arc":[[41.7278709411621,44.764778137207],[39.9046897888184,116.407173156738]],"countries":["Georgia","China"],"title":"Gender differences in patients with COVID-19: Focus on severity and mortality"},{"arc":[[41.7278709411621,44.764778137207],[31.0254402160645,121.436302185059]],"countries":["Georgia","China"],"title":"Gender differences in patients with COVID-19: Focus on severity and mortality"},{"arc":[[41.7278709411621,44.764778137207],[30.5363693237305,114.365432739258]],"countries":["Georgia","China"],"title":"Gender differences in patients with COVID-19: Focus on severity and mortality"},{"arc":[[39.9046897888184,116.407173156738],[31.0254402160645,121.436302185059]],"countries":["China"],"title":"Gender differences in patients with COVID-19: Focus on severity and mortality"},{"arc":[[39.9046897888184,116.407173156738],[30.5363693237305,114.365432739258]],"countries":["China"],"title":"Gender differences in patients with COVID-19: Focus on severity and mortality"},{"arc":[[31.0254402160645,121.436302185059],[30.5363693237305,114.365432739258]],"countries":["China"],"title":"Gender differences in patients with COVID-19: Focus on severity and mortality"},{"arc":[[41.7278709411621,44.764778137207],[30.5363693237305,114.365432739258]],"countries":["Georgia","China"],"title":"Aberrant expression of long noncoding RNAs in chronic thromboembolic pulmonary hypertension"},{"arc":[[41.7278709411621,44.764778137207],[36.5631141662598,103.735809326172]],"countries":["China","Georgia"],"title":"Comparison of Patients Hospitalized With Influenza A Subtypes H7N9, H5N1, and 2009 Pandemic H1N1"},{"arc":[[41.7278709411621,44.764778137207],[31.2988891601562,121.499168395996]],"countries":["Georgia","China"],"title":"Comparison of Patients Hospitalized With Influenza A Subtypes H7N9, H5N1, and 2009 Pandemic H1N1"},{"arc":[[41.7278709411621,44.764778137207],[22.333080291748,114.191223144531]],"countries":["Georgia","Hong Kong SAR"],"title":"Comparison of Patients Hospitalized With Influenza A Subtypes H7N9, H5N1, and 2009 Pandemic H1N1"},{"arc":[[41.7278709411621,44.764778137207],[11.2589302062988,75.7811813354492]],"countries":["Georgia","India"],"title":"Comparison of Patients Hospitalized With Influenza A Subtypes H7N9, H5N1, and 2009 Pandemic H1N1"},{"arc":[[41.7278709411621,44.764778137207],[22.2802925109863,114.142951965332]],"countries":["Georgia","Hong Kong SAR"],"title":"Comparison of Patients Hospitalized With Influenza A Subtypes H7N9, H5N1, and 2009 Pandemic H1N1"},{"arc":[[41.7278709411621,44.764778137207],[30.2633018493652,120.122261047363]],"countries":["Georgia","China"],"title":"Comparison of Patients Hospitalized With Influenza A Subtypes H7N9, H5N1, and 2009 Pandemic H1N1"},{"arc":[[36.5631141662598,103.735809326172],[31.2988891601562,121.499168395996]],"countries":["China"],"title":"Comparison of Patients Hospitalized With Influenza A Subtypes H7N9, H5N1, and 2009 Pandemic H1N1"},{"arc":[[36.5631141662598,103.735809326172],[22.333080291748,114.191223144531]],"countries":["China","Hong Kong SAR"],"title":"Comparison of Patients Hospitalized With Influenza A Subtypes H7N9, H5N1, and 2009 Pandemic H1N1"},{"arc":[[36.5631141662598,103.735809326172],[11.2589302062988,75.7811813354492]],"countries":["China","India"],"title":"Comparison of Patients Hospitalized With Influenza A Subtypes H7N9, H5N1, and 2009 Pandemic H1N1"},{"arc":[[36.5631141662598,103.735809326172],[22.2802925109863,114.142951965332]],"countries":["China","Hong Kong SAR"],"title":"Comparison of Patients Hospitalized With Influenza A Subtypes H7N9, H5N1, and 2009 Pandemic H1N1"},{"arc":[[36.5631141662598,103.735809326172],[30.2633018493652,120.122261047363]],"countries":["China"],"title":"Comparison of Patients Hospitalized With Influenza A Subtypes H7N9, H5N1, and 2009 Pandemic H1N1"},{"arc":[[31.2988891601562,121.499168395996],[22.333080291748,114.191223144531]],"countries":["China","Hong Kong SAR"],"title":"Comparison of Patients Hospitalized With Influenza A Subtypes H7N9, H5N1, and 2009 Pandemic H1N1"},{"arc":[[31.2988891601562,121.499168395996],[11.2589302062988,75.7811813354492]],"countries":["China","India"],"title":"Comparison of Patients Hospitalized With Influenza A Subtypes H7N9, H5N1, and 2009 Pandemic H1N1"},{"arc":[[31.2988891601562,121.499168395996],[22.2802925109863,114.142951965332]],"countries":["China","Hong Kong SAR"],"title":"Comparison of Patients Hospitalized With Influenza A Subtypes H7N9, H5N1, and 2009 Pandemic H1N1"},{"arc":[[31.2988891601562,121.499168395996],[30.2633018493652,120.122261047363]],"countries":["China"],"title":"Comparison of Patients Hospitalized With Influenza A Subtypes H7N9, H5N1, and 2009 Pandemic H1N1"},{"arc":[[22.333080291748,114.191223144531],[11.2589302062988,75.7811813354492]],"countries":["Hong Kong SAR","India"],"title":"Comparison of Patients Hospitalized With Influenza A Subtypes H7N9, H5N1, and 2009 Pandemic H1N1"},{"arc":[[22.333080291748,114.191223144531],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR"],"title":"Comparison of Patients Hospitalized With Influenza A Subtypes H7N9, H5N1, and 2009 Pandemic H1N1"},{"arc":[[22.333080291748,114.191223144531],[30.2633018493652,120.122261047363]],"countries":["Hong Kong SAR","China"],"title":"Comparison of Patients Hospitalized With Influenza A Subtypes H7N9, H5N1, and 2009 Pandemic H1N1"},{"arc":[[11.2589302062988,75.7811813354492],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR","India"],"title":"Comparison of Patients Hospitalized With Influenza A Subtypes H7N9, H5N1, and 2009 Pandemic H1N1"},{"arc":[[11.2589302062988,75.7811813354492],[30.2633018493652,120.122261047363]],"countries":["India","China"],"title":"Comparison of Patients Hospitalized With Influenza A Subtypes H7N9, H5N1, and 2009 Pandemic H1N1"},{"arc":[[22.2802925109863,114.142951965332],[30.2633018493652,120.122261047363]],"countries":["Hong Kong SAR","China"],"title":"Comparison of Patients Hospitalized With Influenza A Subtypes H7N9, H5N1, and 2009 Pandemic H1N1"},{"arc":[[51.4884300231934,-3.17879009246826],[51.5002288818359,-0.178939998149872]],"countries":["United Kingdom"],"title":"CD200 Receptor Restriction of Myeloid Cell Responses Antagonizes Antiviral Immunity and Facilitates Cytomegalovirus Persistence within Mucosal Tissue"},{"arc":[[51.4884300231934,-3.17879009246826],[55.9452209472656,-3.18803000450134]],"countries":["United Kingdom"],"title":"CD200 Receptor Restriction of Myeloid Cell Responses Antagonizes Antiviral Immunity and Facilitates Cytomegalovirus Persistence within Mucosal Tissue"},{"arc":[[51.4884300231934,-3.17879009246826],[53.4706993103027,-2.23559999465942]],"countries":["United Kingdom"],"title":"CD200 Receptor Restriction of Myeloid Cell Responses Antagonizes Antiviral Immunity and Facilitates Cytomegalovirus Persistence within Mucosal Tissue"},{"arc":[[51.5002288818359,-0.178939998149872],[55.9452209472656,-3.18803000450134]],"countries":["United Kingdom"],"title":"CD200 Receptor Restriction of Myeloid Cell Responses Antagonizes Antiviral Immunity and Facilitates Cytomegalovirus Persistence within Mucosal Tissue"},{"arc":[[51.5002288818359,-0.178939998149872],[53.4706993103027,-2.23559999465942]],"countries":["United Kingdom"],"title":"CD200 Receptor Restriction of Myeloid Cell Responses Antagonizes Antiviral Immunity and Facilitates Cytomegalovirus Persistence within Mucosal Tissue"},{"arc":[[55.9452209472656,-3.18803000450134],[53.4706993103027,-2.23559999465942]],"countries":["United Kingdom"],"title":"CD200 Receptor Restriction of Myeloid Cell Responses Antagonizes Antiviral Immunity and Facilitates Cytomegalovirus Persistence within Mucosal Tissue"},{"arc":[[41.5059089660645,-81.6090927124023],[41.5047302246094,-81.6907424926758]],"countries":["United States"],"title":"Network-based Drug Repurposing for Human Coronavirus"},{"arc":[[42.4763488769531,-7.98753976821899],[30.0418796539307,80.311149597168]],"countries":["Spain","India"],"title":"ABMA, a small molecule that inhibits intracellular toxins and pathogens by interfering with late endosomal compartments OPEN"},{"arc":[[42.4763488769531,-7.98753976821899],[40.7182693481445,46.4133987426758]],"countries":["Azerbaijan","Spain"],"title":"ABMA, a small molecule that inhibits intracellular toxins and pathogens by interfering with late endosomal compartments OPEN"},{"arc":[[42.4763488769531,-7.98753976821899],[31.4627456665039,-99.3330459594727]],"countries":["United States","Spain"],"title":"ABMA, a small molecule that inhibits intracellular toxins and pathogens by interfering with late endosomal compartments OPEN"},{"arc":[[42.4763488769531,-7.98753976821899],[43.6221504211426,7.0402398109436]],"countries":["Spain","France"],"title":"ABMA, a small molecule that inhibits intracellular toxins and pathogens by interfering with late endosomal compartments OPEN"},{"arc":[[42.4763488769531,-7.98753976821899],[48.7307891845703,2.17218995094299]],"countries":["Spain","France"],"title":"ABMA, a small molecule that inhibits intracellular toxins and pathogens by interfering with late endosomal compartments OPEN"},{"arc":[[42.4763488769531,-7.98753976821899],[49.787841796875,9.93556022644043]],"countries":["Spain","Germany"],"title":"ABMA, a small molecule that inhibits intracellular toxins and pathogens by interfering with late endosomal compartments OPEN"},{"arc":[[30.0418796539307,80.311149597168],[40.7182693481445,46.4133987426758]],"countries":["Azerbaijan","India"],"title":"ABMA, a small molecule that inhibits intracellular toxins and pathogens by interfering with late endosomal compartments OPEN"},{"arc":[[30.0418796539307,80.311149597168],[31.4627456665039,-99.3330459594727]],"countries":["United States","India"],"title":"ABMA, a small molecule that inhibits intracellular toxins and pathogens by interfering with late endosomal compartments OPEN"},{"arc":[[30.0418796539307,80.311149597168],[43.6221504211426,7.0402398109436]],"countries":["India","France"],"title":"ABMA, a small molecule that inhibits intracellular toxins and pathogens by interfering with late endosomal compartments OPEN"},{"arc":[[30.0418796539307,80.311149597168],[48.7307891845703,2.17218995094299]],"countries":["India","France"],"title":"ABMA, a small molecule that inhibits intracellular toxins and pathogens by interfering with late endosomal compartments OPEN"},{"arc":[[30.0418796539307,80.311149597168],[49.787841796875,9.93556022644043]],"countries":["India","Germany"],"title":"ABMA, a small molecule that inhibits intracellular toxins and pathogens by interfering with late endosomal compartments OPEN"},{"arc":[[40.7182693481445,46.4133987426758],[31.4627456665039,-99.3330459594727]],"countries":["United States","Azerbaijan"],"title":"ABMA, a small molecule that inhibits intracellular toxins and pathogens by interfering with late endosomal compartments OPEN"},{"arc":[[40.7182693481445,46.4133987426758],[43.6221504211426,7.0402398109436]],"countries":["Azerbaijan","France"],"title":"ABMA, a small molecule that inhibits intracellular toxins and pathogens by interfering with late endosomal compartments OPEN"},{"arc":[[40.7182693481445,46.4133987426758],[48.7307891845703,2.17218995094299]],"countries":["Azerbaijan","France"],"title":"ABMA, a small molecule that inhibits intracellular toxins and pathogens by interfering with late endosomal compartments OPEN"},{"arc":[[40.7182693481445,46.4133987426758],[49.787841796875,9.93556022644043]],"countries":["Azerbaijan","Germany"],"title":"ABMA, a small molecule that inhibits intracellular toxins and pathogens by interfering with late endosomal compartments OPEN"},{"arc":[[31.4627456665039,-99.3330459594727],[43.6221504211426,7.0402398109436]],"countries":["United States","France"],"title":"ABMA, a small molecule that inhibits intracellular toxins and pathogens by interfering with late endosomal compartments OPEN"},{"arc":[[31.4627456665039,-99.3330459594727],[48.7307891845703,2.17218995094299]],"countries":["United States","France"],"title":"ABMA, a small molecule that inhibits intracellular toxins and pathogens by interfering with late endosomal compartments OPEN"},{"arc":[[31.4627456665039,-99.3330459594727],[49.787841796875,9.93556022644043]],"countries":["United States","Germany"],"title":"ABMA, a small molecule that inhibits intracellular toxins and pathogens by interfering with late endosomal compartments OPEN"},{"arc":[[43.6221504211426,7.0402398109436],[48.7307891845703,2.17218995094299]],"countries":["France"],"title":"ABMA, a small molecule that inhibits intracellular toxins and pathogens by interfering with late endosomal compartments OPEN"},{"arc":[[43.6221504211426,7.0402398109436],[49.787841796875,9.93556022644043]],"countries":["France","Germany"],"title":"ABMA, a small molecule that inhibits intracellular toxins and pathogens by interfering with late endosomal compartments OPEN"},{"arc":[[48.7307891845703,2.17218995094299],[49.787841796875,9.93556022644043]],"countries":["France","Germany"],"title":"ABMA, a small molecule that inhibits intracellular toxins and pathogens by interfering with late endosomal compartments OPEN"},{"arc":[[36.5631141662598,103.735809326172],[41.118278503418,85.1935272216797]],"countries":["China"],"title":"Complex dynamics in an SIS epidemic model induced by nonlinear incidence"},{"arc":[[26.7023582458496,-80.0865325927734],[23.2024116516113,113.38606262207]],"countries":["China","United States"],"title":"Analysis of the sex ratio of reported gonorrhoea incidence in Shenzhen, China"},{"arc":[[51.1218070983887,10.4006948471069],[47.3191909790039,5.06463003158569]],"countries":["Germany","France"],"title":"Robitaille et al. 1 DUSP1 regulates apoptosis and cell migration, but not the JIP1-protected cytokine response, during Respiratory Syncytial Virus and Sendai Virus infection"},{"arc":[[51.1218070983887,10.4006948471069],[40.7182693481445,46.4133987426758]],"countries":["Azerbaijan","Germany"],"title":"Imported Episodic Rabies Increases Patient Demand for and Physician Delivery of Antirabies Prophylaxis"},{"arc":[[54.6490783691406,-8.43280029296875],[39.0048141479492,-77.0975341796875]],"countries":["Ireland","United States"],"title":"Proceedings of the Food and Drug Administration public workshop on pathogen reduction technologies for blood safety 2018"},{"arc":[[54.6490783691406,-8.43280029296875],[44.9734497070312,-93.2378997802734]],"countries":["Ireland","United States"],"title":"Proceedings of the Food and Drug Administration public workshop on pathogen reduction technologies for blood safety 2018"},{"arc":[[39.0048141479492,-77.0975341796875],[44.9734497070312,-93.2378997802734]],"countries":["United States"],"title":"Proceedings of the Food and Drug Administration public workshop on pathogen reduction technologies for blood safety 2018"},{"arc":[[30.4009304046631,78.0787124633789],[51.4681205749512,0.0636989995837212]],"countries":["India","United Kingdom"],"title":"Curcumin Nanoparticles Ameliorate ICAM-1 Expression in TNF-a-Treated Lung Epithelial Cells through p47 phox and MAPKs/AP-1 Pathways"},{"arc":[[30.4009304046631,78.0787124633789],[35.876606,126.8157]],"countries":["India","South Korea"],"title":"Curcumin Nanoparticles Ameliorate ICAM-1 Expression in TNF-a-Treated Lung Epithelial Cells through p47 phox and MAPKs/AP-1 Pathways"},{"arc":[[30.4009304046631,78.0787124633789],[36.5631141662598,103.735809326172]],"countries":["China","India"],"title":"Curcumin Nanoparticles Ameliorate ICAM-1 Expression in TNF-a-Treated Lung Epithelial Cells through p47 phox and MAPKs/AP-1 Pathways"},{"arc":[[30.4009304046631,78.0787124633789],[22.6201400756836,120.31226348877]],"countries":["India","Taiwan"],"title":"Curcumin Nanoparticles Ameliorate ICAM-1 Expression in TNF-a-Treated Lung Epithelial Cells through p47 phox and MAPKs/AP-1 Pathways"},{"arc":[[30.4009304046631,78.0787124633789],[23.7489929199219,120.971282958984]],"countries":["Taiwan","India"],"title":"Curcumin Nanoparticles Ameliorate ICAM-1 Expression in TNF-a-Treated Lung Epithelial Cells through p47 phox and MAPKs/AP-1 Pathways"},{"arc":[[51.4681205749512,0.0636989995837212],[35.876606,126.8157]],"countries":["United Kingdom","South Korea"],"title":"Curcumin Nanoparticles Ameliorate ICAM-1 Expression in TNF-a-Treated Lung Epithelial Cells through p47 phox and MAPKs/AP-1 Pathways"},{"arc":[[51.4681205749512,0.0636989995837212],[36.5631141662598,103.735809326172]],"countries":["China","United Kingdom"],"title":"Curcumin Nanoparticles Ameliorate ICAM-1 Expression in TNF-a-Treated Lung Epithelial Cells through p47 phox and MAPKs/AP-1 Pathways"},{"arc":[[51.4681205749512,0.0636989995837212],[22.6201400756836,120.31226348877]],"countries":["United Kingdom","Taiwan"],"title":"Curcumin Nanoparticles Ameliorate ICAM-1 Expression in TNF-a-Treated Lung Epithelial Cells through p47 phox and MAPKs/AP-1 Pathways"},{"arc":[[51.4681205749512,0.0636989995837212],[23.7489929199219,120.971282958984]],"countries":["Taiwan","United Kingdom"],"title":"Curcumin Nanoparticles Ameliorate ICAM-1 Expression in TNF-a-Treated Lung Epithelial Cells through p47 phox and MAPKs/AP-1 Pathways"},{"arc":[[35.876606,126.8157],[36.5631141662598,103.735809326172]],"countries":["China","South Korea"],"title":"Curcumin Nanoparticles Ameliorate ICAM-1 Expression in TNF-a-Treated Lung Epithelial Cells through p47 phox and MAPKs/AP-1 Pathways"},{"arc":[[35.876606,126.8157],[22.6201400756836,120.31226348877]],"countries":["South Korea","Taiwan"],"title":"Curcumin Nanoparticles Ameliorate ICAM-1 Expression in TNF-a-Treated Lung Epithelial Cells through p47 phox and MAPKs/AP-1 Pathways"},{"arc":[[35.876606,126.8157],[23.7489929199219,120.971282958984]],"countries":["Taiwan","South Korea"],"title":"Curcumin Nanoparticles Ameliorate ICAM-1 Expression in TNF-a-Treated Lung Epithelial Cells through p47 phox and MAPKs/AP-1 Pathways"},{"arc":[[36.5631141662598,103.735809326172],[22.6201400756836,120.31226348877]],"countries":["China","Taiwan"],"title":"Curcumin Nanoparticles Ameliorate ICAM-1 Expression in TNF-a-Treated Lung Epithelial Cells through p47 phox and MAPKs/AP-1 Pathways"},{"arc":[[36.5631141662598,103.735809326172],[23.7489929199219,120.971282958984]],"countries":["China","Taiwan"],"title":"Curcumin Nanoparticles Ameliorate ICAM-1 Expression in TNF-a-Treated Lung Epithelial Cells through p47 phox and MAPKs/AP-1 Pathways"},{"arc":[[22.6201400756836,120.31226348877],[23.7489929199219,120.971282958984]],"countries":["Taiwan"],"title":"Curcumin Nanoparticles Ameliorate ICAM-1 Expression in TNF-a-Treated Lung Epithelial Cells through p47 phox and MAPKs/AP-1 Pathways"},{"arc":[[35.876606,126.8157],[51.4559898376465,-0.24176000058651]],"countries":["South Korea","United Kingdom"],"title":"A Randomised Controlled Trial of Face Masks and Hand Hygiene in Reducing Influenza Transmission in Households"},{"arc":[[35.876606,126.8157],[22.2802925109863,114.142951965332]],"countries":["South Korea","Hong Kong SAR"],"title":"A Randomised Controlled Trial of Face Masks and Hand Hygiene in Reducing Influenza Transmission in Households"},{"arc":[[51.4559898376465,-0.24176000058651],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR","United Kingdom"],"title":"A Randomised Controlled Trial of Face Masks and Hand Hygiene in Reducing Influenza Transmission in Households"},{"arc":[[52.5251808166504,13.3792200088501],[65.3224716186523,25.3776607513428]],"countries":["Germany","Finland"],"title":"Virology Journal Reference gene selection for quantitative real-time PCR analysis in virus infected cells: SARS corona virus, Yellow fever virus, Human Herpesvirus-6, Camelpox virus and Cytomegalovirus infections"},{"arc":[[52.5251808166504,13.3792200088501],[40.7182693481445,46.4133987426758]],"countries":["Azerbaijan","Germany"],"title":"Virology Journal Reference gene selection for quantitative real-time PCR analysis in virus infected cells: SARS corona virus, Yellow fever virus, Human Herpesvirus-6, Camelpox virus and Cytomegalovirus infections"},{"arc":[[65.3224716186523,25.3776607513428],[40.7182693481445,46.4133987426758]],"countries":["Azerbaijan","Finland"],"title":"Virology Journal Reference gene selection for quantitative real-time PCR analysis in virus infected cells: SARS corona virus, Yellow fever virus, Human Herpesvirus-6, Camelpox virus and Cytomegalovirus infections"},{"arc":[[42.9547386169434,-78.8192367553711],[22.3419208526611,91.8058929443359]],"countries":["United States","Bangladesh"],"title":"Assessment of transport stress on cattle travelling a long distance (648 km), from Jessore (Indian border) to Chittagong, Bangladesh"},{"arc":[[42.9547386169434,-78.8192367553711],[42.4089393615723,-71.1182174682617]],"countries":["United States"],"title":"Assessment of transport stress on cattle travelling a long distance (648 km), from Jessore (Indian border) to Chittagong, Bangladesh"},{"arc":[[22.3419208526611,91.8058929443359],[42.4089393615723,-71.1182174682617]],"countries":["Bangladesh","United States"],"title":"Assessment of transport stress on cattle travelling a long distance (648 km), from Jessore (Indian border) to Chittagong, Bangladesh"},{"arc":[[29.7095108032227,-95.3981781005859],[-37.7035598754883,145.180358886719]],"countries":["United States","Australia"],"title":"Heme Oxygenase-1-Expressing Dendritic Cells Promote Foxp3 + Regulatory T Cell Differentiation and Induce Less Severe Airway Inflammation in Murine Models"},{"arc":[[29.7095108032227,-95.3981781005859],[22.6201400756836,120.31226348877]],"countries":["United States","Taiwan"],"title":"Heme Oxygenase-1-Expressing Dendritic Cells Promote Foxp3 + Regulatory T Cell Differentiation and Induce Less Severe Airway Inflammation in Murine Models"},{"arc":[[-37.7035598754883,145.180358886719],[22.6201400756836,120.31226348877]],"countries":["Australia","Taiwan"],"title":"Heme Oxygenase-1-Expressing Dendritic Cells Promote Foxp3 + Regulatory T Cell Differentiation and Induce Less Severe Airway Inflammation in Murine Models"},{"arc":[[42.3374290466309,-71.1058197021484],[-27.4479598999023,153.016067504883]],"countries":["United States","Australia"],"title":"Using internet search queries for infectious disease surveillance: screening diseases for suitability"},{"arc":[[31.2988891601562,121.499168395996],[37.7697296142578,-122.466094970703]],"countries":["United States","China"],"title":"The Cytokine and Chemokine Profiles in Patients with Hand, Foot and Mouth Disease of Different Severities in Shanghai, China, 2010"},{"arc":[[31.2988891601562,121.499168395996],[31.2988891601562,121.499168395996]],"countries":["China"],"title":"The Cytokine and Chemokine Profiles in Patients with Hand, Foot and Mouth Disease of Different Severities in Shanghai, China, 2010"},{"arc":[[31.2988891601562,121.499168395996],[22.333080291748,114.191223144531]],"countries":["China","Hong Kong SAR"],"title":"The Cytokine and Chemokine Profiles in Patients with Hand, Foot and Mouth Disease of Different Severities in Shanghai, China, 2010"},{"arc":[[31.2988891601562,121.499168395996],[22.2802925109863,114.142951965332]],"countries":["China","Hong Kong SAR"],"title":"The Cytokine and Chemokine Profiles in Patients with Hand, Foot and Mouth Disease of Different Severities in Shanghai, China, 2010"},{"arc":[[37.7697296142578,-122.466094970703],[31.2988891601562,121.499168395996]],"countries":["United States","China"],"title":"The Cytokine and Chemokine Profiles in Patients with Hand, Foot and Mouth Disease of Different Severities in Shanghai, China, 2010"},{"arc":[[37.7697296142578,-122.466094970703],[22.333080291748,114.191223144531]],"countries":["United States","Hong Kong SAR"],"title":"The Cytokine and Chemokine Profiles in Patients with Hand, Foot and Mouth Disease of Different Severities in Shanghai, China, 2010"},{"arc":[[37.7697296142578,-122.466094970703],[22.2802925109863,114.142951965332]],"countries":["United States","Hong Kong SAR"],"title":"The Cytokine and Chemokine Profiles in Patients with Hand, Foot and Mouth Disease of Different Severities in Shanghai, China, 2010"},{"arc":[[22.333080291748,114.191223144531],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR"],"title":"The Cytokine and Chemokine Profiles in Patients with Hand, Foot and Mouth Disease of Different Severities in Shanghai, China, 2010"},{"arc":[[36.5631141662598,103.735809326172],[23.2024116516113,113.38606262207]],"countries":["China"],"title":"Isolation and characterization of a variant porcine epidemic diarrhea virus in China"},{"arc":[[36.5631141662598,103.735809326172],[44.3972511291504,-69.5694427490234]],"countries":["China","United States"],"title":"Isolation and characterization of a variant porcine epidemic diarrhea virus in China"},{"arc":[[23.2024116516113,113.38606262207],[23.2024116516113,113.38606262207]],"countries":["China"],"title":"Isolation and characterization of a variant porcine epidemic diarrhea virus in China"},{"arc":[[23.2024116516113,113.38606262207],[44.3972511291504,-69.5694427490234]],"countries":["China","United States"],"title":"Isolation and characterization of a variant porcine epidemic diarrhea virus in China"},{"arc":[[36.5631141662598,103.735809326172],[33.8806037902832,113.619728088379]],"countries":["China"],"title":"Complete Genome Sequence of Porcine Epidemic Diarrhea Virus from an Outbreak in a Vaccinated Farm in Shandong, China"},{"arc":[[36.5631141662598,103.735809326172],[37.7697296142578,-122.466094970703]],"countries":["China","United States"],"title":"Chemical screen identifies a geroprotective role of quercetin in premature aging"},{"arc":[[36.5631141662598,103.735809326172],[23.1312255859375,113.347915649414]],"countries":["China"],"title":"Chemical screen identifies a geroprotective role of quercetin in premature aging"},{"arc":[[36.5631141662598,103.735809326172],[40.9437103271484,40.2619209289551]],"countries":["Turkey","China"],"title":"Chemical screen identifies a geroprotective role of quercetin in premature aging"},{"arc":[[36.5631141662598,103.735809326172],[32.0483512878418,118.79808807373]],"countries":["China"],"title":"Chemical screen identifies a geroprotective role of quercetin in premature aging"},{"arc":[[37.7697296142578,-122.466094970703],[23.1312255859375,113.347915649414]],"countries":["United States","China"],"title":"Chemical screen identifies a geroprotective role of quercetin in premature aging"},{"arc":[[37.7697296142578,-122.466094970703],[40.9437103271484,40.2619209289551]],"countries":["Turkey","United States"],"title":"Chemical screen identifies a geroprotective role of quercetin in premature aging"},{"arc":[[37.7697296142578,-122.466094970703],[32.0483512878418,118.79808807373]],"countries":["United States","China"],"title":"Chemical screen identifies a geroprotective role of quercetin in premature aging"},{"arc":[[23.1312255859375,113.347915649414],[40.9437103271484,40.2619209289551]],"countries":["Turkey","China"],"title":"Chemical screen identifies a geroprotective role of quercetin in premature aging"},{"arc":[[23.1312255859375,113.347915649414],[32.0483512878418,118.79808807373]],"countries":["China"],"title":"Chemical screen identifies a geroprotective role of quercetin in premature aging"},{"arc":[[40.9437103271484,40.2619209289551],[32.0483512878418,118.79808807373]],"countries":["Turkey","China"],"title":"Chemical screen identifies a geroprotective role of quercetin in premature aging"},{"arc":[[36.5631141662598,103.735809326172],[38.8350486755371,-77.3112411499023]],"countries":["China","United States"],"title":"Significant Prognostic Predictor for Patients with Severe Sepsis and Septic Shock"},{"arc":[[36.5631141662598,103.735809326172],[23.9117393493652,120.687438964844]],"countries":["China","Taiwan"],"title":"Significant Prognostic Predictor for Patients with Severe Sepsis and Septic Shock"},{"arc":[[36.5631141662598,103.735809326172],[41.8842506408691,-87.6324462890625]],"countries":["China","United States"],"title":"Significant Prognostic Predictor for Patients with Severe Sepsis and Septic Shock"},{"arc":[[38.8350486755371,-77.3112411499023],[23.9117393493652,120.687438964844]],"countries":["United States","Taiwan"],"title":"Significant Prognostic Predictor for Patients with Severe Sepsis and Septic Shock"},{"arc":[[38.8350486755371,-77.3112411499023],[41.8842506408691,-87.6324462890625]],"countries":["United States"],"title":"Significant Prognostic Predictor for Patients with Severe Sepsis and Septic Shock"},{"arc":[[23.9117393493652,120.687438964844],[41.8842506408691,-87.6324462890625]],"countries":["Taiwan","United States"],"title":"Significant Prognostic Predictor for Patients with Severe Sepsis and Septic Shock"},{"arc":[[40.9437103271484,40.2619209289551],[37.7697296142578,-122.466094970703]],"countries":["Turkey","United States"],"title":"An Open Receptor-Binding Cavity of Hemagglutinin-Esterase-Fusion Glycoprotein from Newly-Identified Influenza D Virus: Basis for Its Broad Cell Tropism"},{"arc":[[40.9437103271484,40.2619209289551],[37.8056831359863,-122.268104553223]],"countries":["Turkey","United States"],"title":"An Open Receptor-Binding Cavity of Hemagglutinin-Esterase-Fusion Glycoprotein from Newly-Identified Influenza D Virus: Basis for Its Broad Cell Tropism"},{"arc":[[37.7697296142578,-122.466094970703],[37.8056831359863,-122.268104553223]],"countries":["United States"],"title":"An Open Receptor-Binding Cavity of Hemagglutinin-Esterase-Fusion Glycoprotein from Newly-Identified Influenza D Virus: Basis for Its Broad Cell Tropism"},{"arc":[[40.9437103271484,40.2619209289551],[32.9907302856445,112.528511047363]],"countries":["Turkey","China"],"title":"The Important Role of Lipid Raft-Mediated Attachment in the Infection of Cultured Cells by Coronavirus Infectious Bronchitis Virus Beaudette Strain"},{"arc":[[32.9907302856445,112.528511047363],[32.9907302856445,112.528511047363]],"countries":["China"],"title":"The Important Role of Lipid Raft-Mediated Attachment in the Infection of Cultured Cells by Coronavirus Infectious Bronchitis Virus Beaudette Strain"},{"arc":[[40.9437103271484,40.2619209289551],[44.0889167785645,113.921737670898]],"countries":["Turkey","China"],"title":"Reverse Transcription Cross- Priming Amplification-Nucleic Acid Test Strip for Rapid Detection of Porcine Epidemic Diarrhea Virus OPEN"},{"arc":[[40.9437103271484,40.2619209289551],[30.6250877380371,102.697288513184]],"countries":["Turkey","China"],"title":"Reverse Transcription Cross- Priming Amplification-Nucleic Acid Test Strip for Rapid Detection of Porcine Epidemic Diarrhea Virus OPEN"},{"arc":[[40.9437103271484,40.2619209289551],[30.2741508483887,120.155151367188]],"countries":["Turkey","China"],"title":"Reverse Transcription Cross- Priming Amplification-Nucleic Acid Test Strip for Rapid Detection of Porcine Epidemic Diarrhea Virus OPEN"},{"arc":[[44.0889167785645,113.921737670898],[30.6250877380371,102.697288513184]],"countries":["China"],"title":"Reverse Transcription Cross- Priming Amplification-Nucleic Acid Test Strip for Rapid Detection of Porcine Epidemic Diarrhea Virus OPEN"},{"arc":[[44.0889167785645,113.921737670898],[30.2741508483887,120.155151367188]],"countries":["China"],"title":"Reverse Transcription Cross- Priming Amplification-Nucleic Acid Test Strip for Rapid Detection of Porcine Epidemic Diarrhea Virus OPEN"},{"arc":[[30.6250877380371,102.697288513184],[30.2741508483887,120.155151367188]],"countries":["China"],"title":"Reverse Transcription Cross- Priming Amplification-Nucleic Acid Test Strip for Rapid Detection of Porcine Epidemic Diarrhea Virus OPEN"},{"arc":[[40.9437103271484,40.2619209289551],[36.0000915527344,-78.9306488037109]],"countries":["Turkey","United States"],"title":"Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and Subclasses"},{"arc":[[40.9437103271484,40.2619209289551],[29.7095108032227,-95.3981781005859]],"countries":["Turkey","United States"],"title":"Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and Subclasses"},{"arc":[[40.9437103271484,40.2619209289551],[32.9907302856445,112.528511047363]],"countries":["Turkey","China"],"title":"Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and Subclasses"},{"arc":[[40.9437103271484,40.2619209289551],[42.0617485046387,-87.6770706176758]],"countries":["Turkey","United States"],"title":"Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and Subclasses"},{"arc":[[36.0000915527344,-78.9306488037109],[29.7095108032227,-95.3981781005859]],"countries":["United States"],"title":"Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and Subclasses"},{"arc":[[36.0000915527344,-78.9306488037109],[32.9907302856445,112.528511047363]],"countries":["United States","China"],"title":"Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and Subclasses"},{"arc":[[36.0000915527344,-78.9306488037109],[42.0617485046387,-87.6770706176758]],"countries":["United States"],"title":"Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and Subclasses"},{"arc":[[29.7095108032227,-95.3981781005859],[32.9907302856445,112.528511047363]],"countries":["United States","China"],"title":"Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and Subclasses"},{"arc":[[29.7095108032227,-95.3981781005859],[42.0617485046387,-87.6770706176758]],"countries":["United States"],"title":"Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and Subclasses"},{"arc":[[32.9907302856445,112.528511047363],[42.0617485046387,-87.6770706176758]],"countries":["China","United States"],"title":"Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and Subclasses"},{"arc":[[40.9437103271484,40.2619209289551],[40.9437103271484,40.2619209289551]],"countries":["Turkey"],"title":"viruses Review From SARS to MERS, Thrusting Coronaviruses into the Spotlight"},{"arc":[[39.9046897888184,116.407173156738],[44.3065299987793,86.0789337158203]],"countries":["China"],"title":"Activation of JNK1/2 and p38 MAPK signaling pathways promotes enterovirus 71 infection in immature dendritic cells"},{"arc":[[37.7697296142578,-122.466094970703],[37.7697296142578,-122.466094970703]],"countries":["United States"],"title":"Modeling Heterogeneity in Direct Infectious Disease Transmission in a Compartmental Model"},{"arc":[[37.7697296142578,-122.466094970703],[54.6490783691406,-8.43280029296875]],"countries":["United States","Ireland"],"title":"Modeling Heterogeneity in Direct Infectious Disease Transmission in a Compartmental Model"},{"arc":[[37.7697296142578,-122.466094970703],[40.9437103271484,40.2619209289551]],"countries":["Turkey","United States"],"title":"Adenoviral vector-based strategies against infectious disease and cancer"},{"arc":[[37.7697296142578,-122.466094970703],[36.5631141662598,103.735809326172]],"countries":["China","United States"],"title":"Combined approaches of EPR and NMR illustrate only one transmembrane helix in the human IFITM3 OPEN"},{"arc":[[37.7697296142578,-122.466094970703],[32.0583801269531,118.79647064209]],"countries":["United States","China"],"title":"Broadly resistant HIV-1 against CD4-binding site neutralizing antibodies"},{"arc":[[37.7697296142578,-122.466094970703],[39.0048141479492,-77.0975341796875]],"countries":["United States"],"title":"Broadly resistant HIV-1 against CD4-binding site neutralizing antibodies"},{"arc":[[37.7697296142578,-122.466094970703],[40.0059814453125,116.326812744141]],"countries":["United States","China"],"title":"Broadly resistant HIV-1 against CD4-binding site neutralizing antibodies"},{"arc":[[32.0583801269531,118.79647064209],[39.0048141479492,-77.0975341796875]],"countries":["China","United States"],"title":"Broadly resistant HIV-1 against CD4-binding site neutralizing antibodies"},{"arc":[[32.0583801269531,118.79647064209],[40.0059814453125,116.326812744141]],"countries":["China"],"title":"Broadly resistant HIV-1 against CD4-binding site neutralizing antibodies"},{"arc":[[39.0048141479492,-77.0975341796875],[40.0059814453125,116.326812744141]],"countries":["United States","China"],"title":"Broadly resistant HIV-1 against CD4-binding site neutralizing antibodies"},{"arc":[[37.7697296142578,-122.466094970703],[31.5884895324707,120.357612609863]],"countries":["United States","China"],"title":"Normal Thoracic Radiographic Appearance of the Cynomolgus Monkey (Macaca fascicularis)"},{"arc":[[37.7697296142578,-122.466094970703],[29.5647106170654,106.550727844238]],"countries":["United States","China"],"title":"Normal Thoracic Radiographic Appearance of the Cynomolgus Monkey (Macaca fascicularis)"},{"arc":[[31.5884895324707,120.357612609863],[29.5647106170654,106.550727844238]],"countries":["China"],"title":"Normal Thoracic Radiographic Appearance of the Cynomolgus Monkey (Macaca fascicularis)"},{"arc":[[37.7697296142578,-122.466094970703],[30.6250877380371,102.697288513184]],"countries":["United States","China"],"title":"Molecular basis of binding between the global post-transcriptional regulator CsrA and the T3SS chaperone CesT"},{"arc":[[37.7697296142578,-122.466094970703],[44.3972511291504,-69.5694427490234]],"countries":["United States"],"title":"Molecular basis of binding between the global post-transcriptional regulator CsrA and the T3SS chaperone CesT"},{"arc":[[30.6250877380371,102.697288513184],[44.3972511291504,-69.5694427490234]],"countries":["China","United States"],"title":"Molecular basis of binding between the global post-transcriptional regulator CsrA and the T3SS chaperone CesT"},{"arc":[[37.7697296142578,-122.466094970703],[26.029390335083,118.138877868652]],"countries":["United States","China"],"title":"Article 1843-L (2019) Influenza Virus-Induced Robust Expression of SOCS3 Contributes to Excessive Production of IL-6"},{"arc":[[37.7697296142578,-122.466094970703],[44.9734497070312,-93.2378997802734]],"countries":["United States"],"title":"Article 1843-L (2019) Influenza Virus-Induced Robust Expression of SOCS3 Contributes to Excessive Production of IL-6"},{"arc":[[26.029390335083,118.138877868652],[44.9734497070312,-93.2378997802734]],"countries":["China","United States"],"title":"Article 1843-L (2019) Influenza Virus-Induced Robust Expression of SOCS3 Contributes to Excessive Production of IL-6"},{"arc":[[37.7697296142578,-122.466094970703],[32.0583801269531,118.79647064209]],"countries":["United States","China"],"title":":1-27. 5. Schwartzman W. Bartonella (Roch-alimaea) infections: beyond cat scratch"},{"arc":[[37.7697296142578,-122.466094970703],[38.9997596740723,-77.0832443237305]],"countries":["United States"],"title":":1-27. 5. Schwartzman W. Bartonella (Roch-alimaea) infections: beyond cat scratch"},{"arc":[[37.7697296142578,-122.466094970703],[39.4959106445312,-98.9899826049805]],"countries":["United States"],"title":":1-27. 5. Schwartzman W. Bartonella (Roch-alimaea) infections: beyond cat scratch"},{"arc":[[37.7697296142578,-122.466094970703],[35.140251159668,-90.0300979614258]],"countries":["United States"],"title":":1-27. 5. Schwartzman W. Bartonella (Roch-alimaea) infections: beyond cat scratch"},{"arc":[[32.0583801269531,118.79647064209],[38.9997596740723,-77.0832443237305]],"countries":["China","United States"],"title":":1-27. 5. Schwartzman W. Bartonella (Roch-alimaea) infections: beyond cat scratch"},{"arc":[[32.0583801269531,118.79647064209],[39.4959106445312,-98.9899826049805]],"countries":["China","United States"],"title":":1-27. 5. Schwartzman W. Bartonella (Roch-alimaea) infections: beyond cat scratch"},{"arc":[[32.0583801269531,118.79647064209],[35.140251159668,-90.0300979614258]],"countries":["China","United States"],"title":":1-27. 5. Schwartzman W. Bartonella (Roch-alimaea) infections: beyond cat scratch"},{"arc":[[38.9997596740723,-77.0832443237305],[39.4959106445312,-98.9899826049805]],"countries":["United States"],"title":":1-27. 5. Schwartzman W. Bartonella (Roch-alimaea) infections: beyond cat scratch"},{"arc":[[38.9997596740723,-77.0832443237305],[35.140251159668,-90.0300979614258]],"countries":["United States"],"title":":1-27. 5. Schwartzman W. Bartonella (Roch-alimaea) infections: beyond cat scratch"},{"arc":[[39.4959106445312,-98.9899826049805],[35.140251159668,-90.0300979614258]],"countries":["United States"],"title":":1-27. 5. Schwartzman W. Bartonella (Roch-alimaea) infections: beyond cat scratch"},{"arc":[[35.9628207555179,-88.9393164950906],[9.36855030059814,-83.6394882202148]],"countries":["United States","Costa Rica"],"title":"Therapeutics and Clinical Risk Management Dovepress Frequency of tuberculosis among diabetic patients in the People's Republic of China"},{"arc":[[35.9628207555179,-88.9393164950906],[41.7278709411621,44.764778137207]],"countries":["Georgia","United States"],"title":"Therapeutics and Clinical Risk Management Dovepress Frequency of tuberculosis among diabetic patients in the People's Republic of China"},{"arc":[[9.36855030059814,-83.6394882202148],[41.7278709411621,44.764778137207]],"countries":["Georgia","Costa Rica"],"title":"Therapeutics and Clinical Risk Management Dovepress Frequency of tuberculosis among diabetic patients in the People's Republic of China"},{"arc":[[35.7442817687988,127.166305541992],[35.7442817687988,127.166305541992]],"countries":["South Korea"],"title":"Preventive Effect of Korean Red Ginseng for Acute Respiratory Illness: A Randomized and Double-Blind Clinical Trial"},{"arc":[[35.7442817687988,127.166305541992],[36.4511566162109,127.861145019531]],"countries":["South Korea"],"title":"Preventive Effect of Korean Red Ginseng for Acute Respiratory Illness: A Randomized and Double-Blind Clinical Trial"},{"arc":[[35.7442817687988,127.166305541992],[40.9437103271484,40.2619209289551]],"countries":["Turkey","South Korea"],"title":"Preventive Effect of Korean Red Ginseng for Acute Respiratory Illness: A Randomized and Double-Blind Clinical Trial"},{"arc":[[36.4511566162109,127.861145019531],[40.9437103271484,40.2619209289551]],"countries":["Turkey","South Korea"],"title":"Preventive Effect of Korean Red Ginseng for Acute Respiratory Illness: A Randomized and Double-Blind Clinical Trial"},{"arc":[[34.8679008483887,126.990997314453],[36.4511566162109,127.861145019531]],"countries":["South Korea"],"title":"Development of Lectin-Linked Immunomagnetic Separation for the Detection of Hepatitis A Virus"},{"arc":[[48.8221206665039,2.33101010322571],[29.649730682373,-82.3411331176758]],"countries":["France","United States"],"title":"Complete Genome Sequence of Human Coronavirus Strain 229E Isolated from Plasma Collected from a Haitian Child in 2016"},{"arc":[[36.662978,126.755133],[40.9437103271484,40.2619209289551]],"countries":["Turkey","South Korea"],"title":"Correlation of microbiological yield with radiographic activity on chest computed tomography in cases of suspected pulmonary tuberculosis"},{"arc":[[36.662978,126.755133],[36.755867,126.30135]],"countries":["South Korea"],"title":"Correlation of microbiological yield with radiographic activity on chest computed tomography in cases of suspected pulmonary tuberculosis"},{"arc":[[36.662978,126.755133],[38.069639,128.173325]],"countries":["South Korea"],"title":"Correlation of microbiological yield with radiographic activity on chest computed tomography in cases of suspected pulmonary tuberculosis"},{"arc":[[36.662978,126.755133],[33.4749794006348,126.530693054199]],"countries":["South Korea"],"title":"Correlation of microbiological yield with radiographic activity on chest computed tomography in cases of suspected pulmonary tuberculosis"},{"arc":[[40.9437103271484,40.2619209289551],[40.9437103271484,40.2619209289551]],"countries":["Turkey"],"title":"Correlation of microbiological yield with radiographic activity on chest computed tomography in cases of suspected pulmonary tuberculosis"},{"arc":[[40.9437103271484,40.2619209289551],[36.755867,126.30135]],"countries":["Turkey","South Korea"],"title":"Correlation of microbiological yield with radiographic activity on chest computed tomography in cases of suspected pulmonary tuberculosis"},{"arc":[[40.9437103271484,40.2619209289551],[38.069639,128.173325]],"countries":["Turkey","South Korea"],"title":"Correlation of microbiological yield with radiographic activity on chest computed tomography in cases of suspected pulmonary tuberculosis"},{"arc":[[40.9437103271484,40.2619209289551],[33.4749794006348,126.530693054199]],"countries":["Turkey","South Korea"],"title":"Correlation of microbiological yield with radiographic activity on chest computed tomography in cases of suspected pulmonary tuberculosis"},{"arc":[[36.755867,126.30135],[38.069639,128.173325]],"countries":["South Korea"],"title":"Correlation of microbiological yield with radiographic activity on chest computed tomography in cases of suspected pulmonary tuberculosis"},{"arc":[[36.755867,126.30135],[33.4749794006348,126.530693054199]],"countries":["South Korea"],"title":"Correlation of microbiological yield with radiographic activity on chest computed tomography in cases of suspected pulmonary tuberculosis"},{"arc":[[38.069639,128.173325],[33.4749794006348,126.530693054199]],"countries":["South Korea"],"title":"Correlation of microbiological yield with radiographic activity on chest computed tomography in cases of suspected pulmonary tuberculosis"},{"arc":[[36.7909545898438,126.799468994141],[36.662978,126.755133]],"countries":["South Korea"],"title":"Clinical Features and Courses of Adenovirus Pneumonia in Healthy Young Adults during an Outbreak among Korean Military Personnel"},{"arc":[[36.7909545898438,126.799468994141],[31.3634490966797,75.5509414672852]],"countries":["South Korea","India"],"title":"Clinical Features and Courses of Adenovirus Pneumonia in Healthy Young Adults during an Outbreak among Korean Military Personnel"},{"arc":[[36.7909545898438,126.799468994141],[35.985864,128.914808]],"countries":["South Korea"],"title":"Clinical Features and Courses of Adenovirus Pneumonia in Healthy Young Adults during an Outbreak among Korean Military Personnel"},{"arc":[[36.662978,126.755133],[31.3634490966797,75.5509414672852]],"countries":["South Korea","India"],"title":"Clinical Features and Courses of Adenovirus Pneumonia in Healthy Young Adults during an Outbreak among Korean Military Personnel"},{"arc":[[36.662978,126.755133],[35.985864,128.914808]],"countries":["South Korea"],"title":"Clinical Features and Courses of Adenovirus Pneumonia in Healthy Young Adults during an Outbreak among Korean Military Personnel"},{"arc":[[31.3634490966797,75.5509414672852],[35.985864,128.914808]],"countries":["South Korea","India"],"title":"Clinical Features and Courses of Adenovirus Pneumonia in Healthy Young Adults during an Outbreak among Korean Military Personnel"},{"arc":[[39.1410217285156,-84.5021362304688],[-25.4304790496826,-49.2845115661621]],"countries":["United States","Brazil"],"title":"Preliminary epidemiological analysis on children and adolescents with novel coronavirus disease 2019 outside Hubei Province, China: an observational study utilizing crowdsourced data"},{"arc":[[22.3337936154897,114.179224932647],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR","Hong Kong-China"],"title":"Molecular Evolution of MERS Coronavirus: Dromedaries as a Recent Intermediate Host or Long-Time Animal Reservoir?"},{"arc":[[41.5047302246094,-81.6907424926758],[41.5059089660645,-81.6090927124023]],"countries":["United States"],"title":"RNase L restricts the mobility of engineered retrotransposons in cultured human cells"},{"arc":[[30.7602596282959,47.6596298217773],[33.5566825866699,23.774206161499]],"countries":["Iraq","NOCOUNTRY"],"title":"Detection of Plant DNA in the Bronchoalveolar Lavage of Patients with Ventilator-Associated Pneumonia"},{"arc":[[39.6785011291504,-104.966621398926],[39.0048141479492,-77.0975341796875]],"countries":["United States"],"title":"Replication and shedding of MERS- CoV in Jamaican fruit bats (Artibeus jamaicensis) OPEN"},{"arc":[[39.6785011291504,-104.966621398926],[43.9649963378906,-112.343688964844]],"countries":["United States","NOCOUNTRY"],"title":"Replication and shedding of MERS- CoV in Jamaican fruit bats (Artibeus jamaicensis) OPEN"},{"arc":[[39.6785011291504,-104.966621398926],[40.4118385314941,-104.692291259766]],"countries":["United States"],"title":"Replication and shedding of MERS- CoV in Jamaican fruit bats (Artibeus jamaicensis) OPEN"},{"arc":[[39.0048141479492,-77.0975341796875],[43.9649963378906,-112.343688964844]],"countries":["United States","NOCOUNTRY"],"title":"Replication and shedding of MERS- CoV in Jamaican fruit bats (Artibeus jamaicensis) OPEN"},{"arc":[[39.0048141479492,-77.0975341796875],[40.4118385314941,-104.692291259766]],"countries":["United States"],"title":"Replication and shedding of MERS- CoV in Jamaican fruit bats (Artibeus jamaicensis) OPEN"},{"arc":[[43.9649963378906,-112.343688964844],[40.4118385314941,-104.692291259766]],"countries":["NOCOUNTRY","United States"],"title":"Replication and shedding of MERS- CoV in Jamaican fruit bats (Artibeus jamaicensis) OPEN"},{"arc":[[39.6785011291504,-104.966621398926],[22.4931182861328,79.7270126342773]],"countries":["United States","India"],"title":"viruses Temperature Sensitive Mutations in Influenza A Viral Ribonucleoprotein Complex Responsible for the Attenuation of the Live Attenuated Influenza Vaccine"},{"arc":[[39.6785011291504,-104.966621398926],[43.1265411376953,-77.6315383911133]],"countries":["United States"],"title":"viruses Temperature Sensitive Mutations in Influenza A Viral Ribonucleoprotein Complex Responsible for the Attenuation of the Live Attenuated Influenza Vaccine"},{"arc":[[22.4931182861328,79.7270126342773],[43.1265411376953,-77.6315383911133]],"countries":["India","United States"],"title":"viruses Temperature Sensitive Mutations in Influenza A Viral Ribonucleoprotein Complex Responsible for the Attenuation of the Live Attenuated Influenza Vaccine"},{"arc":[[40.8081588745117,-73.9636535644531],[40.8075561523438,-73.9640808105469]],"countries":["United States"],"title":"Stress-induced phospho-ubiquitin formation causes parkin degradation"},{"arc":[[40.8081588745117,-73.9636535644531],[42.9370803833008,-75.6106948852539]],"countries":["United States"],"title":"Stress-induced phospho-ubiquitin formation causes parkin degradation"},{"arc":[[40.8075561523438,-73.9640808105469],[42.9370803833008,-75.6106948852539]],"countries":["United States"],"title":"Stress-induced phospho-ubiquitin formation causes parkin degradation"},{"arc":[[40.8075561523438,-73.9640808105469],[7.50905990600586,16.0927104949951]],"countries":["United States","Central African Republic"],"title":"336 | Influenza Other Respi Viruses"},{"arc":[[40.152660369873,-80.2116928100586],[51.1082496643066,17.0269107818604]],"countries":["United States","Poland"],"title":"Production of Recombinant EAV with Tagged Structural Protein Gp3 to Study Artervirus Minor Protein Localization in Infected Cells"},{"arc":[[51.88564,-8.53312],[41.750358581543,-72.6930084228516]],"countries":["Ireland","United States"],"title":"BMC Veterinary Research Molecular characterisation of a bovine-like rotavirus detected from a giraffe"},{"arc":[[51.88564,-8.53312],[53.3086013793945,-6.22065019607544]],"countries":["Ireland"],"title":"BMC Veterinary Research Molecular characterisation of a bovine-like rotavirus detected from a giraffe"},{"arc":[[41.750358581543,-72.6930084228516],[53.3086013793945,-6.22065019607544]],"countries":["United States","Ireland"],"title":"BMC Veterinary Research Molecular characterisation of a bovine-like rotavirus detected from a giraffe"},{"arc":[[42.4463500976562,-76.4826889038086],[22.333080291748,114.191223144531]],"countries":["United States","Hong Kong SAR"],"title":"Ezrin Interacts with the SARS Coronavirus Spike Protein and Restrains Infection at the Entry Stage"},{"arc":[[42.4463500976562,-76.4826889038086],[40.7182693481445,46.4133987426758]],"countries":["Azerbaijan","United States"],"title":"Ezrin Interacts with the SARS Coronavirus Spike Protein and Restrains Infection at the Entry Stage"},{"arc":[[42.4463500976562,-76.4826889038086],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR","United States"],"title":"Ezrin Interacts with the SARS Coronavirus Spike Protein and Restrains Infection at the Entry Stage"},{"arc":[[22.333080291748,114.191223144531],[40.7182693481445,46.4133987426758]],"countries":["Azerbaijan","Hong Kong SAR"],"title":"Ezrin Interacts with the SARS Coronavirus Spike Protein and Restrains Infection at the Entry Stage"},{"arc":[[22.333080291748,114.191223144531],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR"],"title":"Ezrin Interacts with the SARS Coronavirus Spike Protein and Restrains Infection at the Entry Stage"},{"arc":[[40.7182693481445,46.4133987426758],[22.2802925109863,114.142951965332]],"countries":["Azerbaijan","Hong Kong SAR"],"title":"Ezrin Interacts with the SARS Coronavirus Spike Protein and Restrains Infection at the Entry Stage"},{"arc":[[22.4975490570068,88.3702697753906],[22.5259609222412,88.3634872436523]],"countries":["India"],"title":"Para-Phenylenediamine Induces Apoptotic Death of Melanoma Cells and Reduces Melanoma Tumour Growth in Mice"},{"arc":[[44.6344795227051,-63.5939788818359],[13.0170698165894,77.6431198120117]],"countries":["Canada","India"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[44.6344795227051,-63.5939788818359],[43.9649963378906,-112.343688964844]],"countries":["Canada","NOCOUNTRY"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[44.6344795227051,-63.5939788818359],[23.3535003662109,116.68221282959]],"countries":["Canada","China"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[44.6344795227051,-63.5939788818359],[40.72495,8.56011]],"countries":["Canada","Italy"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[44.6344795227051,-63.5939788818359],[35.7868995666504,-93.9436416625977]],"countries":["United States","Canada"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[44.6344795227051,-63.5939788818359],[49.8096008300781,-97.1333312988281]],"countries":["Canada"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[44.6344795227051,-63.5939788818359],[52.1374397277832,-106.627517700195]],"countries":["Canada"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[13.0170698165894,77.6431198120117],[43.9649963378906,-112.343688964844]],"countries":["India","NOCOUNTRY"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[13.0170698165894,77.6431198120117],[23.3535003662109,116.68221282959]],"countries":["India","China"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[13.0170698165894,77.6431198120117],[40.72495,8.56011]],"countries":["India","Italy"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[13.0170698165894,77.6431198120117],[35.7868995666504,-93.9436416625977]],"countries":["United States","India"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[13.0170698165894,77.6431198120117],[49.8096008300781,-97.1333312988281]],"countries":["India","Canada"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[13.0170698165894,77.6431198120117],[52.1374397277832,-106.627517700195]],"countries":["India","Canada"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[43.9649963378906,-112.343688964844],[23.3535003662109,116.68221282959]],"countries":["China","NOCOUNTRY"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[43.9649963378906,-112.343688964844],[40.72495,8.56011]],"countries":["NOCOUNTRY","Italy"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[43.9649963378906,-112.343688964844],[35.7868995666504,-93.9436416625977]],"countries":["United States","NOCOUNTRY"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[43.9649963378906,-112.343688964844],[49.8096008300781,-97.1333312988281]],"countries":["NOCOUNTRY","Canada"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[43.9649963378906,-112.343688964844],[52.1374397277832,-106.627517700195]],"countries":["NOCOUNTRY","Canada"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[23.3535003662109,116.68221282959],[40.72495,8.56011]],"countries":["China","Italy"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[23.3535003662109,116.68221282959],[35.7868995666504,-93.9436416625977]],"countries":["United States","China"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[23.3535003662109,116.68221282959],[49.8096008300781,-97.1333312988281]],"countries":["China","Canada"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[23.3535003662109,116.68221282959],[52.1374397277832,-106.627517700195]],"countries":["China","Canada"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[40.72495,8.56011],[35.7868995666504,-93.9436416625977]],"countries":["United States","Italy"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[40.72495,8.56011],[49.8096008300781,-97.1333312988281]],"countries":["Italy","Canada"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[40.72495,8.56011],[52.1374397277832,-106.627517700195]],"countries":["Italy","Canada"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[35.7868995666504,-93.9436416625977],[49.8096008300781,-97.1333312988281]],"countries":["United States","Canada"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[35.7868995666504,-93.9436416625977],[52.1374397277832,-106.627517700195]],"countries":["United States","Canada"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[49.8096008300781,-97.1333312988281],[52.1374397277832,-106.627517700195]],"countries":["Canada"],"title":"Outbreak 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness"},{"arc":[[-37.8466987609863,145.120620727539],[40.9437103271484,40.2619209289551]],"countries":["Turkey","Australia"],"title":"Investigation of the Plasmodium falciparum Food Vacuole through Inducible Expression of the Chloroquine Resistance Transporter (PfCRT)"},{"arc":[[-37.8466987609863,145.120620727539],[-37.797981262207,144.959045410156]],"countries":["Australia"],"title":"Investigation of the Plasmodium falciparum Food Vacuole through Inducible Expression of the Chloroquine Resistance Transporter (PfCRT)"},{"arc":[[40.9437103271484,40.2619209289551],[-37.797981262207,144.959045410156]],"countries":["Turkey","Australia"],"title":"Investigation of the Plasmodium falciparum Food Vacuole through Inducible Expression of the Chloroquine Resistance Transporter (PfCRT)"},{"arc":[[39.9407119750977,116.43531036377],[39.2892150878906,117.349395751953]],"countries":["China"],"title":"Outcome reporting from protocols of clinical trials of Coronavirus Disease 2019 (COVID-19): a review"},{"arc":[[39.9407119750977,116.43531036377],[23.2024116516113,113.38606262207]],"countries":["China"],"title":"Outcome reporting from protocols of clinical trials of Coronavirus Disease 2019 (COVID-19): a review"},{"arc":[[39.2892150878906,117.349395751953],[23.2024116516113,113.38606262207]],"countries":["China"],"title":"Outcome reporting from protocols of clinical trials of Coronavirus Disease 2019 (COVID-19): a review"},{"arc":[[36.0000915527344,-78.9306488037109],[22.3796997070312,114.201698303223]],"countries":["United States","Hong Kong SAR"],"title":"A Mini Review of the Zoonotic Threat Potential of influenza viruses, Coronaviruses, Adenoviruses, and enteroviruses"},{"arc":[[42.7586784362793,-82.483512878418],[23.8029747009277,108.794311523438]],"countries":["China","United States"],"title":"Non-periodic outbreaks of recurrent epidemics and its network modelling OPEN"},{"arc":[[42.7586784362793,-82.483512878418],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR","United States"],"title":"Non-periodic outbreaks of recurrent epidemics and its network modelling OPEN"},{"arc":[[23.8029747009277,108.794311523438],[22.2802925109863,114.142951965332]],"countries":["China","Hong Kong SAR"],"title":"Non-periodic outbreaks of recurrent epidemics and its network modelling OPEN"},{"arc":[[48.8330574035645,2.36277794837952],[43.6319427490234,3.86388897895813]],"countries":["France"],"title":"ARTICLE Fragment-based discovery of a new family of non-peptidic small-molecule cyclophilin inhibitors with potent antiviral activities"},{"arc":[[48.8330574035645,2.36277794837952],[48.8769454956055,2.35916709899902]],"countries":["France"],"title":"ARTICLE Fragment-based discovery of a new family of non-peptidic small-molecule cyclophilin inhibitors with potent antiviral activities"},{"arc":[[43.6319427490234,3.86388897895813],[48.8769454956055,2.35916709899902]],"countries":["France"],"title":"ARTICLE Fragment-based discovery of a new family of non-peptidic small-molecule cyclophilin inhibitors with potent antiviral activities"},{"arc":[[4.58086013793945,-74.4432830810547],[0.335489988327026,32.5687217712402]],"countries":["Colombia","Uganda"],"title":"Applying evolutionary concepts to wildlife disease ecology and management"},{"arc":[[4.58086013793945,-74.4432830810547],[45.5065994262695,-73.5779571533203]],"countries":["Colombia","Canada"],"title":"Applying evolutionary concepts to wildlife disease ecology and management"},{"arc":[[0.335489988327026,32.5687217712402],[45.5065994262695,-73.5779571533203]],"countries":["Uganda","Canada"],"title":"Applying evolutionary concepts to wildlife disease ecology and management"},{"arc":[[33.789680480957,-84.3255462646484],[33.7483100891113,-84.39111328125]],"countries":["United States"],"title":"ARTICLE A polyvalent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques"},{"arc":[[33.789680480957,-84.3255462646484],[33.7713203430176,-84.3944091796875]],"countries":["United States"],"title":"ARTICLE A polyvalent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques"},{"arc":[[33.789680480957,-84.3255462646484],[-37.7035598754883,145.180358886719]],"countries":["Australia","United States"],"title":"ARTICLE A polyvalent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques"},{"arc":[[33.789680480957,-84.3255462646484],[39.4959106445312,-98.9899826049805]],"countries":["United States"],"title":"ARTICLE A polyvalent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques"},{"arc":[[33.789680480957,-84.3255462646484],[43.0754890441895,-89.4199829101562]],"countries":["United States"],"title":"ARTICLE A polyvalent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques"},{"arc":[[33.7483100891113,-84.39111328125],[33.7713203430176,-84.3944091796875]],"countries":["United States"],"title":"ARTICLE A polyvalent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques"},{"arc":[[33.7483100891113,-84.39111328125],[-37.7035598754883,145.180358886719]],"countries":["Australia","United States"],"title":"ARTICLE A polyvalent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques"},{"arc":[[33.7483100891113,-84.39111328125],[39.4959106445312,-98.9899826049805]],"countries":["United States"],"title":"ARTICLE A polyvalent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques"},{"arc":[[33.7483100891113,-84.39111328125],[43.0754890441895,-89.4199829101562]],"countries":["United States"],"title":"ARTICLE A polyvalent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques"},{"arc":[[33.7713203430176,-84.3944091796875],[-37.7035598754883,145.180358886719]],"countries":["Australia","United States"],"title":"ARTICLE A polyvalent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques"},{"arc":[[33.7713203430176,-84.3944091796875],[39.4959106445312,-98.9899826049805]],"countries":["United States"],"title":"ARTICLE A polyvalent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques"},{"arc":[[33.7713203430176,-84.3944091796875],[43.0754890441895,-89.4199829101562]],"countries":["United States"],"title":"ARTICLE A polyvalent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques"},{"arc":[[-37.7035598754883,145.180358886719],[39.4959106445312,-98.9899826049805]],"countries":["Australia","United States"],"title":"ARTICLE A polyvalent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques"},{"arc":[[-37.7035598754883,145.180358886719],[43.0754890441895,-89.4199829101562]],"countries":["Australia","United States"],"title":"ARTICLE A polyvalent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques"},{"arc":[[39.4959106445312,-98.9899826049805],[43.0754890441895,-89.4199829101562]],"countries":["United States"],"title":"ARTICLE A polyvalent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques"},{"arc":[[33.789680480957,-84.3255462646484],[28.7162494659424,77.2728576660156]],"countries":["United States","India"],"title":"Case Investigations of Infectious Diseases Occurring in Workplaces, United States, 2006-2015 A Tale of Two Kitchens, Meals, and Microbes"},{"arc":[[33.789680480957,-84.3255462646484],[40.1836891174316,-80.2459411621094]],"countries":["United States"],"title":"Case Investigations of Infectious Diseases Occurring in Workplaces, United States, 2006-2015 A Tale of Two Kitchens, Meals, and Microbes"},{"arc":[[28.7162494659424,77.2728576660156],[40.1836891174316,-80.2459411621094]],"countries":["India","United States"],"title":"Case Investigations of Infectious Diseases Occurring in Workplaces, United States, 2006-2015 A Tale of Two Kitchens, Meals, and Microbes"},{"arc":[[33.7483100891113,-84.39111328125],[40.9437103271484,40.2619209289551]],"countries":["Turkey","United States"],"title":"Detection of Novel SARS-like and Other Coronaviruses in Bats from Kenya"},{"arc":[[33.7483100891113,-84.39111328125],[0.537028014659882,37.8567771911621]],"countries":["United States","Kenya"],"title":"Detection of Novel SARS-like and Other Coronaviruses in Bats from Kenya"},{"arc":[[33.7483100891113,-84.39111328125],[39.4959106445312,-98.9899826049805]],"countries":["United States"],"title":"Detection of Novel SARS-like and Other Coronaviruses in Bats from Kenya"},{"arc":[[40.9437103271484,40.2619209289551],[0.537028014659882,37.8567771911621]],"countries":["Turkey","Kenya"],"title":"Detection of Novel SARS-like and Other Coronaviruses in Bats from Kenya"},{"arc":[[40.9437103271484,40.2619209289551],[39.4959106445312,-98.9899826049805]],"countries":["Turkey","United States"],"title":"Detection of Novel SARS-like and Other Coronaviruses in Bats from Kenya"},{"arc":[[0.537028014659882,37.8567771911621],[39.4959106445312,-98.9899826049805]],"countries":["United States","Kenya"],"title":"Detection of Novel SARS-like and Other Coronaviruses in Bats from Kenya"},{"arc":[[51.9100685119629,4.46534013748169],[51.9100685119629,4.46534013748169]],"countries":["Netherlands"],"title":"Functional Genomics Highlights Differential Induction of Antiviral Pathways in the Lungs of SARS-CoV-Infected Macaques"},{"arc":[[51.9100685119629,4.46534013748169],[47.6565093994141,-122.312088012695]],"countries":["Netherlands","United States"],"title":"Functional Genomics Highlights Differential Induction of Antiviral Pathways in the Lungs of SARS-CoV-Infected Macaques"},{"arc":[[51.9100685119629,4.46534013748169],[27.7711906433105,-82.6387634277344]],"countries":["Netherlands","United States"],"title":"Cryptococcus gattii VGIIb-like Variant in White-Tailed Deer, Nova Scotia, Canada"},{"arc":[[51.9100685119629,4.46534013748169],[-27.6047096252441,151.929931640625]],"countries":["Netherlands","Australia"],"title":"SARS Risk Perception, Knowledge, Precautions, and Information Sources, the Netherlands"},{"arc":[[37.7000007629395,141],[54.6906204223633,25.2698001861572]],"countries":["Japan","Lithuania"],"title":"Structural bioinformatics SKEMPI 2.0: an updated benchmark of changes in protein-protein binding energy, kinetics and thermodynamics upon mutation"},{"arc":[[40.9437103271484,40.2619209289551],[46.6430816650391,1.2641099691391]],"countries":["Turkey","France"],"title":"Public Health Emergency of International Concern (PHEIC) has Declared Twice in 2014; Polio and Ebola at the Top"},{"arc":[[-5.80592012405396,-35.2105407714844],[-23.5594444274902,-46.7238883972168]],"countries":["Brazil","NOCOUNTRY"],"title":"Chloroquine Inhibits Dengue Virus Type 2 Replication in Vero Cells but Not in C6/36 Cells"},{"arc":[[-35.0198211669922,138.568862915039],[-34.9212799072266,138.603546142578]],"countries":["Australia"],"title":"Intracranial Injection of Dengue Virus Induces Interferon Stimulated Genes and CD8 + T Cell Infiltration by Sphingosine Kinase 1 Independent Pathways"},{"arc":[[-35.0198211669922,138.568862915039],[-27.6047096252441,151.929931640625]],"countries":["Australia"],"title":"Intracranial Injection of Dengue Virus Induces Interferon Stimulated Genes and CD8 + T Cell Infiltration by Sphingosine Kinase 1 Independent Pathways"},{"arc":[[-34.9212799072266,138.603546142578],[-27.6047096252441,151.929931640625]],"countries":["Australia"],"title":"Intracranial Injection of Dengue Virus Induces Interferon Stimulated Genes and CD8 + T Cell Infiltration by Sphingosine Kinase 1 Independent Pathways"},{"arc":[[50.9214782714844,6.3621997833252],[50.7775192260742,6.07814979553223]],"countries":["Germany"],"title":"The conserved macrodomains of the non-structural proteins of Chikungunya virus and other pathogenic positive strand RNA viruses function as mono-ADP- ribosylhydrolases OPEN"},{"arc":[[38.0572509765625,-97.9326782226562],[39.527660369873,-119.813529968262]],"countries":["United States"],"title":"Transgenic mice expressing tunable levels of DUX4 develop characteristic facioscapulohumeral muscular dystrophy-like pathophysiology ranging in severity Title: FSHD-like transgenic mouse models of varying severity"},{"arc":[[50.8360481262207,4.3706259727478],[50.8360481262207,4.3706259727478]],"countries":["Belgium"],"title":"The Journey of in vivo Virus Engineered Dendritic Cells From Bench to Bedside: A Bumpy Road"},{"arc":[[40.7182693481445,46.4133987426758],[38.0361785888672,-78.5016174316406]],"countries":["Azerbaijan","United States"],"title":"Clomiphene and Its Isomers Block Ebola Virus Particle Entry and Infection with Similar Potency: Potential Therapeutic Implications"},{"arc":[[31.2988891601562,121.499168395996],[54.0102615356445,-2.78708004951477]],"countries":["China","United Kingdom"],"title":"Patterns of human social contact and contact with animals in Shanghai, China"},{"arc":[[31.2988891601562,121.499168395996],[22.2802925109863,114.142951965332]],"countries":["China","Hong Kong SAR"],"title":"Patterns of human social contact and contact with animals in Shanghai, China"},{"arc":[[54.0102615356445,-2.78708004951477],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR","United Kingdom"],"title":"Patterns of human social contact and contact with animals in Shanghai, China"},{"arc":[[31.2988891601562,121.499168395996],[40.6830215454102,-76.2544097900391]],"countries":["China","United States"],"title":"High Throughput Sequencing for Detection of Foodborne Pathogens"},{"arc":[[31.2988891601562,121.499168395996],[31.0254402160645,121.436302185059]],"countries":["China"],"title":"High Throughput Sequencing for Detection of Foodborne Pathogens"},{"arc":[[31.2988891601562,121.499168395996],[51.9635810852051,7.61390018463135]],"countries":["China","Germany"],"title":"High Throughput Sequencing for Detection of Foodborne Pathogens"},{"arc":[[40.6830215454102,-76.2544097900391],[31.0254402160645,121.436302185059]],"countries":["China","United States"],"title":"High Throughput Sequencing for Detection of Foodborne Pathogens"},{"arc":[[40.6830215454102,-76.2544097900391],[51.9635810852051,7.61390018463135]],"countries":["United States","Germany"],"title":"High Throughput Sequencing for Detection of Foodborne Pathogens"},{"arc":[[31.0254402160645,121.436302185059],[51.9635810852051,7.61390018463135]],"countries":["China","Germany"],"title":"High Throughput Sequencing for Detection of Foodborne Pathogens"},{"arc":[[31.2988891601562,121.499168395996],[32.0583801269531,118.79647064209]],"countries":["China"],"title":"Is Tuberculosis Treatment Really Free in China? A Study Comparing Two Areas with Different Management Models"},{"arc":[[31.2988891601562,121.499168395996],[32.1895904541016,119.425003051758]],"countries":["China"],"title":"Is Tuberculosis Treatment Really Free in China? A Study Comparing Two Areas with Different Management Models"},{"arc":[[32.0583801269531,118.79647064209],[32.1895904541016,119.425003051758]],"countries":["China"],"title":"Is Tuberculosis Treatment Really Free in China? A Study Comparing Two Areas with Different Management Models"},{"arc":[[26.029390335083,118.138877868652],[31.0254402160645,121.436302185059]],"countries":["China"],"title":"Glucocorticosteroid in Treatment of Severe Pneumonia"},{"arc":[[26.029390335083,118.138877868652],[31.2148895263672,121.564643859863]],"countries":["China"],"title":"Glucocorticosteroid in Treatment of Severe Pneumonia"},{"arc":[[31.0254402160645,121.436302185059],[31.2148895263672,121.564643859863]],"countries":["China"],"title":"Glucocorticosteroid in Treatment of Severe Pneumonia"},{"arc":[[-22.881010055542,-43.352668762207],[40.9437103271484,40.2619209289551]],"countries":["Turkey","Brazil"],"title":",3-Diphenyl-4,5-dihydro-1H-pyrazol-5- one"},{"arc":[[45.4953117370605,15.5533599853516],[36.5042343139648,138.984161376953]],"countries":["Croatia","Japan"],"title":"The Emerging Role of Rhinoviruses in Lower Respiratory Tract Infections in Children -Clinical and Molecular Epidemiological Study From Croatia"},{"arc":[[45.4953117370605,15.5533599853516],[45.8072395324707,15.9675703048706]],"countries":["Croatia"],"title":"The Emerging Role of Rhinoviruses in Lower Respiratory Tract Infections in Children -Clinical and Molecular Epidemiological Study From Croatia"},{"arc":[[36.5042343139648,138.984161376953],[45.8072395324707,15.9675703048706]],"countries":["Croatia","Japan"],"title":"The Emerging Role of Rhinoviruses in Lower Respiratory Tract Infections in Children -Clinical and Molecular Epidemiological Study From Croatia"},{"arc":[[1.29041004180908,103.852111816406],[27.6073627471924,111.713684082031]],"countries":["China","Singapore"],"title":"A cascade reaction network mimicking the basic functional steps of acquired immune response"},{"arc":[[1.29041004180908,103.852111816406],[45.188892364502,-91.2747573852539]],"countries":["Singapore","United States"],"title":"A cascade reaction network mimicking the basic functional steps of acquired immune response"},{"arc":[[1.29041004180908,103.852111816406],[29.649730682373,-82.3411331176758]],"countries":["Singapore","United States"],"title":"A cascade reaction network mimicking the basic functional steps of acquired immune response"},{"arc":[[27.6073627471924,111.713684082031],[45.188892364502,-91.2747573852539]],"countries":["China","United States"],"title":"A cascade reaction network mimicking the basic functional steps of acquired immune response"},{"arc":[[27.6073627471924,111.713684082031],[29.649730682373,-82.3411331176758]],"countries":["China","United States"],"title":"A cascade reaction network mimicking the basic functional steps of acquired immune response"},{"arc":[[45.188892364502,-91.2747573852539],[29.649730682373,-82.3411331176758]],"countries":["United States"],"title":"A cascade reaction network mimicking the basic functional steps of acquired immune response"},{"arc":[[38.9076614379883,-77.0716094970703],[42.373161315918,-71.1181182861328]],"countries":["United States"],"title":"Toward a Common Secure Future: Four Global Commissions in the Wake of Ebola"},{"arc":[[38.9076614379883,-77.0716094970703],[51.5204315185547,-0.130309998989105]],"countries":["United States","United Kingdom"],"title":"Toward a Common Secure Future: Four Global Commissions in the Wake of Ebola"},{"arc":[[38.9076614379883,-77.0716094970703],[33.779167175293,-84.3869476318359]],"countries":["United States"],"title":"Toward a Common Secure Future: Four Global Commissions in the Wake of Ebola"},{"arc":[[38.9076614379883,-77.0716094970703],[9.5854320526123,8.09356498718262]],"countries":["United States","Nigeria"],"title":"Toward a Common Secure Future: Four Global Commissions in the Wake of Ebola"},{"arc":[[38.9076614379883,-77.0716094970703],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR","United States"],"title":"Toward a Common Secure Future: Four Global Commissions in the Wake of Ebola"},{"arc":[[42.373161315918,-71.1181182861328],[51.5204315185547,-0.130309998989105]],"countries":["United States","United Kingdom"],"title":"Toward a Common Secure Future: Four Global Commissions in the Wake of Ebola"},{"arc":[[42.373161315918,-71.1181182861328],[33.779167175293,-84.3869476318359]],"countries":["United States"],"title":"Toward a Common Secure Future: Four Global Commissions in the Wake of Ebola"},{"arc":[[42.373161315918,-71.1181182861328],[9.5854320526123,8.09356498718262]],"countries":["United States","Nigeria"],"title":"Toward a Common Secure Future: Four Global Commissions in the Wake of Ebola"},{"arc":[[42.373161315918,-71.1181182861328],[22.2802925109863,114.142951965332]],"countries":["United States","Hong Kong SAR"],"title":"Toward a Common Secure Future: Four Global Commissions in the Wake of Ebola"},{"arc":[[51.5204315185547,-0.130309998989105],[33.779167175293,-84.3869476318359]],"countries":["United Kingdom","United States"],"title":"Toward a Common Secure Future: Four Global Commissions in the Wake of Ebola"},{"arc":[[51.5204315185547,-0.130309998989105],[9.5854320526123,8.09356498718262]],"countries":["United Kingdom","Nigeria"],"title":"Toward a Common Secure Future: Four Global Commissions in the Wake of Ebola"},{"arc":[[51.5204315185547,-0.130309998989105],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR","United Kingdom"],"title":"Toward a Common Secure Future: Four Global Commissions in the Wake of Ebola"},{"arc":[[33.779167175293,-84.3869476318359],[9.5854320526123,8.09356498718262]],"countries":["United States","Nigeria"],"title":"Toward a Common Secure Future: Four Global Commissions in the Wake of Ebola"},{"arc":[[33.779167175293,-84.3869476318359],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR","United States"],"title":"Toward a Common Secure Future: Four Global Commissions in the Wake of Ebola"},{"arc":[[9.5854320526123,8.09356498718262],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR","Nigeria"],"title":"Toward a Common Secure Future: Four Global Commissions in the Wake of Ebola"},{"arc":[[36.0004425048828,-78.9623413085938],[52.2593307495117,-109.820449829102]],"countries":["United States","Canada"],"title":"Analysis of Ebola Virus Entry Into Macrophages"},{"arc":[[36.0004425048828,-78.9623413085938],[50.8101806640625,8.77422046661377]],"countries":["United States","Germany"],"title":"Analysis of Ebola Virus Entry Into Macrophages"},{"arc":[[36.0004425048828,-78.9623413085938],[50.7775192260742,6.07814979553223]],"countries":["United States","Germany"],"title":"Analysis of Ebola Virus Entry Into Macrophages"},{"arc":[[36.0004425048828,-78.9623413085938],[52.3722686767578,9.73814964294434]],"countries":["United States","Germany"],"title":"Analysis of Ebola Virus Entry Into Macrophages"},{"arc":[[52.2593307495117,-109.820449829102],[50.8101806640625,8.77422046661377]],"countries":["Canada","Germany"],"title":"Analysis of Ebola Virus Entry Into Macrophages"},{"arc":[[52.2593307495117,-109.820449829102],[50.7775192260742,6.07814979553223]],"countries":["Canada","Germany"],"title":"Analysis of Ebola Virus Entry Into Macrophages"},{"arc":[[52.2593307495117,-109.820449829102],[52.3722686767578,9.73814964294434]],"countries":["Germany","Canada"],"title":"Analysis of Ebola Virus Entry Into Macrophages"},{"arc":[[50.8101806640625,8.77422046661377],[50.8101806640625,8.77422046661377]],"countries":["Germany"],"title":"Analysis of Ebola Virus Entry Into Macrophages"},{"arc":[[50.8101806640625,8.77422046661377],[50.7775192260742,6.07814979553223]],"countries":["Germany"],"title":"Analysis of Ebola Virus Entry Into Macrophages"},{"arc":[[50.8101806640625,8.77422046661377],[52.3722686767578,9.73814964294434]],"countries":["Germany"],"title":"Analysis of Ebola Virus Entry Into Macrophages"},{"arc":[[50.7775192260742,6.07814979553223],[52.3722686767578,9.73814964294434]],"countries":["Germany"],"title":"Analysis of Ebola Virus Entry Into Macrophages"},{"arc":[[36.0004425048828,-78.9623413085938],[52.2593307495117,-109.820449829102]],"countries":["United States","Canada"],"title":"Analysis of IFITM-IFITM Interactions by a Flow Cytometry-Based FRET Assay"},{"arc":[[35.4135284423828,136.771347045898],[20.2663593292236,85.8105697631836]],"countries":["Japan","India"],"title":"Genetic and antigenic analysis of Chlamydia pecorum strains isolated from calves with diarrhea"},{"arc":[[35.4135284423828,136.771347045898],[34.1732597351074,131.47900390625]],"countries":["Japan"],"title":"Genetic and antigenic analysis of Chlamydia pecorum strains isolated from calves with diarrhea"},{"arc":[[20.2663593292236,85.8105697631836],[34.1732597351074,131.47900390625]],"countries":["India","Japan"],"title":"Genetic and antigenic analysis of Chlamydia pecorum strains isolated from calves with diarrhea"},{"arc":[[34.0983047485352,-117.269203186035],[42.373161315918,-71.1181182861328]],"countries":["United States"],"title":"Globalization and Health Antibiotic resistance as a global threat: Evidence from China, Kuwait and the United States"},{"arc":[[34.0983047485352,-117.269203186035],[29.31842,47.97301]],"countries":["United States","Kuwait"],"title":"Globalization and Health Antibiotic resistance as a global threat: Evidence from China, Kuwait and the United States"},{"arc":[[42.373161315918,-71.1181182861328],[29.31842,47.97301]],"countries":["United States","Kuwait"],"title":"Globalization and Health Antibiotic resistance as a global threat: Evidence from China, Kuwait and the United States"},{"arc":[[-27.5583305358887,153.051071166992],[-37.7035598754883,145.180358886719]],"countries":["Australia"],"title":"Role of Pentraxin 3 in Shaping Arthritogenic Alphaviral Disease: From Enhanced Viral Replication to Immunomodulation"},{"arc":[[-27.5583305358887,153.051071166992],[1.29041004180908,103.852111816406]],"countries":["Singapore","Australia"],"title":"Role of Pentraxin 3 in Shaping Arthritogenic Alphaviral Disease: From Enhanced Viral Replication to Immunomodulation"},{"arc":[[-27.5583305358887,153.051071166992],[-37.797981262207,144.959045410156]],"countries":["Australia"],"title":"Role of Pentraxin 3 in Shaping Arthritogenic Alphaviral Disease: From Enhanced Viral Replication to Immunomodulation"},{"arc":[[-37.7035598754883,145.180358886719],[1.29041004180908,103.852111816406]],"countries":["Australia","Singapore"],"title":"Role of Pentraxin 3 in Shaping Arthritogenic Alphaviral Disease: From Enhanced Viral Replication to Immunomodulation"},{"arc":[[-37.7035598754883,145.180358886719],[-37.797981262207,144.959045410156]],"countries":["Australia"],"title":"Role of Pentraxin 3 in Shaping Arthritogenic Alphaviral Disease: From Enhanced Viral Replication to Immunomodulation"},{"arc":[[1.29041004180908,103.852111816406],[-37.797981262207,144.959045410156]],"countries":["Singapore","Australia"],"title":"Role of Pentraxin 3 in Shaping Arthritogenic Alphaviral Disease: From Enhanced Viral Replication to Immunomodulation"},{"arc":[[23.2024116516113,113.38606262207],[50.837776184082,4.33750009536743]],"countries":["China","Belgium"],"title":"Supplementary Information for Crystal structure and activity-based labeling reveal the mechanisms for linkage-specific substrate recognition by deubiquitinase USP9X"},{"arc":[[23.2024116516113,113.38606262207],[40.0059814453125,116.326812744141]],"countries":["China"],"title":"Supplementary Information for Crystal structure and activity-based labeling reveal the mechanisms for linkage-specific substrate recognition by deubiquitinase USP9X"},{"arc":[[23.2024116516113,113.38606262207],[39.6668891906738,-75.7527618408203]],"countries":["China","United States"],"title":"Supplementary Information for Crystal structure and activity-based labeling reveal the mechanisms for linkage-specific substrate recognition by deubiquitinase USP9X"},{"arc":[[23.2024116516113,113.38606262207],[43.6486892700195,-79.3854370117188]],"countries":["China","Canada"],"title":"Supplementary Information for Crystal structure and activity-based labeling reveal the mechanisms for linkage-specific substrate recognition by deubiquitinase USP9X"},{"arc":[[50.837776184082,4.33750009536743],[40.0059814453125,116.326812744141]],"countries":["Belgium","China"],"title":"Supplementary Information for Crystal structure and activity-based labeling reveal the mechanisms for linkage-specific substrate recognition by deubiquitinase USP9X"},{"arc":[[50.837776184082,4.33750009536743],[39.6668891906738,-75.7527618408203]],"countries":["Belgium","United States"],"title":"Supplementary Information for Crystal structure and activity-based labeling reveal the mechanisms for linkage-specific substrate recognition by deubiquitinase USP9X"},{"arc":[[50.837776184082,4.33750009536743],[43.6486892700195,-79.3854370117188]],"countries":["Canada","Belgium"],"title":"Supplementary Information for Crystal structure and activity-based labeling reveal the mechanisms for linkage-specific substrate recognition by deubiquitinase USP9X"},{"arc":[[40.0059814453125,116.326812744141],[39.6668891906738,-75.7527618408203]],"countries":["China","United States"],"title":"Supplementary Information for Crystal structure and activity-based labeling reveal the mechanisms for linkage-specific substrate recognition by deubiquitinase USP9X"},{"arc":[[40.0059814453125,116.326812744141],[43.6486892700195,-79.3854370117188]],"countries":["Canada","China"],"title":"Supplementary Information for Crystal structure and activity-based labeling reveal the mechanisms for linkage-specific substrate recognition by deubiquitinase USP9X"},{"arc":[[39.6668891906738,-75.7527618408203],[43.6486892700195,-79.3854370117188]],"countries":["Canada","United States"],"title":"Supplementary Information for Crystal structure and activity-based labeling reveal the mechanisms for linkage-specific substrate recognition by deubiquitinase USP9X"},{"arc":[[23.1290798187256,113.264358520508],[51.1218070983887,10.4006948471069]],"countries":["Germany","China"],"title":"Spontaneous breathing during mechanical ventilation Wrigge and colleagues [4] demonstrated that spontaneous breathing with airway pressure release ventilation promotes Year in review 2005: Critical Care -Respirology: mechanical ventilation, infection, monitoring, and education"},{"arc":[[23.1290798187256,113.264358520508],[43.6486892700195,-79.3854370117188]],"countries":["China","Canada"],"title":"Spontaneous breathing during mechanical ventilation Wrigge and colleagues [4] demonstrated that spontaneous breathing with airway pressure release ventilation promotes Year in review 2005: Critical Care -Respirology: mechanical ventilation, infection, monitoring, and education"},{"arc":[[51.1218070983887,10.4006948471069],[43.6486892700195,-79.3854370117188]],"countries":["Germany","Canada"],"title":"Spontaneous breathing during mechanical ventilation Wrigge and colleagues [4] demonstrated that spontaneous breathing with airway pressure release ventilation promotes Year in review 2005: Critical Care -Respirology: mechanical ventilation, infection, monitoring, and education"},{"arc":[[22.5713901519775,88.3903274536133],[22.49587059021,88.3711624145508]],"countries":["India"],"title":"Strategies for vaccine design for corona virus using Immunoinformatics techniques"},{"arc":[[34.7286605834961,137.739303588867],[40.9437103271484,40.2619209289551]],"countries":["Turkey","Japan"],"title":"Antiviral Activity of Glycyrrhizin against Hepatitis C Virus In Vitro"},{"arc":[[34.7286605834961,137.739303588867],[35.7130813598633,139.445846557617]],"countries":["Japan"],"title":"Antiviral Activity of Glycyrrhizin against Hepatitis C Virus In Vitro"},{"arc":[[40.9437103271484,40.2619209289551],[40.9437103271484,40.2619209289551]],"countries":["Turkey"],"title":"Antiviral Activity of Glycyrrhizin against Hepatitis C Virus In Vitro"},{"arc":[[40.9437103271484,40.2619209289551],[35.7130813598633,139.445846557617]],"countries":["Turkey","Japan"],"title":"Antiviral Activity of Glycyrrhizin against Hepatitis C Virus In Vitro"},{"arc":[[45.8021583557129,126.535797119141],[36.5631141662598,103.735809326172]],"countries":["China"],"title":"Complement Receptor C5aR1 Inhibition Reduces Pyroptosis in hDPP4-Transgenic Mice Infected with MERS-CoV"},{"arc":[[42.373161315918,-71.1181182861328],[42.373161315918,-71.1181182861328]],"countries":["United States"],"title":"Quantifying the success of measles vaccination campaigns in the Rohingya refugee camps"},{"arc":[[42.373161315918,-71.1181182861328],[37.8056831359863,-122.268104553223]],"countries":["United States"],"title":"Quantifying the success of measles vaccination campaigns in the Rohingya refugee camps"},{"arc":[[42.3354797363281,-71.1043930053711],[28.6001033782959,-81.198616027832]],"countries":["United States"],"title":"A potent human neutralizing antibody Fc- dependently reduces established HBV infections"},{"arc":[[42.3354797363281,-71.1043930053711],[40.0059814453125,116.326812744141]],"countries":["United States","China"],"title":"A potent human neutralizing antibody Fc- dependently reduces established HBV infections"},{"arc":[[28.6001033782959,-81.198616027832],[40.0059814453125,116.326812744141]],"countries":["United States","China"],"title":"A potent human neutralizing antibody Fc- dependently reduces established HBV infections"},{"arc":[[42.373161315918,-71.1181182861328],[22.2802925109863,114.142951965332]],"countries":["United States","Hong Kong SAR"],"title":"Fractional Dosing of Yellow Fever Vaccine to Extend Supply: A Modeling Study"},{"arc":[[49.2629,-123.24671],[37.8056831359863,-122.268104553223]],"countries":["Canada","United States"],"title":"Specific Single or Double Proline Substitutions in the \"Spring-loaded\" Coiled-Coil Region of the Influenza Hemagglutinin Impair or Abolish Membrane Fusion Activity"},{"arc":[[49.2629,-123.24671],[38.0361785888672,-78.5016174316406]],"countries":["Canada","United States"],"title":"Specific Single or Double Proline Substitutions in the \"Spring-loaded\" Coiled-Coil Region of the Influenza Hemagglutinin Impair or Abolish Membrane Fusion Activity"},{"arc":[[37.8056831359863,-122.268104553223],[38.0361785888672,-78.5016174316406]],"countries":["United States"],"title":"Specific Single or Double Proline Substitutions in the \"Spring-loaded\" Coiled-Coil Region of the Influenza Hemagglutinin Impair or Abolish Membrane Fusion Activity"},{"arc":[[49.4181175231934,8.66556262969971],[49.9887084960938,8.23101043701172]],"countries":["Germany"],"title":"RNA Modifications Modulate Activation of Innate Toll-Like Receptors"},{"arc":[[50.8358001708984,12.9225702285767],[48.150390625,11.5805997848511]],"countries":["Germany"],"title":"EBV-gp350 Confers B-Cell Tropism to Tailored Exosomes and Is a Neo-Antigen in Normal and Malignant B Cells- A New Option for the Treatment of B-CLL"},{"arc":[[55.908260345459,-3.31926989555359],[51.5002288818359,-0.178939998149872]],"countries":["United Kingdom"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[55.908260345459,-3.31926989555359],[51.5204315185547,-0.130309998989105]],"countries":["United Kingdom"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[55.908260345459,-3.31926989555359],[44.5645294189453,-123.274147033691]],"countries":["United Kingdom","United States"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[55.908260345459,-3.31926989555359],[40.3495407104492,-74.6600875854492]],"countries":["United Kingdom","United States"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[55.908260345459,-3.31926989555359],[52.2025413513184,0.119549997150898]],"countries":["United Kingdom"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[55.908260345459,-3.31926989555359],[42.2762107849121,-83.7407531738281]],"countries":["United States","United Kingdom"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[51.5002288818359,-0.178939998149872],[51.5204315185547,-0.130309998989105]],"countries":["United Kingdom"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[51.5002288818359,-0.178939998149872],[44.5645294189453,-123.274147033691]],"countries":["United Kingdom","United States"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[51.5002288818359,-0.178939998149872],[40.3495407104492,-74.6600875854492]],"countries":["United Kingdom","United States"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[51.5002288818359,-0.178939998149872],[52.2025413513184,0.119549997150898]],"countries":["United Kingdom"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[51.5002288818359,-0.178939998149872],[42.2762107849121,-83.7407531738281]],"countries":["United States","United Kingdom"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[51.5204315185547,-0.130309998989105],[44.5645294189453,-123.274147033691]],"countries":["United Kingdom","United States"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[51.5204315185547,-0.130309998989105],[40.3495407104492,-74.6600875854492]],"countries":["United Kingdom","United States"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[51.5204315185547,-0.130309998989105],[52.2025413513184,0.119549997150898]],"countries":["United Kingdom"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[51.5204315185547,-0.130309998989105],[42.2762107849121,-83.7407531738281]],"countries":["United States","United Kingdom"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[44.5645294189453,-123.274147033691],[40.3495407104492,-74.6600875854492]],"countries":["United States"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[44.5645294189453,-123.274147033691],[52.2025413513184,0.119549997150898]],"countries":["United Kingdom","United States"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[44.5645294189453,-123.274147033691],[42.2762107849121,-83.7407531738281]],"countries":["United States"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[40.3495407104492,-74.6600875854492],[52.2025413513184,0.119549997150898]],"countries":["United Kingdom","United States"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[40.3495407104492,-74.6600875854492],[42.2762107849121,-83.7407531738281]],"countries":["United States"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[52.2025413513184,0.119549997150898],[42.2762107849121,-83.7407531738281]],"countries":["United States","United Kingdom"],"title":"A mechanistic spatio-temporal framework for modelling individual-to-individual transmission-With an application to the 2014-2015 West Africa Ebola outbreak"},{"arc":[[43.383487701416,142.571090698242],[42.9547386169434,-78.8192367553711]],"countries":["United States","Japan"],"title":"Real time detection of farm-level swine mycobacteriosis outbreak using time series modeling of the number of condemned intestines in abattoirs"},{"arc":[[43.383487701416,142.571090698242],[40.9437103271484,40.2619209289551]],"countries":["Turkey","Japan"],"title":"Effect of thermal control of dry fomites on regulating the survival of human pathogenic bacteria responsible for nosocomial infections"},{"arc":[[22.333080291748,114.191223144531],[22.333080291748,114.191223144531]],"countries":["Hong Kong SAR"],"title":"Beliefs and Knowledge about Vaccination against AH1N1pdm09 Infection and Uptake Factors among Chinese Parents"},{"arc":[[22.333080291748,114.191223144531],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR"],"title":"Detection of novel astroviruses in urban brown rats and previously known astroviruses in humans"},{"arc":[[22.333080291748,114.191223144531],[-33.9181594848633,151.228820800781]],"countries":["Hong Kong SAR","Australia"],"title":"A review of medical masks and respirators for use during an influenza pandemic"},{"arc":[[51.5227890014648,-0.136329993605614],[55.947639465332,-3.18207001686096]],"countries":["United Kingdom"],"title":"The role of host genetic factors in respiratory tract infectious diseases: systematic review, meta- analyses and field synopsis"},{"arc":[[51.5227890014648,-0.136329993605614],[55.9452209472656,-3.18803000450134]],"countries":["United Kingdom"],"title":"The role of host genetic factors in respiratory tract infectious diseases: systematic review, meta- analyses and field synopsis"},{"arc":[[55.947639465332,-3.18207001686096],[55.9452209472656,-3.18803000450134]],"countries":["United Kingdom"],"title":"The role of host genetic factors in respiratory tract infectious diseases: systematic review, meta- analyses and field synopsis"},{"arc":[[27.9197807312012,78.085693359375],[38.6370010375977,-90.2646026611328]],"countries":["India","United States"],"title":"NADPH Oxidase and Guanylate Binding Protein 5 Restrict Survival of Avirulent Type III Strains of Toxoplasma gondii in Naive Macrophages"},{"arc":[[11.0134401321411,76.9366226196289],[41.6625213623047,-91.536506652832]],"countries":["India","United States"],"title":"Porcine Deltacoronavirus Nucleocapsid Protein Suppressed IFN- Production by Interfering Porcine RIG-I dsRNA-Binding and K63-Linked Polyubiquitination"},{"arc":[[40.9437103271484,40.2619209289551],[30.6250877380371,102.697288513184]],"countries":["Turkey","China"],"title":"Isolation and Selection of Duck Primary Cells as Pathogenic and Innate Immunologic Cell Models for Duck Plague Virus"},{"arc":[[40.9437103271484,40.2619209289551],[44.9734497070312,-93.2378997802734]],"countries":["Turkey","United States"],"title":"Isolation and Selection of Duck Primary Cells as Pathogenic and Innate Immunologic Cell Models for Duck Plague Virus"},{"arc":[[30.6250877380371,102.697288513184],[44.9734497070312,-93.2378997802734]],"countries":["China","United States"],"title":"Isolation and Selection of Duck Primary Cells as Pathogenic and Innate Immunologic Cell Models for Duck Plague Virus"},{"arc":[[42.9547386169434,-78.8192367553711],[23.7489929199219,120.971282958984]],"countries":["United States","Taiwan"],"title":"Avian Influenza Risk Perception and Preventive Behavior among Traditional Market Workers and Shoppers in Taiwan: Practical Implications for Prevention"},{"arc":[[-27.4977779388428,153.012771606445],[-22.5757026672363,144.535293579102]],"countries":["Australia"],"title":"Cough-generated aerosols of Pseudomonas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis"},{"arc":[[-27.4977779388428,153.012771606445],[56.4049682617188,8.59008979797363]],"countries":["Australia","Denmark"],"title":"Cough-generated aerosols of Pseudomonas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis"},{"arc":[[-27.4977779388428,153.012771606445],[-27.3900699615479,153.023635864258]],"countries":["Australia"],"title":"Cough-generated aerosols of Pseudomonas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis"},{"arc":[[-27.4977779388428,153.012771606445],[-27.4977779388428,153.012771606445]],"countries":["Australia"],"title":"Cough-generated aerosols of Pseudomonas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis"},{"arc":[[-27.4977779388428,153.012771606445],[-33.8852996826172,151.188766479492]],"countries":["Australia"],"title":"Cough-generated aerosols of Pseudomonas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis"},{"arc":[[-22.5757026672363,144.535293579102],[56.4049682617188,8.59008979797363]],"countries":["Australia","Denmark"],"title":"Cough-generated aerosols of Pseudomonas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis"},{"arc":[[-22.5757026672363,144.535293579102],[-27.3900699615479,153.023635864258]],"countries":["Australia"],"title":"Cough-generated aerosols of Pseudomonas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis"},{"arc":[[-22.5757026672363,144.535293579102],[-27.4977779388428,153.012771606445]],"countries":["Australia"],"title":"Cough-generated aerosols of Pseudomonas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis"},{"arc":[[-22.5757026672363,144.535293579102],[-33.8852996826172,151.188766479492]],"countries":["Australia"],"title":"Cough-generated aerosols of Pseudomonas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis"},{"arc":[[56.4049682617188,8.59008979797363],[-27.3900699615479,153.023635864258]],"countries":["Denmark","Australia"],"title":"Cough-generated aerosols of Pseudomonas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis"},{"arc":[[56.4049682617188,8.59008979797363],[-27.4977779388428,153.012771606445]],"countries":["Australia","Denmark"],"title":"Cough-generated aerosols of Pseudomonas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis"},{"arc":[[56.4049682617188,8.59008979797363],[-33.8852996826172,151.188766479492]],"countries":["Australia","Denmark"],"title":"Cough-generated aerosols of Pseudomonas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis"},{"arc":[[-27.3900699615479,153.023635864258],[-27.4977779388428,153.012771606445]],"countries":["Australia"],"title":"Cough-generated aerosols of Pseudomonas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis"},{"arc":[[-27.3900699615479,153.023635864258],[-33.8852996826172,151.188766479492]],"countries":["Australia"],"title":"Cough-generated aerosols of Pseudomonas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis"},{"arc":[[51.5002288818359,-0.178939998149872],[51.5002288818359,-0.178939998149872]],"countries":["United Kingdom"],"title":"Supplementary Text: The spatial resolution of epidemic peaks"},{"arc":[[51.5002288818359,-0.178939998149872],[52.598876953125,-1.46688103675842]],"countries":["United Kingdom"],"title":"Antiviral Screening of Multiple Compounds against Ebola Virus"},{"arc":[[51.5002288818359,-0.178939998149872],[53.403148651123,-2.96319007873535]],"countries":["United Kingdom"],"title":"Antiviral Screening of Multiple Compounds against Ebola Virus"},{"arc":[[52.598876953125,-1.46688103675842],[53.403148651123,-2.96319007873535]],"countries":["United Kingdom"],"title":"Antiviral Screening of Multiple Compounds against Ebola Virus"},{"arc":[[51.5002288818359,-0.178939998149872],[40.9437103271484,40.2619209289551]],"countries":["Turkey","United Kingdom"],"title":"Biological targets for isatin and its analogues: Implications for therapy"},{"arc":[[22.9680194854736,88.5302581787109],[22.9680194854736,88.5302581787109]],"countries":["India"],"title":"Mouse Hepatitis Virus Infection Upregulates Genes Involved in Innate Immune Responses"},{"arc":[[22.9680194854736,88.5302581787109],[39.9484710693359,-75.1576614379883]],"countries":["India","United States"],"title":"Mouse Hepatitis Virus Infection Upregulates Genes Involved in Innate Immune Responses"},{"arc":[[22.9680194854736,88.5302581787109],[40.0039215087891,-105.26683807373]],"countries":["India","United States"],"title":"Mouse Hepatitis Virus Infection Upregulates Genes Involved in Innate Immune Responses"},{"arc":[[22.9680194854736,88.5302581787109],[39.9530487060547,-75.1940231323242]],"countries":["United States","India"],"title":"Mouse Hepatitis Virus Infection Upregulates Genes Involved in Innate Immune Responses"},{"arc":[[39.9484710693359,-75.1576614379883],[40.0039215087891,-105.26683807373]],"countries":["United States"],"title":"Mouse Hepatitis Virus Infection Upregulates Genes Involved in Innate Immune Responses"},{"arc":[[39.9484710693359,-75.1576614379883],[39.9530487060547,-75.1940231323242]],"countries":["United States"],"title":"Mouse Hepatitis Virus Infection Upregulates Genes Involved in Innate Immune Responses"},{"arc":[[40.0039215087891,-105.26683807373],[39.9530487060547,-75.1940231323242]],"countries":["United States"],"title":"Mouse Hepatitis Virus Infection Upregulates Genes Involved in Innate Immune Responses"},{"arc":[[41.0193405151367,-8.43128967285156],[31.2830429077148,121.502998352051]],"countries":["Portugal","China"],"title":"Predicting Interactions between Virus and Host Proteins Using Repeat Patterns and Composition of Amino Acids"},{"arc":[[53.1598205566406,45.2158508300781],[48.8571701049805,2.3413999080658]],"countries":["France","Russia"],"title":"NAR Breakthrough Article Generating genomic platforms to study Candida albicans pathogenesis"},{"arc":[[53.1598205566406,45.2158508300781],[65.3224716186523,25.3776607513428]],"countries":["Russia","Finland"],"title":"NAR Breakthrough Article Generating genomic platforms to study Candida albicans pathogenesis"},{"arc":[[53.1598205566406,45.2158508300781],[57.1647491455078,-2.10070991516113]],"countries":["Russia","United Kingdom"],"title":"NAR Breakthrough Article Generating genomic platforms to study Candida albicans pathogenesis"},{"arc":[[53.1598205566406,45.2158508300781],[50.877628326416,4.70719003677368]],"countries":["Russia","Belgium"],"title":"NAR Breakthrough Article Generating genomic platforms to study Candida albicans pathogenesis"},{"arc":[[48.8571701049805,2.3413999080658],[65.3224716186523,25.3776607513428]],"countries":["France","Finland"],"title":"NAR Breakthrough Article Generating genomic platforms to study Candida albicans pathogenesis"},{"arc":[[48.8571701049805,2.3413999080658],[57.1647491455078,-2.10070991516113]],"countries":["France","United Kingdom"],"title":"NAR Breakthrough Article Generating genomic platforms to study Candida albicans pathogenesis"},{"arc":[[48.8571701049805,2.3413999080658],[50.877628326416,4.70719003677368]],"countries":["France","Belgium"],"title":"NAR Breakthrough Article Generating genomic platforms to study Candida albicans pathogenesis"},{"arc":[[65.3224716186523,25.3776607513428],[57.1647491455078,-2.10070991516113]],"countries":["Finland","United Kingdom"],"title":"NAR Breakthrough Article Generating genomic platforms to study Candida albicans pathogenesis"},{"arc":[[65.3224716186523,25.3776607513428],[50.877628326416,4.70719003677368]],"countries":["Belgium","Finland"],"title":"NAR Breakthrough Article Generating genomic platforms to study Candida albicans pathogenesis"},{"arc":[[57.1647491455078,-2.10070991516113],[50.877628326416,4.70719003677368]],"countries":["Belgium","United Kingdom"],"title":"NAR Breakthrough Article Generating genomic platforms to study Candida albicans pathogenesis"},{"arc":[[40.7182693481445,46.4133987426758],[38.9907493591309,48.5817184448242]],"countries":["Azerbaijan"],"title":"Supplementary Information Mechanisms for lyssavirus persistence in non-synanthropic bats in Europe: insights from a modeling study"},{"arc":[[40.7182693481445,46.4133987426758],[30.7602596282959,47.6596298217773]],"countries":["Azerbaijan","Iraq"],"title":"Supplementary Information Mechanisms for lyssavirus persistence in non-synanthropic bats in Europe: insights from a modeling study"},{"arc":[[40.7182693481445,46.4133987426758],[41.3872909545898,2.16295003890991]],"countries":["Azerbaijan","Spain"],"title":"Supplementary Information Mechanisms for lyssavirus persistence in non-synanthropic bats in Europe: insights from a modeling study"},{"arc":[[38.9907493591309,48.5817184448242],[30.7602596282959,47.6596298217773]],"countries":["Iraq","Azerbaijan"],"title":"Supplementary Information Mechanisms for lyssavirus persistence in non-synanthropic bats in Europe: insights from a modeling study"},{"arc":[[38.9907493591309,48.5817184448242],[41.3872909545898,2.16295003890991]],"countries":["Azerbaijan","Spain"],"title":"Supplementary Information Mechanisms for lyssavirus persistence in non-synanthropic bats in Europe: insights from a modeling study"},{"arc":[[30.7602596282959,47.6596298217773],[41.3872909545898,2.16295003890991]],"countries":["Iraq","Spain"],"title":"Supplementary Information Mechanisms for lyssavirus persistence in non-synanthropic bats in Europe: insights from a modeling study"},{"arc":[[40.7182693481445,46.4133987426758],[22.333080291748,114.191223144531]],"countries":["Azerbaijan","Hong Kong SAR"],"title":"Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus"},{"arc":[[40.7182693481445,46.4133987426758],[22.2802925109863,114.142951965332]],"countries":["Azerbaijan","Hong Kong SAR"],"title":"Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus"},{"arc":[[22.333080291748,114.191223144531],[22.2802925109863,114.142951965332]],"countries":["Hong Kong SAR"],"title":"Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus"},{"arc":[[51.1218070983887,10.4006948471069],[46.7798385620117,-71.2695007324219]],"countries":["Germany","Canada"],"title":"Design and Validation with Influenza A Virus of an Aerosol Transmission Chamber for Ferrets"},{"arc":[[51.1218070983887,10.4006948471069],[51.1218070983887,10.4006948471069]],"countries":["Germany"],"title":"Genomic Analyses of Human European Diversity at the Southwestern Edge: Isolation, African Influence and Disease Associations in the Canary Islands"},{"arc":[[51.1218070983887,10.4006948471069],[28.4607791900635,-16.2639007568359]],"countries":["Germany","Spain"],"title":"Genomic Analyses of Human European Diversity at the Southwestern Edge: Isolation, African Influence and Disease Associations in the Canary Islands"},{"arc":[[34.0983047485352,-117.269203186035],[36.4511566162109,127.861145019531]],"countries":["South Korea","United States"],"title":"Bacterial diversity of bat guano from Cabalyorisa Cave, Mabini, Pangasinan, Philippines: A first report on the metagenome of Philippine bat guano"},{"arc":[[34.0983047485352,-117.269203186035],[15.040599822998,120.937843322754]],"countries":["United States","Philippines"],"title":"Bacterial diversity of bat guano from Cabalyorisa Cave, Mabini, Pangasinan, Philippines: A first report on the metagenome of Philippine bat guano"},{"arc":[[34.0983047485352,-117.269203186035],[14.1818799972534,121.225212097168]],"countries":["United States","Philippines"],"title":"Bacterial diversity of bat guano from Cabalyorisa Cave, Mabini, Pangasinan, Philippines: A first report on the metagenome of Philippine bat guano"},{"arc":[[36.4511566162109,127.861145019531],[15.040599822998,120.937843322754]],"countries":["South Korea","Philippines"],"title":"Bacterial diversity of bat guano from Cabalyorisa Cave, Mabini, Pangasinan, Philippines: A first report on the metagenome of Philippine bat guano"},{"arc":[[36.4511566162109,127.861145019531],[14.1818799972534,121.225212097168]],"countries":["South Korea","Philippines"],"title":"Bacterial diversity of bat guano from Cabalyorisa Cave, Mabini, Pangasinan, Philippines: A first report on the metagenome of Philippine bat guano"},{"arc":[[15.040599822998,120.937843322754],[14.1818799972534,121.225212097168]],"countries":["Philippines"],"title":"Bacterial diversity of bat guano from Cabalyorisa Cave, Mabini, Pangasinan, Philippines: A first report on the metagenome of Philippine bat guano"},{"arc":[[38.3544387817383,47.6333312988281],[51.7589988708496,-1.26400005817413]],"countries":["United Kingdom","Iran"],"title":"Stochastic dynamics of an epidemics with recurrent spillovers from an endemic reservoir"},{"arc":[[44.5259094238281,11.0393409729004],[44.9734497070312,-93.2378997802734]],"countries":["Italy","United States"],"title":"Porcine Epidemic Diarrhea Virus and Discovery of a Recombinant Swine Enteric Coronavirus, Italy Emerging Infectious Diseases Journal Podcasts"},{"arc":[[44.5259094238281,11.0393409729004],[44.5259094238281,11.0393409729004]],"countries":["Italy"],"title":"Porcine Epidemic Diarrhea Virus and Discovery of a Recombinant Swine Enteric Coronavirus, Italy Emerging Infectious Diseases Journal Podcasts"},{"arc":[[44.9734497070312,-93.2378997802734],[44.5259094238281,11.0393409729004]],"countries":["Italy","United States"],"title":"Porcine Epidemic Diarrhea Virus and Discovery of a Recombinant Swine Enteric Coronavirus, Italy Emerging Infectious Diseases Journal Podcasts"},{"arc":[[50.0608100891113,19.9325695037842],[51.4459609985352,7.26070976257324]],"countries":["Poland","Germany"],"title":"Croup Is Associated with the Novel Coronavirus NL63"},{"arc":[[50.0608100891113,19.9325695037842],[-33.8479499816895,151.028793334961]],"countries":["Poland","Australia"],"title":"Croup Is Associated with the Novel Coronavirus NL63"},{"arc":[[50.0608100891113,19.9325695037842],[52.421459197998,-1.43792998790741]],"countries":["United Kingdom","Poland"],"title":"Croup Is Associated with the Novel Coronavirus NL63"},{"arc":[[50.0608100891113,19.9325695037842],[52.3687591552734,4.89012002944946]],"countries":["Netherlands","Poland"],"title":"Croup Is Associated with the Novel Coronavirus NL63"},{"arc":[[51.4459609985352,7.26070976257324],[-33.8479499816895,151.028793334961]],"countries":["Australia","Germany"],"title":"Croup Is Associated with the Novel Coronavirus NL63"},{"arc":[[51.4459609985352,7.26070976257324],[52.421459197998,-1.43792998790741]],"countries":["United Kingdom","Germany"],"title":"Croup Is Associated with the Novel Coronavirus NL63"},{"arc":[[51.4459609985352,7.26070976257324],[52.3687591552734,4.89012002944946]],"countries":["Netherlands","Germany"],"title":"Croup Is Associated with the Novel Coronavirus NL63"},{"arc":[[-33.8479499816895,151.028793334961],[52.421459197998,-1.43792998790741]],"countries":["United Kingdom","Australia"],"title":"Croup Is Associated with the Novel Coronavirus NL63"},{"arc":[[-33.8479499816895,151.028793334961],[52.3687591552734,4.89012002944946]],"countries":["Netherlands","Australia"],"title":"Croup Is Associated with the Novel Coronavirus NL63"},{"arc":[[52.421459197998,-1.43792998790741],[52.3687591552734,4.89012002944946]],"countries":["United Kingdom","Netherlands"],"title":"Croup Is Associated with the Novel Coronavirus NL63"},{"arc":[[11.2745704650879,75.8362274169922],[39.9484710693359,-75.1576614379883]],"countries":["India","United States"],"title":"Comparison of Heterologous Prime-Boost Strategies against Human Immunodeficiency Virus Type 1 Gag Using Negative Stranded RNA Viruses"},{"arc":[[11.2745704650879,75.8362274169922],[39.4959106445312,-98.9899826049805]],"countries":["India","United States"],"title":"Comparison of Heterologous Prime-Boost Strategies against Human Immunodeficiency Virus Type 1 Gag Using Negative Stranded RNA Viruses"},{"arc":[[11.2745704650879,75.8362274169922],[42.8013381958008,-1.65971994400024]],"countries":["India","Spain"],"title":"Comparison of Heterologous Prime-Boost Strategies against Human Immunodeficiency Virus Type 1 Gag Using Negative Stranded RNA Viruses"},{"arc":[[39.9484710693359,-75.1576614379883],[39.4959106445312,-98.9899826049805]],"countries":["United States"],"title":"Comparison of Heterologous Prime-Boost Strategies against Human Immunodeficiency Virus Type 1 Gag Using Negative Stranded RNA Viruses"},{"arc":[[39.9484710693359,-75.1576614379883],[42.8013381958008,-1.65971994400024]],"countries":["United States","Spain"],"title":"Comparison of Heterologous Prime-Boost Strategies against Human Immunodeficiency Virus Type 1 Gag Using Negative Stranded RNA Viruses"},{"arc":[[39.4959106445312,-98.9899826049805],[42.8013381958008,-1.65971994400024]],"countries":["United States","Spain"],"title":"Comparison of Heterologous Prime-Boost Strategies against Human Immunodeficiency Virus Type 1 Gag Using Negative Stranded RNA Viruses"},{"arc":[[31.0254402160645,121.436302185059],[31.0254402160645,121.436302185059]],"countries":["China"],"title":"EXPERIMENTAL AND THERAPEUTIC MEDICINE Dimethyloxaloylglycine increases bone repair capacity of adipose-derived stem cells in the treatment of osteonecrosis of the femoral head"},{"arc":[[43.8378410339355,126.549438476562],[39.1381492614746,117.150108337402]],"countries":["China"],"title":"First Discovery and Stucture-Activity Relationship Study of Phenanthroquinolizidines as Novel Antiviral Agents against Tobacco Mosaic Virus (TMV)"},{"arc":[[49.9887084960938,8.23101043701172],[49.9887084960938,8.23101043701172]],"countries":["Germany"],"title":"ADAM17-dependent signaling is required for oncogenic human papillomavirus entry platform assembly"},{"arc":[[49.9887084960938,8.23101043701172],[54.28927,10.88155]],"countries":["Germany"],"title":"ADAM17-dependent signaling is required for oncogenic human papillomavirus entry platform assembly"},{"arc":[[49.9887084960938,8.23101043701172],[50.7338905334473,7.10222196578979]],"countries":["Germany"],"title":"ADAM17-dependent signaling is required for oncogenic human papillomavirus entry platform assembly"},{"arc":[[54.28927,10.88155],[50.7338905334473,7.10222196578979]],"countries":["Germany"],"title":"ADAM17-dependent signaling is required for oncogenic human papillomavirus entry platform assembly"},{"arc":[[39.2973403930664,-76.6152191162109],[38.5466918945312,-121.744567871094]],"countries":["United States"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[39.2973403930664,-76.6152191162109],[38.2007598876953,-122.447616577148]],"countries":["United States"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[39.2973403930664,-76.6152191162109],[45.5065994262695,-73.5779571533203]],"countries":["United States","Canada"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[39.2973403930664,-76.6152191162109],[6.48379993438721,2.35245990753174]],"countries":["United States","Benin"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[39.2973403930664,-76.6152191162109],[47.3191909790039,5.06463003158569]],"countries":["United States","France"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[39.2973403930664,-76.6152191162109],[-19.0004577636719,29.8718376159668]],"countries":["United States","Zimbabwe"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[38.5466918945312,-121.744567871094],[38.2007598876953,-122.447616577148]],"countries":["United States"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[38.5466918945312,-121.744567871094],[45.5065994262695,-73.5779571533203]],"countries":["United States","Canada"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[38.5466918945312,-121.744567871094],[6.48379993438721,2.35245990753174]],"countries":["United States","Benin"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[38.5466918945312,-121.744567871094],[47.3191909790039,5.06463003158569]],"countries":["United States","France"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[38.5466918945312,-121.744567871094],[-19.0004577636719,29.8718376159668]],"countries":["United States","Zimbabwe"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[38.2007598876953,-122.447616577148],[45.5065994262695,-73.5779571533203]],"countries":["United States","Canada"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[38.2007598876953,-122.447616577148],[6.48379993438721,2.35245990753174]],"countries":["United States","Benin"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[38.2007598876953,-122.447616577148],[47.3191909790039,5.06463003158569]],"countries":["United States","France"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[38.2007598876953,-122.447616577148],[-19.0004577636719,29.8718376159668]],"countries":["United States","Zimbabwe"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[45.5065994262695,-73.5779571533203],[6.48379993438721,2.35245990753174]],"countries":["Canada","Benin"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[45.5065994262695,-73.5779571533203],[47.3191909790039,5.06463003158569]],"countries":["Canada","France"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[45.5065994262695,-73.5779571533203],[-19.0004577636719,29.8718376159668]],"countries":["Canada","Zimbabwe"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[6.48379993438721,2.35245990753174],[47.3191909790039,5.06463003158569]],"countries":["France","Benin"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[6.48379993438721,2.35245990753174],[-19.0004577636719,29.8718376159668]],"countries":["Benin","Zimbabwe"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[47.3191909790039,5.06463003158569],[47.3191909790039,5.06463003158569]],"countries":["France"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[47.3191909790039,5.06463003158569],[-19.0004577636719,29.8718376159668]],"countries":["France","Zimbabwe"],"title":"Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother- To-Child Transmission"},{"arc":[[31.2481803894043,36.7880096435547],[40.9437103271484,40.2619209289551]],"countries":["Turkey","Jordan"],"title":"Presence of Infectious Bronchitis Virus Strain CK/CH/LDL/97I in the Middle East"},{"arc":[[31.5643100738525,130.557098388672],[35.6457710266113,139.746292114258]],"countries":["Japan"],"title":"Gradual Increase of High Mobility Group Protein B1 in the Lungs after the Onset of Acute Exacerbation of Idiopathic Pulmonary Fibrosis"},{"arc":[[31.5643100738525,130.557098388672],[42.9547386169434,-78.8192367553711]],"countries":["United States","Japan"],"title":"Gradual Increase of High Mobility Group Protein B1 in the Lungs after the Onset of Acute Exacerbation of Idiopathic Pulmonary Fibrosis"},{"arc":[[31.5643100738525,130.557098388672],[38.248908996582,140.889892578125]],"countries":["Japan"],"title":"Gradual Increase of High Mobility Group Protein B1 in the Lungs after the Onset of Acute Exacerbation of Idiopathic Pulmonary Fibrosis"},{"arc":[[31.5643100738525,130.557098388672],[50.8984107971191,-1.43060600757599]],"countries":["Japan","United Kingdom"],"title":"Gradual Increase of High Mobility Group Protein B1 in the Lungs after the Onset of Acute Exacerbation of Idiopathic Pulmonary Fibrosis"},{"arc":[[31.5643100738525,130.557098388672],[38.9000015258789,140.682998657227]],"countries":["Japan"],"title":"Gradual Increase of High Mobility Group Protein B1 in the Lungs after the Onset of Acute Exacerbation of Idiopathic Pulmonary Fibrosis"},{"arc":[[31.5643100738525,130.557098388672],[9.36855030059814,-83.6394882202148]],"countries":["Costa Rica","Japan"],"title":"Gradual Increase of High Mobility Group Protein B1 in the Lungs after the Onset of Acute Exacerbation of Idiopathic Pulmonary Fibrosis"},{"arc":[[35.6457710266113,139.746292114258],[42.9547386169434,-78.8192367553711]],"countries":["United States","Japan"],"title":"Gradual Increase of High Mobility Group Protein B1 in the Lungs after the Onset of Acute Exacerbation of Idiopathic Pulmonary Fibrosis"},{"arc":[[35.6457710266113,139.746292114258],[38.248908996582,140.889892578125]],"countries":["Japan"],"title":"Gradual Increase of High Mobility Group Protein B1 in the Lungs after the Onset of Acute Exacerbation of Idiopathic Pulmonary Fibrosis"},{"arc":[[35.6457710266113,139.746292114258],[50.8984107971191,-1.43060600757599]],"countries":["Japan","United Kingdom"],"title":"Gradual Increase of High Mobility Group Protein B1 in the Lungs after the Onset of Acute Exacerbation of Idiopathic Pulmonary Fibrosis"},{"arc":[[35.6457710266113,139.746292114258],[38.9000015258789,140.682998657227]],"countries":["Japan"],"title":"Gradual Increase of High Mobility Group Protein B1 in the Lungs after the Onset of Acute Exacerbation of Idiopathic Pulmonary Fibrosis"},{"arc":[[35.6457710266113,139.746292114258],[9.36855030059814,-83.6394882202148]],"countries":["Costa Rica","Japan"],"title":"Gradual Increase of High Mobility Group Protein B1 in the Lungs after the Onset of Acute Exacerbation of Idiopathic Pulmonary Fibrosis"},{"arc":[[42.9547386169434,-78.8192367553711],[38.248908996582,140.889892578125]],"countries":["United States","Japan"],"title":"Gradual Increase of High Mobility Group Protein B1 in the Lungs after the Onset of Acute Exacerbation of Idiopathic Pulmonary Fibrosis"},{"arc":[[42.9547386169434,-78.8192367553711],[50.8984107971191,-1.43060600757599]],"countries":["United States","United Kingdom"],"title":"Gradual Increase of High Mobility Group Protein B1 in the Lungs after the Onset of Acute Exacerbation of Idiopathic Pulmonary Fibrosis"},{"arc":[[42.9547386169434,-78.8192367553711],[38.9000015258789,140.682998657227]],"countries":["United States","Japan"],"title":"Gradual Increase of High Mobility Group Protein B1 in the Lungs after the Onset of Acute Exacerbation of Idiopathic Pulmonary Fibrosis"},{"arc":[[42.9547386169434,-78.8192367553711],[9.36855030059814,-83.6394882202148]],"countries":["United States","Costa Rica"],"title":"Gradual Increase of High Mobility Group Protein B1 in the Lungs after the Onset of Acute Exacerbation of Idiopathic Pulmonary Fibrosis"},{"arc":[[38.248908996582,140.889892578125],[50.8984107971191,-1.43060600757599]],"countries":["Japan","United Kingdom"],"title":"Gradual Increase of High Mobility Group Protein B1 in the Lungs after the Onset of Acute Exacerbation of Idiopathic Pulmonary Fibrosis"},{"arc":[[38.248908996582,140.889892578125],[38.9000015258789,140.682998657227]],"countries":["Japan"],"title":"Gradual Increase of High Mobility Group Protein B1 in the Lungs after the Onset of Acute Exacerbation of Idiopathic Pulmonary Fibrosis"},{"arc":[[38.248908996582,140.889892578125],[9.36855030059814,-83.6394882202148]],"countries":["Costa Rica","Japan"],"title":"Gradual Increase of High Mobility Group Protein B1 in the Lungs after the Onset of Acute Exacerbation of Idiopathic Pulmonary Fibrosis"},{"arc":[[50.8984107971191,-1.43060600757599],[38.9000015258789,140.682998657227]],"countries":["United Kingdom","Japan"],"title":"Gradual Increase of High Mobility Group Protein B1 in the Lungs after the Onset of Acute Exacerbation of Idiopathic Pulmonary Fibrosis"},{"arc":[[50.8984107971191,-1.43060600757599],[9.36855030059814,-83.6394882202148]],"countries":["Costa Rica","United Kingdom"],"title":"Gradual Increase of High Mobility Group Protein B1 in the Lungs after the Onset of Acute Exacerbation of Idiopathic Pulmonary Fibrosis"},{"arc":[[38.9000015258789,140.682998657227],[38.9000015258789,140.682998657227]],"countries":["Japan"],"title":"Gradual Increase of High Mobility Group Protein B1 in the Lungs after the Onset of Acute Exacerbation of Idiopathic Pulmonary Fibrosis"},{"arc":[[38.9000015258789,140.682998657227],[9.36855030059814,-83.6394882202148]],"countries":["Costa Rica","Japan"],"title":"Gradual Increase of High Mobility Group Protein B1 in the Lungs after the Onset of Acute Exacerbation of Idiopathic Pulmonary Fibrosis"},{"arc":[[39.1860809326172,-96.5832672119141],[32.0583801269531,118.79647064209]],"countries":["China","United States"],"title":"Time-varying transmission dynamics of Novel Coronavirus Pneumonia in China At a Glance Commentary Scientific Knowledge on the Subject: Since"},{"arc":[[39.1860809326172,-96.5832672119141],[40.0059814453125,116.326812744141]],"countries":["United States","China"],"title":"Time-varying transmission dynamics of Novel Coronavirus Pneumonia in China At a Glance Commentary Scientific Knowledge on the Subject: Since"},{"arc":[[32.0583801269531,118.79647064209],[40.0059814453125,116.326812744141]],"countries":["China"],"title":"Time-varying transmission dynamics of Novel Coronavirus Pneumonia in China At a Glance Commentary Scientific Knowledge on the Subject: Since"},{"arc":[[32.9700012207031,130.679992675781],[34.9831085205078,138.392242431641]],"countries":["Japan"],"title":"molecules Computational Molecular Docking and X-ray Crystallographic Studies of Catechins in New Drug Design Strategies"},{"arc":[[32.9700012207031,130.679992675781],[38.2499389648438,140.334671020508]],"countries":["Japan"],"title":"molecules Computational Molecular Docking and X-ray Crystallographic Studies of Catechins in New Drug Design Strategies"},{"arc":[[34.9831085205078,138.392242431641],[38.2499389648438,140.334671020508]],"countries":["Japan"],"title":"molecules Computational Molecular Docking and X-ray Crystallographic Studies of Catechins in New Drug Design Strategies"},{"arc":[[59.3478507995605,18.0294704437256],[1.29718005657196,103.77774810791]],"countries":["Singapore","Sweden"],"title":"Overexpression of the nucleocapsid protein of Middle East respiratory syndrome coronavirus up-regulates CXCL10"},{"arc":[[59.3478507995605,18.0294704437256],[44.954719543457,-93.2659912109375]],"countries":["Sweden","United States"],"title":"Overexpression of the nucleocapsid protein of Middle East respiratory syndrome coronavirus up-regulates CXCL10"},{"arc":[[1.29718005657196,103.77774810791],[44.954719543457,-93.2659912109375]],"countries":["Singapore","United States"],"title":"Overexpression of the nucleocapsid protein of Middle East respiratory syndrome coronavirus up-regulates CXCL10"},{"arc":[[55.8003005981445,49.108268737793],[55.8003005981445,49.108268737793]],"countries":["Russia"],"title":"Article 747 ORIGINAL RESEARCH"},{"arc":[[39.5981788635254,-105.98900604248],[30.6127891540527,-96.339599609375]],"countries":["United States"],"title":"ANNALS OF THE NEW YORK ACADEMY OF SCIENCES From farm management to bacteriophage therapy: strategies to reduce antibiotic use in animal agriculture"},{"arc":[[39.5981788635254,-105.98900604248],[42.7923316955566,-77.3426208496094]],"countries":["United States"],"title":"ANNALS OF THE NEW YORK ACADEMY OF SCIENCES From farm management to bacteriophage therapy: strategies to reduce antibiotic use in animal agriculture"},{"arc":[[39.5981788635254,-105.98900604248],[45.3814086914062,-71.9311065673828]],"countries":["United States","Canada"],"title":"ANNALS OF THE NEW YORK ACADEMY OF SCIENCES From farm management to bacteriophage therapy: strategies to reduce antibiotic use in animal agriculture"},{"arc":[[39.5981788635254,-105.98900604248],[44.9734497070312,-93.2378997802734]],"countries":["United States"],"title":"ANNALS OF THE NEW YORK ACADEMY OF SCIENCES From farm management to bacteriophage therapy: strategies to reduce antibiotic use in animal agriculture"},{"arc":[[39.5981788635254,-105.98900604248],[43.0089416503906,-81.2617721557617]],"countries":["United States","Canada"],"title":"ANNALS OF THE NEW YORK ACADEMY OF SCIENCES From farm management to bacteriophage therapy: strategies to reduce antibiotic use in animal agriculture"},{"arc":[[30.6127891540527,-96.339599609375],[42.7923316955566,-77.3426208496094]],"countries":["United States"],"title":"ANNALS OF THE NEW YORK ACADEMY OF SCIENCES From farm management to bacteriophage therapy: strategies to reduce antibiotic use in animal agriculture"},{"arc":[[30.6127891540527,-96.339599609375],[45.3814086914062,-71.9311065673828]],"countries":["United States","Canada"],"title":"ANNALS OF THE NEW YORK ACADEMY OF SCIENCES From farm management to bacteriophage therapy: strategies to reduce antibiotic use in animal agriculture"},{"arc":[[30.6127891540527,-96.339599609375],[44.9734497070312,-93.2378997802734]],"countries":["United States"],"title":"ANNALS OF THE NEW YORK ACADEMY OF SCIENCES From farm management to bacteriophage therapy: strategies to reduce antibiotic use in animal agriculture"},{"arc":[[30.6127891540527,-96.339599609375],[43.0089416503906,-81.2617721557617]],"countries":["United States","Canada"],"title":"ANNALS OF THE NEW YORK ACADEMY OF SCIENCES From farm management to bacteriophage therapy: strategies to reduce antibiotic use in animal agriculture"},{"arc":[[42.7923316955566,-77.3426208496094],[45.3814086914062,-71.9311065673828]],"countries":["United States","Canada"],"title":"ANNALS OF THE NEW YORK ACADEMY OF SCIENCES From farm management to bacteriophage therapy: strategies to reduce antibiotic use in animal agriculture"},{"arc":[[42.7923316955566,-77.3426208496094],[44.9734497070312,-93.2378997802734]],"countries":["United States"],"title":"ANNALS OF THE NEW YORK ACADEMY OF SCIENCES From farm management to bacteriophage therapy: strategies to reduce antibiotic use in animal agriculture"},{"arc":[[42.7923316955566,-77.3426208496094],[43.0089416503906,-81.2617721557617]],"countries":["United States","Canada"],"title":"ANNALS OF THE NEW YORK ACADEMY OF SCIENCES From farm management to bacteriophage therapy: strategies to reduce antibiotic use in animal agriculture"},{"arc":[[45.3814086914062,-71.9311065673828],[44.9734497070312,-93.2378997802734]],"countries":["Canada","United States"],"title":"ANNALS OF THE NEW YORK ACADEMY OF SCIENCES From farm management to bacteriophage therapy: strategies to reduce antibiotic use in animal agriculture"},{"arc":[[45.3814086914062,-71.9311065673828],[43.0089416503906,-81.2617721557617]],"countries":["Canada"],"title":"ANNALS OF THE NEW YORK ACADEMY OF SCIENCES From farm management to bacteriophage therapy: strategies to reduce antibiotic use in animal agriculture"},{"arc":[[44.9734497070312,-93.2378997802734],[43.0089416503906,-81.2617721557617]],"countries":["Canada","United States"],"title":"ANNALS OF THE NEW YORK ACADEMY OF SCIENCES From farm management to bacteriophage therapy: strategies to reduce antibiotic use in animal agriculture"},{"arc":[[21.4919700622559,39.2515716552734],[24.7343902587891,46.6319313049316]],"countries":["Saudi Arabia"],"title":"Tropical Medicine and Infectious Disease Meningococcal Vaccine for Hajj Pilgrims: Compliance, Predictors, and Barriers"},{"arc":[[21.4919700622559,39.2515716552734],[-33.8027992248535,150.991256713867]],"countries":["Saudi Arabia","Australia"],"title":"Tropical Medicine and Infectious Disease Meningococcal Vaccine for Hajj Pilgrims: Compliance, Predictors, and Barriers"},{"arc":[[21.4919700622559,39.2515716552734],[-33.8852996826172,151.188766479492]],"countries":["Australia","Saudi Arabia"],"title":"Tropical Medicine and Infectious Disease Meningococcal Vaccine for Hajj Pilgrims: Compliance, Predictors, and Barriers"},{"arc":[[21.4919700622559,39.2515716552734],[18.2514591217041,42.4844818115234]],"countries":["Saudi Arabia"],"title":"Tropical Medicine and Infectious Disease Meningococcal Vaccine for Hajj Pilgrims: Compliance, Predictors, and Barriers"},{"arc":[[24.7343902587891,46.6319313049316],[-33.8027992248535,150.991256713867]],"countries":["Saudi Arabia","Australia"],"title":"Tropical Medicine and Infectious Disease Meningococcal Vaccine for Hajj Pilgrims: Compliance, Predictors, and Barriers"},{"arc":[[24.7343902587891,46.6319313049316],[-33.8852996826172,151.188766479492]],"countries":["Australia","Saudi Arabia"],"title":"Tropical Medicine and Infectious Disease Meningococcal Vaccine for Hajj Pilgrims: Compliance, Predictors, and Barriers"},{"arc":[[24.7343902587891,46.6319313049316],[18.2514591217041,42.4844818115234]],"countries":["Saudi Arabia"],"title":"Tropical Medicine and Infectious Disease Meningococcal Vaccine for Hajj Pilgrims: Compliance, Predictors, and Barriers"},{"arc":[[-33.8027992248535,150.991256713867],[-33.8852996826172,151.188766479492]],"countries":["Australia"],"title":"Tropical Medicine and Infectious Disease Meningococcal Vaccine for Hajj Pilgrims: Compliance, Predictors, and Barriers"},{"arc":[[-33.8027992248535,150.991256713867],[18.2514591217041,42.4844818115234]],"countries":["Australia","Saudi Arabia"],"title":"Tropical Medicine and Infectious Disease Meningococcal Vaccine for Hajj Pilgrims: Compliance, Predictors, and Barriers"},{"arc":[[-33.8852996826172,151.188766479492],[18.2514591217041,42.4844818115234]],"countries":["Australia","Saudi Arabia"],"title":"Tropical Medicine and Infectious Disease Meningococcal Vaccine for Hajj Pilgrims: Compliance, Predictors, and Barriers"},{"arc":[[24.7343902587891,46.6319313049316],[24.7343902587891,46.6319313049316]],"countries":["Saudi Arabia"],"title":"Article 9 Alangari AA (2020) Multiple Family Members With Delayed Cord Separtion and Combined Immunodeficiency With Novel Mutation in IKBKB"},{"arc":[[24.7343902587891,46.6319313049316],[40.9437103271484,40.2619209289551]],"countries":["Turkey","Saudi Arabia"],"title":"Article 9 Alangari AA (2020) Multiple Family Members With Delayed Cord Separtion and Combined Immunodeficiency With Novel Mutation in IKBKB"},{"arc":[[24.7343902587891,46.6319313049316],[40.8453598022461,14.2576427459717]],"countries":["Saudi Arabia","Italy"],"title":"Article 9 Alangari AA (2020) Multiple Family Members With Delayed Cord Separtion and Combined Immunodeficiency With Novel Mutation in IKBKB"},{"arc":[[40.9437103271484,40.2619209289551],[40.8453598022461,14.2576427459717]],"countries":["Turkey","Italy"],"title":"Article 9 Alangari AA (2020) Multiple Family Members With Delayed Cord Separtion and Combined Immunodeficiency With Novel Mutation in IKBKB"},{"arc":[[42.9547386169434,-78.8192367553711],[36.4511566162109,127.861145019531]],"countries":["United States","South Korea"],"title":"Risk Perception, Preventive Behaviors, and Vaccination Coverage in the Korean Population during the 2009- 2010 Pandemic Influenza A (H1N1): Comparison between High-Risk Group and Non-High-Risk Group"},{"arc":[[36.4511566162109,127.861145019531],[38.0390396118164,-84.5066909790039]],"countries":["South Korea","United States"],"title":"2 convergent Research center for emerging Virus infection"},{"arc":[[50.877628326416,4.70719003677368],[50.877628326416,4.70719003677368]],"countries":["Belgium"],"title":"Modular approach to customise sample preparation procedures for viral metagenomics: a reproducible protocol for virome analysis"},{"arc":[[50.877628326416,4.70719003677368],[53.9120407104492,15.1994600296021]],"countries":["Belgium","Poland"],"title":"Modular approach to customise sample preparation procedures for viral metagenomics: a reproducible protocol for virome analysis"},{"arc":[[53.9120407104492,15.1994600296021],[50.877628326416,4.70719003677368]],"countries":["Belgium","Poland"],"title":"Modular approach to customise sample preparation procedures for viral metagenomics: a reproducible protocol for virome analysis"},{"arc":[[29.31842,47.97301],[40.9437103271484,40.2619209289551]],"countries":["Turkey","Kuwait"],"title":"E- The Prevalence of Human Bocavirus, Human Coronavirus-NL63, Human Metapneumovirus, Human Polyomavirus KI and WU in Respiratory Tract Infections in Kuwait"},{"arc":[[43.8378410339355,126.549438476562],[48.6535606384277,-0.836489975452423]],"countries":["China","France"],"title":"Physiological Level Production of Antigen-Specific Human Immunoglobulin in Cloned Transchromosomic Cattle"},{"arc":[[43.8378410339355,126.549438476562],[41.7409400939941,-111.814712524414]],"countries":["China","United States"],"title":"Physiological Level Production of Antigen-Specific Human Immunoglobulin in Cloned Transchromosomic Cattle"},{"arc":[[48.6535606384277,-0.836489975452423],[41.7409400939941,-111.814712524414]],"countries":["France","United States"],"title":"Physiological Level Production of Antigen-Specific Human Immunoglobulin in Cloned Transchromosomic Cattle"},{"arc":[[54.0102615356445,-2.78708004951477],[51.4570693969727,-2.60121011734009]],"countries":["United Kingdom"],"title":"6 NIHR Health Protection Research Unit in Gastrointestinal Infections"},{"arc":[[54.0102615356445,-2.78708004951477],[53.403148651123,-2.96319007873535]],"countries":["United Kingdom"],"title":"6 NIHR Health Protection Research Unit in Gastrointestinal Infections"},{"arc":[[51.4570693969727,-2.60121011734009],[53.403148651123,-2.96319007873535]],"countries":["United Kingdom"],"title":"6 NIHR Health Protection Research Unit in Gastrointestinal Infections"},{"arc":[[52.159309387207,4.48662710189819],[52.1658325195312,4.47749996185303]],"countries":["Netherlands"],"title":"The Nature of Protein Domain Evolution: Shaping the Interaction Network"},{"arc":[[52.159309387207,4.48662710189819],[30.0160102844238,31.4056301116943]],"countries":["Netherlands","Egypt"],"title":"The Nature of Protein Domain Evolution: Shaping the Interaction Network"},{"arc":[[52.1658325195312,4.47749996185303],[30.0160102844238,31.4056301116943]],"countries":["Netherlands","Egypt"],"title":"The Nature of Protein Domain Evolution: Shaping the Interaction Network"},{"arc":[[36.6533355712891,137.981689453125],[-37.7035598754883,145.180358886719]],"countries":["Australia","Japan"],"title":"Genomic Motifs as a Novel Indicator of the Relationship between Strains Isolated from the Epidemic of Porcine Epidemic Diarrhea in 2013-2014"},{"arc":[[36.6533355712891,137.981689453125],[33.9102592468262,132.183929443359]],"countries":["Japan"],"title":"Genomic Motifs as a Novel Indicator of the Relationship between Strains Isolated from the Epidemic of Porcine Epidemic Diarrhea in 2013-2014"},{"arc":[[-37.7035598754883,145.180358886719],[33.9102592468262,132.183929443359]],"countries":["Australia","Japan"],"title":"Genomic Motifs as a Novel Indicator of the Relationship between Strains Isolated from the Epidemic of Porcine Epidemic Diarrhea in 2013-2014"},{"arc":[[30.4157905578613,-91.1773529052734],[-27.4977779388428,153.012771606445]],"countries":["Australia","United States"],"title":"Type 1 Interferons and NK Cells Limit Murine Cytomegalovirus Escape from the Lymph Node Subcapsular Sinus"},{"arc":[[49.1416664123535,2.63333296775818],[17.0776653289795,-61.7987098693848]],"countries":["Antigua and Barbuda","France"],"title":"Originalien und bersichten Disinfection of aircraft Appropriate disinfectants and standard operating procedures for highly infectious diseases"},{"arc":[[49.1416664123535,2.63333296775818],[39.9166984558105,3.08330011367798]],"countries":["France","Spain"],"title":"Originalien und bersichten Disinfection of aircraft Appropriate disinfectants and standard operating procedures for highly infectious diseases"},{"arc":[[17.0776653289795,-61.7987098693848],[39.9166984558105,3.08330011367798]],"countries":["Antigua and Barbuda","Spain"],"title":"Originalien und bersichten Disinfection of aircraft Appropriate disinfectants and standard operating procedures for highly infectious diseases"},{"arc":[[42.9547386169434,-78.8192367553711],[31.4627456665039,-99.3330459594727]],"countries":["United States"],"title":"Article 1197 1 Original research Citation: Darling TL, Sherwood LJ and Hayhurst A (2017) Intracellular Crosslinking of Filoviral Nucleoproteins with Xintrabodies Restricts Viral Packaging"},{"arc":[[44.6669807434082,-90.1736297607422],[51.5086784362793,-0.143889993429184]],"countries":["United States","United Kingdom"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[44.6669807434082,-90.1736297607422],[33.4540901184082,-88.7920227050781]],"countries":["United States"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[44.6669807434082,-90.1736297607422],[49.9682197570801,6.49822998046875]],"countries":["United States","Germany"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[44.6669807434082,-90.1736297607422],[30.6127891540527,-96.339599609375]],"countries":["United States"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[44.6669807434082,-90.1736297607422],[37.7633209228516,-122.458541870117]],"countries":["United States"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[44.6669807434082,-90.1736297607422],[29.649730682373,-82.3411331176758]],"countries":["United States"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[51.5086784362793,-0.143889993429184],[33.4540901184082,-88.7920227050781]],"countries":["United Kingdom","United States"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[51.5086784362793,-0.143889993429184],[49.9682197570801,6.49822998046875]],"countries":["United Kingdom","Germany"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[51.5086784362793,-0.143889993429184],[30.6127891540527,-96.339599609375]],"countries":["United Kingdom","United States"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[51.5086784362793,-0.143889993429184],[37.7633209228516,-122.458541870117]],"countries":["United Kingdom","United States"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[51.5086784362793,-0.143889993429184],[29.649730682373,-82.3411331176758]],"countries":["United Kingdom","United States"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[33.4540901184082,-88.7920227050781],[49.9682197570801,6.49822998046875]],"countries":["United States","Germany"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[33.4540901184082,-88.7920227050781],[30.6127891540527,-96.339599609375]],"countries":["United States"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[33.4540901184082,-88.7920227050781],[37.7633209228516,-122.458541870117]],"countries":["United States"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[33.4540901184082,-88.7920227050781],[29.649730682373,-82.3411331176758]],"countries":["United States"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[49.9682197570801,6.49822998046875],[30.6127891540527,-96.339599609375]],"countries":["Germany","United States"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[49.9682197570801,6.49822998046875],[37.7633209228516,-122.458541870117]],"countries":["Germany","United States"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[49.9682197570801,6.49822998046875],[29.649730682373,-82.3411331176758]],"countries":["Germany","United States"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[30.6127891540527,-96.339599609375],[37.7633209228516,-122.458541870117]],"countries":["United States"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[30.6127891540527,-96.339599609375],[29.649730682373,-82.3411331176758]],"countries":["United States"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[37.7633209228516,-122.458541870117],[29.649730682373,-82.3411331176758]],"countries":["United States"],"title":"Ball Python Nidovirus: a Candidate Etiologic Agent for Severe Respiratory Disease in Python regius"},{"arc":[[43.2623291015625,-79.915641784668],[38.987850189209,-76.9389038085938]],"countries":["Canada","United States"],"title":"viruses Bats and Coronaviruses"},{"arc":[[43.2623291015625,-79.915641784668],[52.1374397277832,-106.627517700195]],"countries":["Canada"],"title":"viruses Bats and Coronaviruses"},{"arc":[[38.987850189209,-76.9389038085938],[52.1374397277832,-106.627517700195]],"countries":["United States","Canada"],"title":"viruses Bats and Coronaviruses"},{"arc":[[39.1381492614746,117.150108337402],[39.1381492614746,117.150108337402]],"countries":["China"],"title":"National Natural Science Foundation of China 81273331 (to R. Xiang) and National Natural Science Foundation of China 81270774"},{"arc":[[39.1381492614746,117.150108337402],[14.3596153259277,-14.4684610366821]],"countries":["Senegal","China"],"title":"National Natural Science Foundation of China 81273331 (to R. Xiang) and National Natural Science Foundation of China 81270774"},{"arc":[[42.7294616699219,-84.4804077148438],[40.0039215087891,-105.26683807373]],"countries":["United States"],"title":"Saturation mutagenesis genome engineering of infective X174 bacteriophage via unamplified oligo pools and golden gate assembly"},{"arc":[[42.7294616699219,-84.4804077148438],[46.7281913757324,-117.006896972656]],"countries":["United States"],"title":"Saturation mutagenesis genome engineering of infective X174 bacteriophage via unamplified oligo pools and golden gate assembly"},{"arc":[[40.0039215087891,-105.26683807373],[46.7281913757324,-117.006896972656]],"countries":["United States"],"title":"Saturation mutagenesis genome engineering of infective X174 bacteriophage via unamplified oligo pools and golden gate assembly"},{"arc":[[40.9437103271484,40.2619209289551],[31.9044609069824,34.8084716796875]],"countries":["Turkey","Israel"],"title":"A systematic view on influenza induced host shutoff"},{"arc":[[-27.4965896606445,153.012985229492],[-37.797981262207,144.959045410156]],"countries":["Australia"],"title":"Direct nanopore sequencing of mRNA reveals landscape of transcript isoforms in apicomplexan parasites"},{"arc":[[-27.4965896606445,153.012985229492],[-37.7994003295898,144.957412719727]],"countries":["Australia"],"title":"Direct nanopore sequencing of mRNA reveals landscape of transcript isoforms in apicomplexan parasites"},{"arc":[[-37.797981262207,144.959045410156],[-37.7994003295898,144.957412719727]],"countries":["Australia"],"title":"Direct nanopore sequencing of mRNA reveals landscape of transcript isoforms in apicomplexan parasites"},{"arc":[[40.7900657653809,-73.9532470703125],[43.6486892700195,-79.3854370117188]],"countries":["United States","Canada"],"title":"Patient Contact Recall after SARS Exposure"},{"arc":[[32.7603302001953,129.866546630859],[34.0592918395996,134.557968139648]],"countries":["Japan"],"title":"CD4-Independent Human Immunodeficiency Virus Infection Involves Participation of Endocytosis and Cathepsin B"},{"arc":[[32.7603302001953,129.866546630859],[27.3640460968018,127.89427947998]],"countries":["Japan","NOCOUNTRY"],"title":"CD4-Independent Human Immunodeficiency Virus Infection Involves Participation of Endocytosis and Cathepsin B"},{"arc":[[34.0592918395996,134.557968139648],[27.3640460968018,127.89427947998]],"countries":["Japan","NOCOUNTRY"],"title":"CD4-Independent Human Immunodeficiency Virus Infection Involves Participation of Endocytosis and Cathepsin B"},{"arc":[[32.0583801269531,118.79647064209],[32.0561103820801,118.775001525879]],"countries":["China"],"title":"Identification and Typing of Human Enterovirus: A Genomic Barcode Approach"},{"arc":[[32.0583801269531,118.79647064209],[43.8378410339355,126.549438476562]],"countries":["China"],"title":"Identification and Typing of Human Enterovirus: A Genomic Barcode Approach"},{"arc":[[32.0583801269531,118.79647064209],[42.3402290344238,-71.0890197753906]],"countries":["China","United States"],"title":"Identification and Typing of Human Enterovirus: A Genomic Barcode Approach"},{"arc":[[32.0583801269531,118.79647064209],[30.5363693237305,114.365432739258]],"countries":["China"],"title":"Identification and Typing of Human Enterovirus: A Genomic Barcode Approach"},{"arc":[[32.0561103820801,118.775001525879],[43.8378410339355,126.549438476562]],"countries":["China"],"title":"Identification and Typing of Human Enterovirus: A Genomic Barcode Approach"},{"arc":[[32.0561103820801,118.775001525879],[42.3402290344238,-71.0890197753906]],"countries":["China","United States"],"title":"Identification and Typing of Human Enterovirus: A Genomic Barcode Approach"},{"arc":[[32.0561103820801,118.775001525879],[30.5363693237305,114.365432739258]],"countries":["China"],"title":"Identification and Typing of Human Enterovirus: A Genomic Barcode Approach"},{"arc":[[43.8378410339355,126.549438476562],[42.3402290344238,-71.0890197753906]],"countries":["China","United States"],"title":"Identification and Typing of Human Enterovirus: A Genomic Barcode Approach"},{"arc":[[43.8378410339355,126.549438476562],[30.5363693237305,114.365432739258]],"countries":["China"],"title":"Identification and Typing of Human Enterovirus: A Genomic Barcode Approach"},{"arc":[[42.3402290344238,-71.0890197753906],[30.5363693237305,114.365432739258]],"countries":["United States","China"],"title":"Identification and Typing of Human Enterovirus: A Genomic Barcode Approach"},{"arc":[[39.1381492614746,117.150108337402],[14.165060043335,121.215789794922]],"countries":["China","Philippines"],"title":"DNA segment of African Swine Fever Virus 1 first detected in hard ticks from sheep and bovine"},{"arc":[[-37.7035598754883,145.180358886719],[35.7081146240234,139.767456054688]],"countries":["Australia","Japan"],"title":"Immortalization and Characterization of Porcine Macrophages that had Been transduced with Lentiviral Vectors encoding the sV40 Large t Antigen and Porcine telomerase Reverse transcriptase"},{"arc":[[46.9460830688477,7.43722105026245],[51.7589988708496,-1.26400005817413]],"countries":["United Kingdom","Switzerland"],"title":"Evolution and Structural Organization of the C Proteins of Paramyxovirinae"},{"arc":[[30.3002605438232,108.037666320801],[23.7489929199219,120.971282958984]],"countries":["Taiwan","China"],"title":"The Infection of Chicken Tracheal Epithelial Cells with a H6N1 Avian Influenza Virus"},{"arc":[[28.7162494659424,77.2728576660156],[52.598876953125,-1.46688103675842]],"countries":["India","United Kingdom"],"title":"Challenges of the Unknown: Clinical Application of Microbial Metagenomics"},{"arc":[[28.7162494659424,77.2728576660156],[6.48379993438721,2.35245990753174]],"countries":["India","Benin"],"title":"Preliminary study on the tick population of Benin wildlife at the moment of its invasion by the Rhipicephalus microplus tick (Canestrini, 1888)"},{"arc":[[28.7162494659424,77.2728576660156],[9.35044002532959,2.61926007270813]],"countries":["India","Benin"],"title":"Preliminary study on the tick population of Benin wildlife at the moment of its invasion by the Rhipicephalus microplus tick (Canestrini, 1888)"},{"arc":[[6.48379993438721,2.35245990753174],[6.48379993438721,2.35245990753174]],"countries":["Benin"],"title":"Preliminary study on the tick population of Benin wildlife at the moment of its invasion by the Rhipicephalus microplus tick (Canestrini, 1888)"},{"arc":[[6.48379993438721,2.35245990753174],[9.35044002532959,2.61926007270813]],"countries":["Benin"],"title":"Preliminary study on the tick population of Benin wildlife at the moment of its invasion by the Rhipicephalus microplus tick (Canestrini, 1888)"},{"arc":[[40.9437103271484,40.2619209289551],[-69.1330032348633,-63.6669998168945]],"countries":["Turkey","Argentina"],"title":"Supplementary Information Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis"},{"arc":[[40.9437103271484,40.2619209289551],[40.9437103271484,40.2619209289551]],"countries":["Turkey"],"title":"Impacts of allergic airway inflammation on lung pathology in a mouse model of influenza A virus infection"},{"arc":[[40.9437103271484,40.2619209289551],[40.9437103271484,40.2619209289551]],"countries":["Turkey"],"title":"Molecular epidemiology and evolutionary histories of human coronavirus OC43 and HKU1 among patients with upper respiratory tract infections in Kuala Lumpur, Malaysia"},{"arc":[[39.0048141479492,-77.0975341796875],[39.0048141479492,-77.0975341796875]],"countries":["United States"],"title":"Lactate Dehydrogenase-Elevating Virus Induces Systemic Lymphocyte Activation via TLR7-Dependent IFNa Responses by Plasmacytoid Dendritic Cells"},{"arc":[[39.0048141479492,-77.0975341796875],[39.0048141479492,-77.0975341796875]],"countries":["United States"],"title":"A Mouse-Adapted SARS-Coronavirus Causes Disease and Mortality in BALB/c Mice"},{"arc":[[39.0048141479492,-77.0975341796875],[39.4959106445312,-98.9899826049805]],"countries":["United States"],"title":"A Mouse-Adapted SARS-Coronavirus Causes Disease and Mortality in BALB/c Mice"},{"arc":[[39.0048141479492,-77.0975341796875],[35.9053153991699,-79.0477142333984]],"countries":["United States"],"title":"A Mouse-Adapted SARS-Coronavirus Causes Disease and Mortality in BALB/c Mice"},{"arc":[[39.0048141479492,-77.0975341796875],[29.3106803894043,-94.7768173217773]],"countries":["United States"],"title":"A Mouse-Adapted SARS-Coronavirus Causes Disease and Mortality in BALB/c Mice"},{"arc":[[39.4959106445312,-98.9899826049805],[35.9053153991699,-79.0477142333984]],"countries":["United States"],"title":"A Mouse-Adapted SARS-Coronavirus Causes Disease and Mortality in BALB/c Mice"},{"arc":[[39.4959106445312,-98.9899826049805],[29.3106803894043,-94.7768173217773]],"countries":["United States"],"title":"A Mouse-Adapted SARS-Coronavirus Causes Disease and Mortality in BALB/c Mice"},{"arc":[[35.9053153991699,-79.0477142333984],[35.9053153991699,-79.0477142333984]],"countries":["United States"],"title":"A Mouse-Adapted SARS-Coronavirus Causes Disease and Mortality in BALB/c Mice"},{"arc":[[35.9053153991699,-79.0477142333984],[29.3106803894043,-94.7768173217773]],"countries":["United States"],"title":"A Mouse-Adapted SARS-Coronavirus Causes Disease and Mortality in BALB/c Mice"},{"arc":[[25.0373706817627,121.563552856445],[25.0373706817627,121.563552856445]],"countries":["Taiwan"],"title":"How to Reduce the Latent Social Risk of Disease: The Determinants of Vaccination against Rabies in Taiwan"},{"arc":[[25.0373706817627,121.563552856445],[23.7489929199219,120.971282958984]],"countries":["Taiwan"],"title":"How to Reduce the Latent Social Risk of Disease: The Determinants of Vaccination against Rabies in Taiwan"},{"arc":[[23.7489929199219,120.971282958984],[25.0119304656982,121.465621948242]],"countries":["Taiwan"],"title":"Are children less susceptible to COVID-19?"},{"arc":[[23.7489929199219,120.971282958984],[24.1632404327393,120.648208618164]],"countries":["Taiwan"],"title":"Are children less susceptible to COVID-19?"},{"arc":[[25.0119304656982,121.465621948242],[24.1632404327393,120.648208618164]],"countries":["Taiwan"],"title":"Are children less susceptible to COVID-19?"},{"arc":[[53.2772102355957,-9.06151008605957],[-33.9606513977051,18.4602298736572]],"countries":["Ireland","South Africa"],"title":"Virology Journal Evidence of HIV-1 adaptation to host HLA alleles following chimp-to-human transmission"},{"arc":[[53.2772102355957,-9.06151008605957],[-33.9339714050293,18.865119934082]],"countries":["Ireland","South Africa"],"title":"Virology Journal Evidence of HIV-1 adaptation to host HLA alleles following chimp-to-human transmission"},{"arc":[[-33.9606513977051,18.4602298736572],[-33.9339714050293,18.865119934082]],"countries":["South Africa"],"title":"Virology Journal Evidence of HIV-1 adaptation to host HLA alleles following chimp-to-human transmission"},{"arc":[[-37.7035598754883,145.180358886719],[51.1082496643066,17.0269107818604]],"countries":["Australia","Poland"],"title":"Whole genome characterisation of quail deltacoronavirus detected in Poland"},{"arc":[[55.1693992614746,-114.511054992676],[-69.1330032348633,-63.6669998168945]],"countries":["Canada","Argentina"],"title":"Supplemental Information Bioengineering and Semisynthesis of an Optimized Cyclophilin Inhibitor for Treatment of Chronic Viral Infection"},{"arc":[[55.1693992614746,-114.511054992676],[50.877628326416,4.70719003677368]],"countries":["Canada","Belgium"],"title":"Supplemental Information Bioengineering and Semisynthesis of an Optimized Cyclophilin Inhibitor for Treatment of Chronic Viral Infection"},{"arc":[[-69.1330032348633,-63.6669998168945],[50.877628326416,4.70719003677368]],"countries":["Argentina","Belgium"],"title":"Supplemental Information Bioengineering and Semisynthesis of an Optimized Cyclophilin Inhibitor for Treatment of Chronic Viral Infection"},{"arc":[[39.0048141479492,-77.0975341796875],[48.9997100830078,12.0921401977539]],"countries":["United States","Germany"],"title":"MyD88-dependent influx of monocytes and neutrophils impairs lymph node B cell responses to chikungunya virus infection via Irf5, Nos2 and Nox2"},{"arc":[[39.0048141479492,-77.0975341796875],[40.0039215087891,-105.26683807373]],"countries":["United States"],"title":"MyD88-dependent influx of monocytes and neutrophils impairs lymph node B cell responses to chikungunya virus infection via Irf5, Nos2 and Nox2"},{"arc":[[39.0048141479492,-77.0975341796875],[42.2762107849121,-83.7407531738281]],"countries":["United States"],"title":"MyD88-dependent influx of monocytes and neutrophils impairs lymph node B cell responses to chikungunya virus infection via Irf5, Nos2 and Nox2"},{"arc":[[39.0048141479492,-77.0975341796875],[38.6370010375977,-90.2646026611328]],"countries":["United States"],"title":"MyD88-dependent influx of monocytes and neutrophils impairs lymph node B cell responses to chikungunya virus infection via Irf5, Nos2 and Nox2"},{"arc":[[48.9997100830078,12.0921401977539],[40.0039215087891,-105.26683807373]],"countries":["Germany","United States"],"title":"MyD88-dependent influx of monocytes and neutrophils impairs lymph node B cell responses to chikungunya virus infection via Irf5, Nos2 and Nox2"},{"arc":[[48.9997100830078,12.0921401977539],[42.2762107849121,-83.7407531738281]],"countries":["United States","Germany"],"title":"MyD88-dependent influx of monocytes and neutrophils impairs lymph node B cell responses to chikungunya virus infection via Irf5, Nos2 and Nox2"},{"arc":[[48.9997100830078,12.0921401977539],[38.6370010375977,-90.2646026611328]],"countries":["Germany","United States"],"title":"MyD88-dependent influx of monocytes and neutrophils impairs lymph node B cell responses to chikungunya virus infection via Irf5, Nos2 and Nox2"},{"arc":[[40.0039215087891,-105.26683807373],[42.2762107849121,-83.7407531738281]],"countries":["United States"],"title":"MyD88-dependent influx of monocytes and neutrophils impairs lymph node B cell responses to chikungunya virus infection via Irf5, Nos2 and Nox2"},{"arc":[[40.0039215087891,-105.26683807373],[38.6370010375977,-90.2646026611328]],"countries":["United States"],"title":"MyD88-dependent influx of monocytes and neutrophils impairs lymph node B cell responses to chikungunya virus infection via Irf5, Nos2 and Nox2"},{"arc":[[42.2762107849121,-83.7407531738281],[38.6370010375977,-90.2646026611328]],"countries":["United States"],"title":"MyD88-dependent influx of monocytes and neutrophils impairs lymph node B cell responses to chikungunya virus infection via Irf5, Nos2 and Nox2"},{"arc":[[36.5631141662598,103.735809326172],[39.6304817199707,118.18058013916]],"countries":["China"],"title":"Expression and role of HEPIS in breast cancer"},{"arc":[[36.5631141662598,103.735809326172],[47.587085723877,14.1412858963013]],"countries":["China","Austria"],"title":"Expression and role of HEPIS in breast cancer"},{"arc":[[39.6304817199707,118.18058013916],[47.587085723877,14.1412858963013]],"countries":["Austria","China"],"title":"Expression and role of HEPIS in breast cancer"},{"arc":[[42.0617485046387,-87.6770706176758],[41.8953018188477,-87.6160507202148]],"countries":["United States"],"title":"Novel Variants of Angiotensin Converting Enzyme-2 of Shorter Molecular Size to Target the Kidney Renin Angiotensin System"},{"arc":[[48.5850410461426,7.73642015457153],[46.5425682067871,24.5580005645752]],"countries":["France","Romania"],"title":"Simulation-based Training as Perceived by Young Anesthesiology and Intensive Care Residents"},{"arc":[[45.5003509521484,-122.686950683594],[38.6365394592285,-90.2294082641602]],"countries":["United States"],"title":"BoHV-4-Based Vector Single Heterologous Antigen Delivery Protects STAT1 (-/-) Mice from Monkeypoxvirus Lethal Challenge"},{"arc":[[45.5003509521484,-122.686950683594],[25.7258,-80.2708]],"countries":["United States"],"title":"BoHV-4-Based Vector Single Heterologous Antigen Delivery Protects STAT1 (-/-) Mice from Monkeypoxvirus Lethal Challenge"},{"arc":[[38.6365394592285,-90.2294082641602],[25.7258,-80.2708]],"countries":["United States"],"title":"BoHV-4-Based Vector Single Heterologous Antigen Delivery Protects STAT1 (-/-) Mice from Monkeypoxvirus Lethal Challenge"},{"arc":[[51.7589988708496,-1.26400005817413],[-37.7035598754883,145.180358886719]],"countries":["Australia","United Kingdom"],"title":"An early report from newly established laboratory- based influenza surveillance in Lao PDR"},{"arc":[[40.7182693481445,46.4133987426758],[41.9015502929688,12.5122203826904]],"countries":["Azerbaijan","Italy"],"title":"ELM-the database of eukaryotic linear motifs"},{"arc":[[40.7182693481445,46.4133987426758],[-20.2309799194336,57.6789588928223]],"countries":["Azerbaijan","Mauritius"],"title":"ELM-the database of eukaryotic linear motifs"},{"arc":[[40.7182693481445,46.4133987426758],[51.7525901794434,-1.25320994853973]],"countries":["Azerbaijan","United Kingdom"],"title":"ELM-the database of eukaryotic linear motifs"},{"arc":[[40.7182693481445,46.4133987426758],[55.9452209472656,-3.18803000450134]],"countries":["Azerbaijan","United Kingdom"],"title":"ELM-the database of eukaryotic linear motifs"},{"arc":[[40.7182693481445,46.4133987426758],[50.9342384338379,-1.39631998538971]],"countries":["Azerbaijan","United Kingdom"],"title":"ELM-the database of eukaryotic linear motifs"},{"arc":[[41.9015502929688,12.5122203826904],[-20.2309799194336,57.6789588928223]],"countries":["Italy","Mauritius"],"title":"ELM-the database of eukaryotic linear motifs"},{"arc":[[41.9015502929688,12.5122203826904],[51.7525901794434,-1.25320994853973]],"countries":["Italy","United Kingdom"],"title":"ELM-the database of eukaryotic linear motifs"},{"arc":[[41.9015502929688,12.5122203826904],[55.9452209472656,-3.18803000450134]],"countries":["Italy","United Kingdom"],"title":"ELM-the database of eukaryotic linear motifs"},{"arc":[[41.9015502929688,12.5122203826904],[50.9342384338379,-1.39631998538971]],"countries":["Italy","United Kingdom"],"title":"ELM-the database of eukaryotic linear motifs"},{"arc":[[-20.2309799194336,57.6789588928223],[51.7525901794434,-1.25320994853973]],"countries":["Mauritius","United Kingdom"],"title":"ELM-the database of eukaryotic linear motifs"},{"arc":[[-20.2309799194336,57.6789588928223],[55.9452209472656,-3.18803000450134]],"countries":["Mauritius","United Kingdom"],"title":"ELM-the database of eukaryotic linear motifs"},{"arc":[[-20.2309799194336,57.6789588928223],[50.9342384338379,-1.39631998538971]],"countries":["Mauritius","United Kingdom"],"title":"ELM-the database of eukaryotic linear motifs"},{"arc":[[51.7525901794434,-1.25320994853973],[55.9452209472656,-3.18803000450134]],"countries":["United Kingdom"],"title":"ELM-the database of eukaryotic linear motifs"},{"arc":[[51.7525901794434,-1.25320994853973],[50.9342384338379,-1.39631998538971]],"countries":["United Kingdom"],"title":"ELM-the database of eukaryotic linear motifs"},{"arc":[[55.9452209472656,-3.18803000450134],[50.9342384338379,-1.39631998538971]],"countries":["United Kingdom"],"title":"ELM-the database of eukaryotic linear motifs"},{"arc":[[50.8101806640625,8.77422046661377],[52.08896,5.1784]],"countries":["Germany","Netherlands"],"title":"The 2 nd sialic acid-binding site of influenza A virus neuraminidase is an important determinant of the hemagglutinin- neuraminidase-receptor balance"},{"arc":[[40.3495407104492,-74.6600875854492],[51.1218070983887,10.4006948471069]],"countries":["Germany","United States"],"title":"Long-term trends in seasonality of mortality in urban Madagascar: the role of the epidemiological transition"},{"arc":[[52.598876953125,-1.46688103675842],[50.2111282348633,-5.48226022720337]],"countries":["United Kingdom"],"title":"Development and Assessment of a Diagnostic DNA Oligonucleotide Microarray for Detection and Typing of Meningitis-Associated Bacterial Species"},{"arc":[[52.598876953125,-1.46688103675842],[50.9340896606445,-1.43508005142212]],"countries":["United Kingdom"],"title":"Development and Assessment of a Diagnostic DNA Oligonucleotide Microarray for Detection and Typing of Meningitis-Associated Bacterial Species"},{"arc":[[50.2111282348633,-5.48226022720337],[50.9340896606445,-1.43508005142212]],"countries":["United Kingdom"],"title":"Development and Assessment of a Diagnostic DNA Oligonucleotide Microarray for Detection and Typing of Meningitis-Associated Bacterial Species"},{"arc":[[-34.8838005065918,138.533294677734],[52.4488296508789,-1.93190002441406]],"countries":["Australia","United Kingdom"],"title":"Cystatin D (CST5): An ultra- early inflammatory biomarker of traumatic brain injury OPEN"},{"arc":[[8.59595775604248,29.9919891357422],[49.4165115356445,8.67146015167236]],"countries":["Germany","South Sudan"],"title":"Nosocomial Epidemiology in Patients with Hematological Disorders"},{"arc":[[8.59595775604248,29.9919891357422],[49.787841796875,9.93556022644043]],"countries":["South Sudan","Germany"],"title":"Nosocomial Epidemiology in Patients with Hematological Disorders"},{"arc":[[49.4165115356445,8.67146015167236],[49.787841796875,9.93556022644043]],"countries":["Germany"],"title":"Nosocomial Epidemiology in Patients with Hematological Disorders"},{"arc":[[-37.7949981689453,144.949722290039],[-27.4939594268799,153.00617980957]],"countries":["Australia"],"title":"Genotypic diversity, circulation patterns, and co-detections among rhinoviruses in Queensland, 2001"},{"arc":[[40.7392616271973,-74.1751403808594],[-37.7035598754883,145.180358886719]],"countries":["Australia","United States"],"title":"CD81 Receptor Regions outside the Large Extracellular Loop Determine Hepatitis C Virus Entry into Hepatoma Cells"},{"arc":[[42.8768310546875,-8.54432010650635],[52.38591,-1.55807]],"countries":["Spain","United Kingdom"],"title":"Bacteremia in Children Hospitalized with Respiratory Syncytial Virus Infection"},{"arc":[[41.7278709411621,44.764778137207],[30.2783069610596,-97.7634506225586]],"countries":["Georgia","United States"],"title":"Knowledge Levels and Training Needs of Disaster Medicine among Health Professionals, Medical Students, and Local Residents in Shanghai, China"},{"arc":[[37.4599990844727,126.949996948242],[35.5382690429688,129.313323974609]],"countries":["South Korea"],"title":"Korean Society for Laboratory Medicine Practice Guidelines for the Molecular Diagnosis of Middle East Respiratory Syndrome During an Outbreak in Korea in 2015"},{"arc":[[31.2378044128418,121.373092651367],[27.9949207305908,120.69938659668]],"countries":["China"],"title":"BMC Infectious Diseases Retrospective analysis of nosocomial infections in the intensive care unit of a tertiary hospital in China during 2003 and 2007"},{"arc":[[27.9949207305908,120.69938659668],[27.9949207305908,120.69938659668]],"countries":["China"],"title":"BMC Infectious Diseases Retrospective analysis of nosocomial infections in the intensive care unit of a tertiary hospital in China during 2003 and 2007"},{"arc":[[37.5721130371094,112.295066833496],[23.3010749816895,77.4245910644531]],"countries":["China","India"],"title":"Veterinary Science pISSN 1229-845X, eISSN 1976-555X"},{"arc":[[37.5721130371094,112.295066833496],[42.2762107849121,-83.7407531738281]],"countries":["China","United States"],"title":"Veterinary Science pISSN 1229-845X, eISSN 1976-555X"},{"arc":[[23.3010749816895,77.4245910644531],[23.3010749816895,77.4245910644531]],"countries":["India"],"title":"Veterinary Science pISSN 1229-845X, eISSN 1976-555X"},{"arc":[[23.3010749816895,77.4245910644531],[42.2762107849121,-83.7407531738281]],"countries":["United States","India"],"title":"Veterinary Science pISSN 1229-845X, eISSN 1976-555X"},{"arc":[[1.29041004180908,103.852111816406],[58.3811416625977,26.7203407287598]],"countries":["Singapore","Estonia"],"title":"Is a Proviral Host Factor for Replication of Chikungunya Virus and Other Alphaviruses"},{"arc":[[41.7278709411621,44.764778137207],[30.5363693237305,114.365432739258]],"countries":["Georgia","China"],"title":"Human Enterovirus Nonstructural Protein 2C ATPase Functions as Both an RNA Helicase and ATP-Independent RNA Chaperone"},{"arc":[[-37.8073997497559,144.97380065918],[-37.797981262207,144.959045410156]],"countries":["Australia"],"title":"Virology Journal Determination of suitable housekeeping genes for normalisation of quantitative real time PCR analysis of cells infected with human immunodeficiency virus and herpes viruses"},{"arc":[[-37.8073997497559,144.97380065918],[-33.8144989013672,150.984664916992]],"countries":["Australia"],"title":"Virology Journal Determination of suitable housekeeping genes for normalisation of quantitative real time PCR analysis of cells infected with human immunodeficiency virus and herpes viruses"},{"arc":[[-37.797981262207,144.959045410156],[-33.8144989013672,150.984664916992]],"countries":["Australia"],"title":"Virology Journal Determination of suitable housekeeping genes for normalisation of quantitative real time PCR analysis of cells infected with human immunodeficiency virus and herpes viruses"},{"arc":[[14.3596153259277,-14.4684610366821],[44.9734497070312,-93.2378997802734]],"countries":["Senegal","United States"],"title":"Citation: Zebrafish TRIM25 Promotes Innate Immune Response to RGNNV Infection by Targeting 2CARD and RD Regions of RIG-I for K63-Linked Ubiquitination"},{"arc":[[51.6088218688965,-3.98343992233276],[53.403148651123,-2.96319007873535]],"countries":["United Kingdom"],"title":"Distinct spread of DNA and RNA viruses among mammals amid prominent role of domestic species"},{"arc":[[32.0805549621582,34.7900009155273],[32.1146583557129,34.8014183044434]],"countries":["Israel"],"title":"Removal of Hepatitis C Virus-Infected Cells by a Zymogenized Bacterial Toxin"},{"arc":[[-35.2755393981934,149.121124267578],[35.7868995666504,-93.9436416625977]],"countries":["United States","Australia"],"title":"Exploring a Proposed WHO Method to Determine Thresholds for Seasonal Influenza Surveillance"},{"arc":[[51.514720916748,-0.124721996486187],[43.6486892700195,-79.3854370117188]],"countries":["United Kingdom","Canada"],"title":"The human coronavirus HCoV-229E S-protein structure and receptor binding"},{"arc":[[51.514720916748,-0.124721996486187],[53.0078887939453,-70.9957275390625]],"countries":["United Kingdom","Canada"],"title":"The human coronavirus HCoV-229E S-protein structure and receptor binding"},{"arc":[[43.6486892700195,-79.3854370117188],[53.0078887939453,-70.9957275390625]],"countries":["Canada"],"title":"The human coronavirus HCoV-229E S-protein structure and receptor binding"},{"arc":[[51.300220489502,-0.645680010318756],[49.4165115356445,8.67146015167236]],"countries":["Germany","United Kingdom"],"title":"Foot-and-mouth disease virus replicates independently of phosphatidylinositol 4-phosphate and type III phosphatidylinositol 4-kinases"},{"arc":[[-36.8504104614258,174.768936157227],[-36.8499984741211,174.770004272461]],"countries":["New Zealand"],"title":"Safety of Tdap vaccine in pregnant women: an observational study"},{"arc":[[-36.8504104614258,174.768936157227],[-45.8632011413574,170.51643371582]],"countries":["New Zealand"],"title":"Safety of Tdap vaccine in pregnant women: an observational study"},{"arc":[[-36.8499984741211,174.770004272461],[-45.8632011413574,170.51643371582]],"countries":["New Zealand"],"title":"Safety of Tdap vaccine in pregnant women: an observational study"},{"arc":[[22.2802925109863,114.142951965332],[39.2523498535156,-76.709716796875]],"countries":["Hong Kong SAR","United States"],"title":"CoVDB: a comprehensive database for comparative analysis of coronavirus genes and genomes"},{"arc":[[52.9340705871582,-1.20404005050659],[-33.8852996826172,151.188766479492]],"countries":["Australia","United Kingdom"],"title":"Discovery and Prevalence of Divergent RNA Viruses in European Field Voles and Rabbits"},{"arc":[[52.9340705871582,-1.20404005050659],[52.9340705871582,-1.20404005050659]],"countries":["United Kingdom"],"title":"Discovery and Prevalence of Divergent RNA Viruses in European Field Voles and Rabbits"},{"arc":[[-33.8852996826172,151.188766479492],[52.9340705871582,-1.20404005050659]],"countries":["Australia","United Kingdom"],"title":"Discovery and Prevalence of Divergent RNA Viruses in European Field Voles and Rabbits"},{"arc":[[-33.8852996826172,151.188766479492],[-33.8852996826172,151.188766479492]],"countries":["Australia"],"title":"Discovery and Prevalence of Divergent RNA Viruses in European Field Voles and Rabbits"},{"arc":[[32.9843292236328,-96.7494430541992],[30.2633018493652,120.122261047363]],"countries":["China","United States"],"title":"The lifecycle of the Ebola virus in host cells"},{"arc":[[35.7868995666504,-93.9436416625977],[37.7633209228516,-122.458541870117]],"countries":["United States"],"title":"Systematic reviews Lessons learnt from implementation of the International Health Regulations: a systematic review"},{"arc":[[35.7868995666504,-93.9436416625977],[39.9530487060547,-75.1940231323242]],"countries":["United States"],"title":"Systematic reviews Lessons learnt from implementation of the International Health Regulations: a systematic review"},{"arc":[[35.7868995666504,-93.9436416625977],[-33.9339714050293,18.865119934082]],"countries":["United States","South Africa"],"title":"Systematic reviews Lessons learnt from implementation of the International Health Regulations: a systematic review"},{"arc":[[35.7868995666504,-93.9436416625977],[35.7868995666504,-93.9436416625977]],"countries":["United States"],"title":"Systematic reviews Lessons learnt from implementation of the International Health Regulations: a systematic review"},{"arc":[[37.7633209228516,-122.458541870117],[39.9530487060547,-75.1940231323242]],"countries":["United States"],"title":"Systematic reviews Lessons learnt from implementation of the International Health Regulations: a systematic review"},{"arc":[[37.7633209228516,-122.458541870117],[-33.9339714050293,18.865119934082]],"countries":["South Africa","United States"],"title":"Systematic reviews Lessons learnt from implementation of the International Health Regulations: a systematic review"},{"arc":[[37.7633209228516,-122.458541870117],[35.7868995666504,-93.9436416625977]],"countries":["United States"],"title":"Systematic reviews Lessons learnt from implementation of the International Health Regulations: a systematic review"},{"arc":[[39.9530487060547,-75.1940231323242],[-33.9339714050293,18.865119934082]],"countries":["United States","South Africa"],"title":"Systematic reviews Lessons learnt from implementation of the International Health Regulations: a systematic review"},{"arc":[[39.9530487060547,-75.1940231323242],[35.7868995666504,-93.9436416625977]],"countries":["United States"],"title":"Systematic reviews Lessons learnt from implementation of the International Health Regulations: a systematic review"},{"arc":[[-33.9339714050293,18.865119934082],[35.7868995666504,-93.9436416625977]],"countries":["United States","South Africa"],"title":"Systematic reviews Lessons learnt from implementation of the International Health Regulations: a systematic review"},{"arc":[[29.9353504180908,-90.123176574707],[29.9353504180908,-90.123176574707]],"countries":["United States"],"title":"Virology Journal Synergistic inhibition of human cytomegalovirus replication by interferon-alpha/beta and interferon-gamma"},{"arc":[[51.1218070983887,10.4006948471069],[40.62796,-8.65243]],"countries":["Germany","Portugal"],"title":"Snapshot of Viral Infections in Wild Carnivores Reveals Ubiquity of Parvovirus and Susceptibility of Egyptian Mongoose to Feline Panleukopenia Virus"},{"arc":[[51.1218070983887,10.4006948471069],[38.7528991699219,-9.1576099395752]],"countries":["Germany","Portugal"],"title":"Snapshot of Viral Infections in Wild Carnivores Reveals Ubiquity of Parvovirus and Susceptibility of Egyptian Mongoose to Feline Panleukopenia Virus"},{"arc":[[40.62796,-8.65243],[38.7528991699219,-9.1576099395752]],"countries":["Portugal"],"title":"Snapshot of Viral Infections in Wild Carnivores Reveals Ubiquity of Parvovirus and Susceptibility of Egyptian Mongoose to Feline Panleukopenia Virus"},{"arc":[[41.6386985778809,-0.898090004920959],[39.008129119873,-75.4674682617188]],"countries":["United States","Spain"],"title":"NOTE Reliability of clinical diagnosis and laboratory testing techniques currently used for identification of canine parvovirus enteritis in clinical settings"},{"arc":[[-23.33411,-51.21125],[-18.9082107543945,-48.264461517334]],"countries":["Brazil"],"title":"EPIDEMIOLOGICAL ASPECTS OF ASTROVIRUS AND CORONAVIRUS IN POULTS IN THE SOUTH EASTERN REGION OF BRAZIL"},{"arc":[[41.6149482727051,0.627550005912781],[33.9571990966797,-83.3740615844727]],"countries":["United States","Spain"],"title":"Key Gaps in the Knowledge of the Porcine Respiratory Reproductive Syndrome Virus (PRRSV)"},{"arc":[[48.5444183349609,12.1591682434082],[40.6412315368652,-8.65390968322754]],"countries":["Germany","Portugal"],"title":"molecules Recyclable Keggin Heteropolyacids as an Environmentally Benign Catalyst for the Synthesis of New 2-Benzoylamino-N-phenyl-benzamide Derivatives under Microwave Irradiations at Solvent-Free Conditions and the Evaluation of Biological Activity"},{"arc":[[51.8983383178711,-8.4727897644043],[40.7652282714844,-111.849472045898]],"countries":["Ireland","United States"],"title":"Stimulation of reverse transcriptase generated cDNAs with specific indels by template RNA structure: retrotransposon, dNTP balance, RT-reagent usage"},{"arc":[[46.2083282470703,6.14274978637695],[46.2083282470703,6.14274978637695]],"countries":["Switzerland"],"title":"The 2014-2015 Ebola outbreak in West Africa: Hands On"},{"arc":[[33.5059394836426,-86.799560546875],[51.4570693969727,-2.60121011734009]],"countries":["United States","United Kingdom"],"title":"Virus taxonomy: the database of the International Committee on Taxonomy of Viruses (ICTV)"},{"arc":[[33.5059394836426,-86.799560546875],[55.8721008300781,-4.28659009933472]],"countries":["United Kingdom","United States"],"title":"Virus taxonomy: the database of the International Committee on Taxonomy of Viruses (ICTV)"},{"arc":[[33.5059394836426,-86.799560546875],[51.7589988708496,-1.26400005817413]],"countries":["United Kingdom","United States"],"title":"Virus taxonomy: the database of the International Committee on Taxonomy of Viruses (ICTV)"},{"arc":[[51.4570693969727,-2.60121011734009],[55.8721008300781,-4.28659009933472]],"countries":["United Kingdom"],"title":"Virus taxonomy: the database of the International Committee on Taxonomy of Viruses (ICTV)"},{"arc":[[51.4570693969727,-2.60121011734009],[51.7589988708496,-1.26400005817413]],"countries":["United Kingdom"],"title":"Virus taxonomy: the database of the International Committee on Taxonomy of Viruses (ICTV)"},{"arc":[[55.8721008300781,-4.28659009933472],[51.7589988708496,-1.26400005817413]],"countries":["United Kingdom"],"title":"Virus taxonomy: the database of the International Committee on Taxonomy of Viruses (ICTV)"},{"arc":[[32.2318115234375,-110.955078125],[-33.9181594848633,151.228820800781]],"countries":["United States","Australia"],"title":"Acute systemic DNA damage in youth does not impair immune defense with aging"},{"arc":[[51.4570693969727,-2.60121011734009],[53.403148651123,-2.96319007873535]],"countries":["United Kingdom"],"title":"Amino acid changes in the spike protein of feline coronavirus correlate with systemic spread of virus from the intestine and not with feline infectious peritonitis"},{"arc":[[51.0766296386719,-114.13208770752],[52.9340705871582,-1.20404005050659]],"countries":["United Kingdom","Canada"],"title":"A questionnaire-based survey on the uptake and use of cattle vaccines in the UK"},{"arc":[[37.8056831359863,-122.268104553223],[42.2762107849121,-83.7407531738281]],"countries":["United States"],"title":"Listeriolysin O Is Necessary and Sufficient to Induce Autophagy during Listeria monocytogenes Infection"},{"arc":[[37.8056831359863,-122.268104553223],[38.6370010375977,-90.2646026611328]],"countries":["United States"],"title":"Listeriolysin O Is Necessary and Sufficient to Induce Autophagy during Listeria monocytogenes Infection"},{"arc":[[42.2762107849121,-83.7407531738281],[38.6370010375977,-90.2646026611328]],"countries":["United States"],"title":"Listeriolysin O Is Necessary and Sufficient to Induce Autophagy during Listeria monocytogenes Infection"},{"arc":[[33.6423301696777,-117.840255737305],[51.4414596557617,-0.947839975357056]],"countries":["United States","United Kingdom"],"title":"Severe Acute Respiratory Syndrome Coronavirus Nonstructural Proteins 3, 4, and 6 Induce Double-Membrane Vesicles"},{"arc":[[40.0039215087891,-105.26683807373],[30.2783069610596,-97.7634506225586]],"countries":["United States"],"title":"XRN1 Is a Species-SpecificVirus Restriction Factor in Yeasts"},{"arc":[[29.649730682373,-82.3411331176758],[45.4067916870117,11.8769426345825]],"countries":["United States","Italy"],"title":"A Randomized Double Blinded Placebo-Controlled Clinical Trial of a Probiotic or Metronidazole for Acute Canine Diarrhea"},{"arc":[[33.9571990966797,-83.3740615844727],[43.1265411376953,-77.6315383911133]],"countries":["United States"],"title":"Moving Forward: Recent Developments for the Ferret Biomedical Research Model"},{"arc":[[8.46434020996094,4.60087013244629],[38.987850189209,-76.9389038085938]],"countries":["Nigeria","United States"],"title":"Lay media reporting of monkeypox in Nigeria Handling editor Seye Abimbola"},{"arc":[[53.8391494750977,10.7079601287842],[51.1082496643066,17.0269107818604]],"countries":["Germany","Poland"],"title":"Substrate specificity profiling of SARS-CoV-2 M pro protease provides basis for anti-COVID-19 drug design"},{"arc":[[41.550708770752,-8.4261302947998],[43.6221504211426,7.0402398109436]],"countries":["Portugal","France"],"title":"Knock out of the BASIGIN/CD147 chaperone of lactate/H + symporters disproves its pro-tumour action via extracellular matrix metalloproteases (MMPs) induction"},{"arc":[[35.9053153991699,-79.0477142333984],[35.9053153991699,-79.0477142333984]],"countries":["United States"],"title":"MAVS-Mediated Apoptosis and Its Inhibition by Viral Proteins"},{"arc":[[35.9053153991699,-79.0477142333984],[32.8126068115234,-96.8384094238281]],"countries":["United States"],"title":"MAVS-Mediated Apoptosis and Its Inhibition by Viral Proteins"},{"arc":[[45.4094390869141,11.8717098236084],[45.4067916870117,11.8769426345825]],"countries":["Italy"],"title":"viruses Ebola Virus Entry: From Molecular Characterization to Drug Discovery"},{"arc":[[40.4406089782715,-79.953971862793],[48.8460693359375,2.35518002510071]],"countries":["France","United States"],"title":"The Reemergent 1977 H1N1 Strain and the Gain-of-Function Debate"},{"arc":[[32.8126068115234,-96.8384094238281],[32.8126068115234,-96.8384094238281]],"countries":["United States"],"title":"The IFN response in bat cells consists of canonical and non-canonical ISGs with unique temporal expression kinetics"},{"arc":[[44.6417846679688,-89.7367401123047],[44.6417846679688,-89.7367401123047]],"countries":["United States"],"title":"Interleukin 35: a key mediator of suppression and the propagation of infectious tolerance"},{"arc":[[34.3412704467773,108.939842224121],[34.3412704467773,108.939842224121]],"countries":["China"],"title":"Beware of asymptomatic transmission: Study on 2019-nCoV prevention and control measures based on extended SEIR model"}]